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One of the outstanding problems facing the
rheumatologist is that of quantitatively measuring 
* ‘ • ■ 
change in disease activity# The methods which are
currently employed generally require to be assessed
qualitatively by either the patient or the physician
and therefore possess both inter- and intra-observer
errors# In general, the criteria described by Galen
namely, tunor^dolor^rubor and calor remain the basis
for modern clinical assessment#
My first approach to the problem of quantitating
joint inflammation was to study the disappearance of
a radioisotope from the joint cavity* Radioactive
xenon (133 Xe) was selected as the most suitable
radioisotope for this purpose.* This is an inert
lipid soluble small molecular weight gas which
possesses a low emission energy and which, unlike
ionised radioisotopes such as radioactive sodium, is
not actively transported across cell membranes but
simply diffuses through tissues in accordance with
~ \  -- -  - .- > » •  r  y . .  Mfr-i'- * '■ * .v  y *. *JT ' * + * “j •*. ■' * -/> * *» ' • '/ -V- "* - '"i
simple physical laws* Over 95% of circulating 
radioactive 133 Xe is exhaled in the expired air
reducing recirculation into the monitored area*
In Chapter 2, I describe observations on thew . • ' . ' ' * '■> ' ‘ . . * S, - . .
clearance rates of 133 Xe from normal and diseased 
human knee joints. In this chapter the techniques of 
injection and of counting are described. Since the 
joint is a complex arrangement of tissues with different 
nicrovascular arrangements it was important to determine 
the tissue subserving isotope clearance. I conducted 
human studies and animal experiments which are described 
in this chapter which demonstrate that the route of 
clearance from the articular cavity is through the venule 
of the synovial membrane and not through cartilage and 
bone blood vessels. A method for constant monitoring 
of femoral flow rate is introduced which has not previous 
boon employed to my knowledge. During these experiments 
it became apparent that the clearance rate was related to 
blood flow. The relating constant was the partition 
coefficient of the isotope for synovial tissue with 
respect to blood and in vitro experiments were conducted 
to measure this. In Chapter 2 the validity of expreeei 
of clearance rates in terms of blood flow is critically 
discussed and normal canine, normal human and inflamed 
human synovial perfusion rates are presented.
Having established tho relationship between clearanc
rates and synovial perfusion, I proceeded to investigate 
the reproducibility of the technique in normal and 
diseased joints. The day to day variability, the site 
and technique of Injection, the effect of large 
injection volumes and of the presence of a knee joint . 
effusion and the influence of the age and sex of the 
subject were Gtudied and the results are recorded in 
Chapter 3.
In the course of these Gtudies it became clear 
that this technique would detect changes in synovial 
blood flow and accordingly I decided to apply the 
method to determine the nature of the innervation of 
the vascular supply to the synovial membrane. My 
initial studies were conducted in dogs and the results 
are described in Chapter b. I have been able to 
demonstrate functionally by Jhc response of the xenon 
clearance rate to the local installation of exogenous 
catecholamines the presence of both and 
adrenergic receptors in synovium. Similarly, it was 
possible to demonstrate muscarinic receptors employing 
methacholine and atropine.y In this chapter I also 
describe experiments with histamino, serotonin,
I ' ( • . * ' » * : ■
atropine and a new alpha-adrenergic blocking agent,
thymoxamlne.
I was able, during the course of the animal 
experiments, to ascertain the doee of the various 
pharmacological substances which was required to 
produce effect locally, but not systeraically, and this 
knowledge enabled me to carry out parallel studies in 
normal and diseased human joints the results of which 
are reported in Chapter 5# In addition, in this 
chapter^I describe studies on the effects of heat and 
of exercise on human synovial vasculature.
Chapter 6 describes studies on the clinical 
significance of the xenon clearance method with 
particular reference to early diagnosis of arthritis, 
to clinical evaluation of anti-inflammatory drugs and 
to synovectomy.
In an attempt to devise a more sensitive index of 
change in disease activity than was afforded by the 
133 Xe clearance technique, I decided to study the 
uptake by the joint of intravenously administered 
radioactive technetium (99 mTc) and in Chapter 7 I 
describe a new quantitative method for joint scans with 
this isotope. I also describe a simplified method for 
determining change in joint inflammation using external 
directional counting. Employing analysis of variance
and co-variance technique© in a double-blind crossover 
clinical trial of various anti-inflammatory agents, I 
have been able to demonstrate that this new simple 
isotope method compares favourably with established 
clinical methods. It is possible that this isotopic 
techniquejWhich has a high degree of reproducibility^ 
may prove to be of value in clinical trials of anti­
inflammatory compounds.
, . ■ ' • -'■ ■ ■ ■ ■ ■ 1 . . * 
Thus far in this thesis the studios described
have been dictated by a logical sequence of thought.
With the. aid of serendipity; however, a further study
was conducted which evolved from the observation that
the clearance rate of intra-articularly injected
charged particles differed from the clearance rate of
133 Xe. The results of this study are reported in the
concluding section of Chapter 7 in which the presence
of an active anion transport mechanism from the joint
cavity across the synovial cell to the synovial blood
* * c  « * • • >  ' ' .  4 V - * • f ,  ' „•**•»* .* \V  «y„ * ' *» *vessels is postulated.
CHAPTER I 
HISTORICAL
The subject of this thesis is the application 
of the clearance rate of radioactive xenon (133 Xe) 
and the uptake of intravenously administered 
radioactive technetium (99 mTc) to the study of 
the physiology, pharmacology and pathology of the 
diarthrodial joint. The work reported in the 
thesis began in 1967 and there were no previous 
reports in the literature relevant to the first and 
very few relevant to the second of these techniques. 
In general, therefore, the historical background to 
individual points is discussed in the relevant 
sections. Frequent reference is however made to 
three main topics, namely, the anatomical arrangement 
of the synovial vasculature, the "pathophysiology" 
of the joint and the "clearance model".
Accordingly, I have presented a historical account 
of the relevant aspects of these topics in this 
chapter.
Jl
A REVIEW OF THE RELEVANT ASPECTS OF THE AflATOMY. PATHOLOGY 
AND PATHOPHYPX0L03Y OF THE VASCULAR SUPPLY TO THE SYNOVIAL 
MEMBRANE Of THE HUMAN KNEE JOINT AND A REV I Elf1 OF THE BASIS 
OF RADIOISOTOPIC DETERMINATION OF BLOOD FLOW
ANATOMYj
(i) Macroscopic .
The arrangement of the vasoular supply to the epiphyslJ 
and knee Joint structures in the adult is well documented 
and complex (Scapinelli, 1968). Blood is supplied from 
the femoral artery, the profunda feraoris, the popliteal, 
the anterior and the posterior tibial arteries by their 
geniculate branches. These branches are commonly the 
descending branch of the lateral circumflex femoral, the 
medial and lateral^superior and inferior^and the middle 
geniculates, the anterior and posterior recurrent tibial 
vessels and the circumflex fibular vessels. These 
vessels combine to form a rich anastomotic network • 
consisting of a superficial and a deep component. From 
the deep network myriads of arterial twigs conduct blood to 
the synovial membrane and epiphysis. The venous drainage 
corresponds to the arterial supply contributing to the 
popliteal and femoral trunk. It is noteworthy that the 
anaetamoscs round the knee has several connections with the 
cruciate anastaraoses which links the popliteal vessels with 
the iliac vascular system. Thus the synovial membrane 
should possess an adequate blood supply in all positions
of the joint* Movement therefore should not Jeopordise 
the circulation*
(ii) Microscopic
The articular surface of the bone Is covered with 
hyaline cartilage 2 to 4 mm* in thickness. ,
Light microscopy discloses four layerss calcified 
cartilage with Haversian systems and scanty blood vessels, 
the radial zone, the transitional zone and the tangential 
zone, which borders on the joint cavity* The latter 
three zones are completely avascular* At its free edges 
this articular cartilage merges with the synovial membrane 
This membrane is composed of two distinct layers* 
Externally there is a layer of dense fibrous tissue into 
which the ligaments and muscles of the joint are inserted* 
The blood supply of this is said (Branemark, 196*9) to be 
distinct from that of the internal layer* The internal 
layer varies in composition in different areas of the 
joint. Bordering on the joint cavity specialised cells 
(synoviocytes) of two main types have been described 
(Barland et al., 1962)i Qhadially and Roy 1966): the
type 9A 9 cell possesses numerous lysosomal vacuoles and is 
probably phagocytic whereas the type 9B9 cell possesses s 
relatively larger amount of endoplasmic reticulum and is 
thought to be the site of synthesis of the hyaluronate
protein, which, together with a dialysate of plasma, 
constitutes the synovial fluid of the joint* Many cells 
are Intermediate in type and may perform both functions*
Beneath these lining cells Key (1928) describes 
three types of connective tissue, areolar, fibrous and 
adipose* In this area are displayed the synovial blood 
vessels, approximately 1 to 3 microns beneath the surfae 
(Norton and Ziff, 1969)•
"ClrculosuB VaBculoBue ArticuXi et Epjphyaeoaue’* 
(Harris lg^ )
Synovial tissue has a complicated system of 
peripheral vessels which are closely connected with the 
vasculature of the epiphysis (Davies and Edwards, 1948 i 
Kelly, 1968)* William Hunter (1743) first described 
the blood supply to the synovial membrane and called it 
"circuius artlcull vasculosus"* A period of confusion 
followed the suggestion by Heuter (1866) that the 
synovial capillaries lay naked on the surface until 
Testut (1880), Hagentorn (1882) and Hammer (1894) 
demonstrated that this was not so* Davies (1946), 
however, emphasised the point that the proximity to 
the surface which confused Heuter was of considerable 
importance in joint disease* Capillaries and venules 
can be seen lying immediately beneath the one to three
layers of synovial cells (Norton and Ziff, 1969 t 
Schumacher, 1969). Policard (1936) remarked upon the 
variation in abundance of blood supply, noting a paucity 
of vessels in ax^oneurotic areas, and he also drew 
attention to the numerous precapillary arterioles in the 
more profusely endowed areas. Davies and Edwards (1948) 
also described regional variations in vasculature. They 
note two or three vascular systems in areolar areas which 
run parallel to the synovial surface and which freely 
intercommunicate. The most superficial plexus is 
composed of arterioles and venules which give off 
capillary loops immediately under the synovial lining.
A proportionately reduced supply is noted in areas 
possessing fibrous connective tissue* Several 
investigators have noted the presence of arterio-venous 
shunts (Scapinclli, 1958 1 Bucciante, i960).
The villus vascular system comprises a central 
arteriole and venule which fails to reach the tip of tho 
villus. In fat pads and at the articular margins the 
vessels break up in a tree-like fashion with no capillary 
loop system. The ligaments and intra-articular discs 
are poorly supplied with blood vessels.
The articular margins of the joints, where synovial
tissue blends into avascular cartilage, is a site of
* i ■ ' • ,   ^ • f - . .  ‘ - • : J  I* ‘ ’* * •  k i t  ‘ j *  ^  ** *
vascular anastamoses, where the synovial vessels freely 
intercommunicate with those of the epiphysis in a
series of arcades. The blood supply to the epiphysis
* • * • -
was first clearly described by Lexer (1904) who 
recognised periosteal, diaphyseal, metaphyseal and 
epiphyseal systems. Harris (1929> 1933) stressed the . 
independence of the diaphyseal and epiphyseal blood
% ' ‘ . . v v:?’> * • . * .V ’ f ’
supply and coined the term "circulus vasculosus 
articuli et epiphyeeosus11. . Anscroff (1934) could only 
demonstrate periosteal, diaphyseal and epiphyseal 
systems and he also noted that in many cases there was 
only one femoral diaphyseal nutrient vessel. This 
vessel nearly alv/ays entered in the middle third of the 
femoral shaft. Laing (L953) also found only one 
nutrient vessel in many cases. Rogers and Gladstone 
(1950) investigated the nutrient supply to the distal 
femoral epiphysis and demonstrated osteal branches of 
genicular vcsecIs entering supracondylar, condylar and 
intercondylar groups of foramina. Much of the venous
- • jv * - I
drainage of bone would appear to leave at the bone 
ends (Steinbach et al., 1957 t Morgan, 1959 and 
Cuthbertson et ol.j 1965)* In the adult, as opposed 
to the child there is no metaphyseal plate and
the diaphyseal and epiphyseal systems communicate.
Thus it would appear that the blood supply to the
* V " • ’•-;* ^ r " f' " - ^  J- • ' ' ' A* - •' - ' ’ V,«’/ >. -■% . %-Ysynovial membrane, epiphyseal bone and intra-nrticular 
structure forms a unified system distinct from the■ i 4 *.*;• v V . • . - - ' “ ,
fibrous capsule and extra-articular structures. The 
numerous sources of supply and their voluminous 
anastamoses should ensure an adequate synovial blood 
flow in all positions of the joint. The venous systezr 
follows the arterial supply.
SUMMARY
The macroscopic and microscopic anatomy of the 
vascular supply of the synovial tissue and related 
structures is complex and many alternative sources 
of supply are available through the knee joint and 
the cruciate anastamoses. The peripheral vasculature 
of the synovium itself varies in amount and arrange­
ment according to the type of supporting connective 
tissue and numerous anastamotic connections are 
present between the epiphyseal and synovial blood 
vessels. N£> single vessel which supplies or drains 
synovial tissue alone is accessible.
Ik
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1 THE PATBOPHTSIOLOQY OF THE SYNOVIAL MEMBRANE
The pathophysiology of the synovial membrane has
been studied in the past by many workers with
conflicting results. One recurrent difficulty has been 
the lack of availability of reproducible quantitative 
techniques.
That the mechanism of removal of colloidal and 
particulate carbon was not mediated by blood flow was 
demonstrated by Key (1926), Working with acidic dyes 
Engel (1940, 1941) and Engel and Forrai (1943) showed 
that synovial permeability was selective. They also
i
demonstrated reduced blood to synovial fluid filtration 
after sympathectomy and they recorded the unexpected 
finding that synovial permeability was reduced in 
inflammation. This was not confirmed by later workers. 
Synovial permeability or "leakage" has been studiedi
by several investigators. Intravenously injected 
bacteria (Lewis and Cluff, 1936 t Bauer, Ropes andi
Waine, 1940 i Shaffer and Bennett, 1939), colloidal iron 
and trypan blue (Kling, 1938) and egg or horse serum 
protein (Bennett and Schaffer, 1939) have all been
I
joint cavity than in either aquaeous humour or 
cerebrospinal fluid* Electrolytes and glucose enter 
the synovial fluid freely (Bauer et al., 1940) and 
small proteins enter more readily than do the larger 
globulins (Hamerman and Barland, 1966 i Schur and 
Sandson, 1963)* On the other hand, employing 
iomunofluorescent techniques, the quantity of globulin 
in synovial membrane does not appear to be elevated 
(Rodman et al., 1967)# In a preliminary study, 
Schumacher (1969) has presented evidence which suggests 
that joint movement may increase synovial leakage.
The basis of the phenomenon of synovial leakage is not 
clearly understood however.
The clearance of intra-articularly administered 
phenolsulphonphthalein (P.S.P.) and phenol red from 
the animal knee joint has been studied extensively and 
in particular the effects of anti-rheumatic drugs have 
been assessed on this model. Selfter and Baeder (1954) 
and Selfter, Baeder and Begany (1949) showed reduction 
of permeability by corticosteroids and Increase in 
permeability with hyaluronidase and investigated the 
effects of endocrine ablation on this system. Other 
workers (Paul, Hodges, Knouse and Wright, 1952 i Hidalgo 
McClure, Henderson, Whitehead and Smyth, 1952) were
unable to reproduce this effect of corticosteroids on 
synovial permeability, Bertolani, Lorenzini and 
Bonati (1951)1 Bianchi (1953) and Sharp (1963) 
demonstrated the effect of drugs on the phenylsul- 
phonylphthalein clearance and Bianchi (1933) defined 
the limitations of this method of study. He noted 
that it depended upon renal function and the 
permeability of peri-articular connective tissue, 
Nakamura! Asai, Sonozaki and Nagano (1967) 
investigated the rate of phenylsulphonylphthalein 
clearance from human knee joints. They demonstrated 
that the clearance rate was influenced by physical 
activity and by local inflammation and that it could 
be decreased by external heating applied to the skin 
over the knee and by intra-articular corticosteroid 
therapy, Branemark et al., (1963^,1966) have studied 
intra-articular and skin temperature. They observed 
that the normal Joint1s response to heat was a rise is 
intra-articular temperature and the reverse was true 
when a cold pack was applied over the patellar region. 
This they termed a "positive reaction". The converse 
of this situation obtained in rheumatoid joints, a 
"negative reaction". This observation has not been
confirmed by other workers (Cosh, 1970)• Hollander 
et al,, (1949a and b; 1951 * Horvath and Hollander
1949) have studied the use of ekin and intra-articular 
temperature in the assessment of joint inflammation.
They showed a correlation with disease activity in 
rheumatoid joints and alteration of temperature with 
vasereactlve substances and heat applied to the skin 
over the Joint, They also demonstrated a parallel 
drop in joint temperature, the synovial fluid white cell 
count and the clinical status following corticosteroid 
therapy. They interpret their results to indicate 
alteration in tissue metabolism in addition to 
circulatory changes. These results were confirmed by 
Gualtleri and Lanzl (1964)*
More recently infra-red energy emmission from the 
joints has been utilised to construct two dimensional 
thermograms (Boas, 1964 t Haberman, Ehrllch and 
Levenson, 1968 : Ring and Cosh, 1968) which reflect 
blood flow, Inflammation and local tissue metabolism. 
Anecdotal evidence of correlations with disease severity 
and with therapeutic effects have been reported in 
preliminary studies, Calorimetric methods (Stewart, 
1911 t Hollander, et al. 1949* and b t 1951) have
obvious limitations as measures of blood flow. As
' . ’ - ■ . ■
Greenfield, Shepherd and Wheelan (1951) have pointed
out, it is impossible to transform heat changes into
units of. blood flow without knowing the temperature of
the blood entering and leaving the relevant segment.
Venous occlusion plethysmography was employed to 
study the normal human knee Joint by Barcroft, Bonnar 
and Edholm (1947) and by Bonney, Hughe© and Janus (1952 
The principle of the method was introduced by Brodie am 
Russell (1905). Despite supplementary techniques in­
cluding adrenaline iontophoresis and ftrapid cooling", 
Bonney et al. were unable to separate synovial blood
‘ r ~ *  n .
flow from blood flow through other superficial and deep 
knee segment structures. It appears unlikely that any 
modification of plethysmography will be able to do this, 
considering the complexity of the anatomy of the 
vascular supply to the synovium previously described 
(p. 'i >.
<*v \ • > • * t- - * ’ w * . " ? ' * ‘ * ' V * J * *!In the past few years, external counting of gamma 
emmitting radioisotopes has been employed to investigate 
the,pathophysiology of the joint. Several radio­
isotopes, including radioactive sodium (22^a or 2W
(Jacox, Johnson and Koontz, 1952 * Harris and Millard, 
1956 l Harris, Millard and Banorjee, 1958 t Davison 
and Wishan, 1958 s Scholer, Lee and Policy, 1959 i 
Laing and Kim, i960 j Harris, 1961 : Wisham and Dworec)
l»i1966), radioactive iodine I) (Verhaege and Lebeurr*
• * . V  • ' v ^  ^  * / >' -r . v4' ' A -"VS. ’ • ; ••. , *-•' ■ <v* A  *
195** s Laing and Kim, I960 jDoering and Miehlke, 1961 
Teearek and Kolar, 196ft t Scoccianti, 1966 : Hernborg, 
1968 and 1969), radioactive gold (Verhaege and Lebeurr<’* - * - % <*' * V* - ' * *•* •.»> .... . ■ W -V,• • V • .-{• . '• * ‘ - '* v> •;- " ’ '■ 2fc*v"v •195ft) and radioiodinated serum proteins (Ahlstrom,
• ' * . , ’ 2\ • . t f ’* . ‘ •
Gedda and Hedberg, 1956 * Kuipers, Francho and 
Robert, 1956 5 Rodnan and McLachlan, I960) have been 
injected intra-articularly and their subsequent clearai 
studied by external directional counting over the joinl- • . ", *. i’v ' " - ' *' • . .  -.v . •' ■ .■* . . - .-■* % r . . 2 - '" • .
Following intra-articular injection, the count
rate over the joint can be expressed as the sum of
exponential components. For the first ftO minutes
* • ■ • * .  t * V  ■ %  * • ’ \  \ .  '  * ‘ '  v  V  _ • - j  > V * .  * *
after injection clearance of all these substances is
fcommonly monoexponential (Q » Qoe ) and when the 
count rate is plotted on semilogarithmic graph paper
against time a straight line is obtained (SchOler,
. ■ * ^,* . * »
Lee and Polley, 1959 1 Hernborg, 1968 and 1969).
From this line the biological half life (Ti value, mini 
of the.isotope within the joint can be calculated.
this being simply the time taken for the original count
rate to halve. Some workers (Harris and Millard, 1956s 
Harris, Millard and Banerjee, 1958 ! Davison and 
Wisham, 1958 * Harris, 1961) employ the slope of the 
line (k) which can be expressed by the relationships
In some studies (Harris, Millard and Banerjee, 1958) 
an extremely fast clearance rate has been noted for a 
few minutes after injection. In these studies two 
lines could be fitted to the eemllogarithmlc plot of 
the results and these are therefore blexponentlal 
(Q * Qo# + Q0e The second slower component
is of the same order of magnitude as is the single 
exponential usually found. The early transient fast 
component has also been found in clearance studies In 
other tissues (Larsen, Lassen and Quaade, 1966 t Sjersen
1967) and there is some evidence to suggest that it is 
an injection artefact (Sjersen, 1967)* This question
is examined[greater detail in a later part of this 
thesis (p, t )•
The clinical results of those clearance studies sure 
remarkably uniform considering the widely different
where Cl b concentration at ti C2 o concentration at t2
A l
chemical and physical properties of the tracer 
substances employed* Clearance from Inflamed joints 
is consistently faster than from normal joints 
(Ahl8trom9 Gedda and Hedberg, 1956 t Harris9 Millard 
and Banerjee9 1958 t Davison and Wisham9 1958 I 
Scoccianti, 1966 and Hernborg, 1968)# In the reports 
in which two joints were studied the one which was more 
severely involved clinically exhibited the faster 
clearance rate (Harris, Millard and Banerjee, 1958 t 
Hernborg, 1968)* The clearance rate can be Increased 
by the external application of heat (Harris, 1961) and 
by an intra-arterlal injection of "Priscoline", an 
adrenolytic and sympatholytic agent (Davison and Wisham, 
1958)* When an inflamed joint, possessing a fast 
clearance rate is treated with intra-articular cortico­
steroid therapy, the clearance rote is reduced (Harris,
i
Millard and Banerjee, 1958 I Scholar, Lee and Polley, 
1959 * Scoccianti, 1966)* In contradiction to the fast 
clearance rates noted in inflammation is the work by 
Hernborg (1969)# He showed that the clearance rate of 
Wa131j from the osteoarthrltlc femoral head was reduced 
when compared with normal joints although the reverse wi 
true in the knee (Hernborg, 1968)* Venous engorgement 
of the femoral head has been demonstrated in
osteoarthritis (Phillips, 1966) and this may explain 
these low clearance rates*
Fast clearance rates have been recorded in 
inflammatory arthritides (Harris, Millard and Banerjee, 
1958 t Scholer, Lee and Polley, 1959 « Scoccianti, 1966) 
and also in osteoarthritis (Davison and Wisham, 1958 t 
Scoccianti, 1966 i Hernborg, 1968 and 1969)* The 
finding of Increased clearance rates in osteoarthritis 
is of particular Interest since this condition is 
commonly considered to be primarily a degenerative 
process* This question is examined in greater detail 
in a later part of this thesis (page ^s).
In another approach to the study of joint 
pathophysiology by gamma emitting radioisotopes, the 
radioisotope is Injected intravenously and a photoscan 
display system is employed to determine the local 
accumulation of radioactivity. The detector head 
moves across the joint in a scanning fashion and counts 
are recorded as dots* A map of varying concentrations 
of radioactivity is assembled, the number of dots in any 
region being proportional to its concentration of 
radioactivity* Recording may be accomplished in 
colour form for clarity. Several gamma emitting radio­
isotopes have been employed in scanning studies of human 
joints* These Include radioactive calcium ( W Ca)
(Danielsson, Dymling and Heripret, 1964 : Bauer, 1968),.-t£';V -■ . ' "• . • .* • *'•' ' < V V X„
radioactive strontium (85qr) (Bauer and Scoccianti,
4- . ’ %\ji V ■>-' * V'/ ’ ‘r , > • if' • • * ' k * t" : •1961 * Danielsson, Dymling and Heripret, 1964 :
- - - ■ •
"• V » i  t ’ * .V A  ' .* . - ; j r  « *’ / * ’ ' '*  * * ^  » ■ . *  . ,  ?-Fellander and Lindberg, 1966 : Holopainen and Rekonen, 
1966 : Kettunen and Rekonen, 1968 : Rekonen and 
Holopainen, 1968 : Lovgren, 1969 : Bauer and Smith,
1969), radioiodinated human serum albumin (Weiss,
,  V . • ■ • • ■ ■ 'Maxfield, Murison and Hidalgo, 1966 j Stasser and 
Thrift, 1968), radioiodinated human plasma fibrinogen 
(Hashimoto, Okado, Satah and Shiokawa, 1969) radio­
iodinated rabbit antibody to human fibrinogen (Jacox,
Spar, Farrer and Rubin, 1969) and radioactive technetium
. *
(99mTc) (Weiss, Maxfield, Murison and Hidalgo, 1966 1 
Alarcon-Segovia et al., 1967a and b j Green and Hays, 
1969 t McCarty, 1970a and b).
' * *>-' -** - "V"*r ’.*** '• * V*V* ’•* " *f f  • - .. , '* « v  * 1
In all of these studies uptake has been higher
V- '  • . . ‘ " - • - 1 • .' * '* ' „ ' % ’*' * J m * ' -4‘ > . * /  ’ , -V * * '* * * •' >
over inflamed than over normal joints (Holopainen and
Rekonen, 1966 : Weiss, Maxfield, Murison and Hidalgo,
1966 t Bauer, 1968 1 Green and Hays, 1969 1 Hashimoto,
Okado, Sata and Shiokawa, 1969 1 Jacox, Spar, Farrer 
and Rubin, 1969 : McCarty, 19709. This finding has
been consistently demonstrated regardless of tho
y  *• V .  1  * *. •* *  • * '  '  y  '
*r / '• •*  v f „  * p  »* '  i 1 • - v  -v  • v- . ‘ * . f * ' y: y . - <  y  - ;  * V . / . - - ;  <individual pathological diagnosis of .
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the inflamed Joint thus demonstrating the non- 
specifity of the technique* The studies with radio­
active calcium and with radioactive strontium have been 
of particular value in the study of bone disease* 
Radioactive strontium scans have been shown to be 
positive prior to the appearance of radiological 
sclerosis in the eacoiliac Joints (Lovgren, 1969)*
Thus the study of Joint pathophysiology has become 
increasingly sophisticated, particularly within the last 
few years and the methods of study are becoming more 
precise* Most of the work with radioisotopes is in 
the early stages and much work remains to be carried out 
in this field. Wo method presently available is 
applicable to the measurement of synovial blood flow 
and no attempt has yet been made to express the 
results obtained by photoscan systems quantitatively.
SUMMARY
The various methods of study which have been 
applied to the pathophysiology of the joint are 
described. These include temperature methods, 
plethysmography and the removal or accumulation of 
various radioactive or non-radioactive tracer 
substances. No method has proved entirely 
satisfactory for all purposes and, in particular, 
no method is available for the measurement of 
synovial blood flow.
REVIEW OF TOE DEVELOPMENT OF "CLEARANCE" STUDIES 
AS A MEASURE OF BLOOD FLOW
For many years a variety of indicator substances 
have been employed in the measurement of blood flow.
The first substances to be used thus were dyes which 
could be measured spectrophotoraetrically, but hydrogen, 
ascorbic acid and even heat or "coolth” have been 
employed. The development of radioactive tracer 
substances is merely an extension of the same technique 
in principle, but in practice the availability of these 
substances has greatly extended the applicability to 
blood flow measurement. This is principally due to 
their range and versatility. This subject has been 
reviewed by McQlrr (1952) and more recently by Veall 
(1968) .
The basis of the indicator method of measuring 
blood flow lies in the principle of conservation of 
material. Kety (I960) delineated the basic equations
QanQi + Qe + Qv+Qpi — --  — ---- (1)
where
Qa « amount of indicator entering the tissue in 
a given period
Q1 s amount retained in the tissue
Qv e amount leaving the tissue in venous blood
Qe n amount excreted by other routes
VI
and Qm * amount metabolised by the tissue, 
however, over a short time Interval where 
F m flow in ml./bin.
Qa(t) » C(a)t * F * ^  t -----------(a)
(l*e* arterial Inflow « arterial concentration x 
blood flow rate) and
Qv(t) • Cv(t) ♦ F . A t ---------- (3)
(i*e# venous outflow e vonous concentration x blood 
flow rate), provided that the tracer Is uniformly 
distributed* The relationship to blood flow 
measurement thus becomes obvious* In the Flck (1870) 
principle, the classical technique for the measurement 
of cardiac output, Q1 Is assumed to be negligible and 
the Inert tracer Is a&tlnietered by constant Infusion 
so that Ca remains uniform* After equilibration Cv 
becomes constant and Qe Is measured over time ^  t*
Substituting (2) and (3) In (1)
1  *  «•
where F * flow rate through the organ*
This technique measures total blood flow Including 
shunts*
The Flck principle was modified by Kety and 
Schmidt (1943) employing nitrous oxide as an Inert
tracer to measure cerebral blood flow, Qe and Qm 
are zero9 since the tracer is neither metabolised nor 
excreted and Qi (tissue uptake) is inserted in (If).
Qi cannot be measured directly so it is assumed that 
Ci (tissue concentration) is proportional to venous 
concentration after blood/tissue equilibrium is reached. 
The relating constant is the partition coefficient (A) 
which is the ratio * at equilibrium9 between the 
solubility of the tracer in tissue9 to its solubility 
in blood. For this to be valid the tracer must be 
freely diffusible in the relevant tissue. Since the 
period of measurement should cover the time it takes 
for the tissue to reach saturation! the venous 
concentration will not be constant. Thus it is 
necessary to Integrate the a~v difference over the 
entire period of measurement. Thus the formula for 
blood flow becomes?
The introduction of radioisotopes which can be 
Injected into a tissue and monitored by external counting 
has allowed modifications of these methods (Kety9 1949). 
Provided that a freely diffusible tracer is introduced 
into a single homogeneous tissue then?
-  (5)
C(t) e C(o)e~kt (6 )
where Co * Initial count rate
Ct e count rate at time 4. 
and k * clearance constant*
This equation is merely that which describes any 
monoexponential function.
Kety tested this theoretical model injecting 
of into muscle. The count rate in each case*
when plotted semilogarithmically against tlme9 yielded 
a straight llnet thus validating the theoretical model. 
The slope of the graph obtained allowed k9 the clearance 
constant, to be calculated sincet
where Cx and Cg are counts per minute at Ti and T2 
respectively and the time interval (Ts - Tl) was of 
sufficient duration to allow a reliable average slope to 
be drawn on the graph. Minor modifications (Lassen et 
al*9 1964) have been made to be mathematics but the 
method remains substantially unchanged. One 
modiflcatlont which facilitates the calculation of the 
results9 is the use of the "half-time" (Ti value - 
minutes) which can be readily obtained from the graph. 
The clearance constant (k) is related to the half time
thus
k «  (7)
(Wisham, Yalow and Freund, 1951)• A further modifi­
cation of more fundamental Importance was the 
conversion of the clearance constant to units of 
blood flow (Thorburn et al., 1963 * Lassen, 1964)*
Provided that the relevant tissue is homogeneous, 
that the tracer isotope is freely diffusible and that 
re-circulation is either minimal or accountable, the 
clearance constant is related to the •perfusion1 
(capillary blood flow) of the tissue by the expression
P a kA (Veall, 1968) ------- (8)
where P ** perfusion in ml. per ml. per minute.
k a the clearance constant 
and A a# the tissue blood partition coefficient.
This expression can be re-written ass
P b • A mlAOO ml/min. — — . (9)
Thus capillary blood flow can be determined in a 
tissue by measuring only the rate of change of tissue 
activity, in arbitrary units, and the partition 
coefficient. The terms "perfusion", "nutritive 
perfusion" and *bapillary blood flow" are employed 
synonymously to indicate that flow through non-nutritive
shunts will not be detected by this method 
(Friedman, 1968).
The most recent modification of the measurement 
of blood flow by this interstitial method is based on 
work by Ingvar and Lassen (1962) and by Hoedt- 
Rasmussen et al. (1966)* Two exponential functions 
with very different k values are obtained in 
interstitial isotoplc studies in brain. These 
workers have analysed this situation theoretically 
and concluded that the different k values may be 
related to white and grey matter respectively. Thus, 
provided there are two adjoining tissues with markedly 
different perfusion rates, blood flow values can be 
derived for each, employing this technique. This has 
now been applied to skin (Sjersen, 1967) to prostatic 
(Andersson et al., 1967) and to renal (Thorburn et al., 
1963) blood flow.
SUMMARY
The gradual development of blood flow measure­
ment by indicator techniques is delineated. With 
each modification of the standard equation, which 
is based on the principle of conservation of 
material, the applicability and range of the 
techniques have been extended. Of particular 
relevance to this thesis, tissue perfusion can be 
derived from the rate change of activity of an 
injected radioisotope and from a knowledge of the 
partition coefficient, under suitable circumstances.
CHAPTER II
In this chapter the physical and biological 
attributes of radioactive xenon (133 Xe) as a 
capillary flow indicator are outlined and the 
technique employed in the 133 Xe studies is
i . • , *:•' r •
introduced.
In preliminary animal experiments the route of 
clearance of intra-articularly injected 133 Xe is 
shown to be blood flow dependent. The route of 
clearance is delineated more precisely in a further
- v . .
series of animal experiment©^approximately 90% of 
the isotope leaving the joint being recoverable in 
the femoral vein. Neither the biological system 
employed nor the technique for constant monitoring 
of femoral venous blood flow have previously been 
described to the best of my knowledge.
Synovial perfusion in the canine joint is 
derived from the clearance rate of intra-8rticularly 
injected 133 Xe and the in vitro measurement of the 
diffusion rate and the partition coefficient of 
133 Xe for synovium with respect to blood. The 
problems of the clearance model are studied with
particular reference to the use of this technique 
in the present context and the validity of the 
expression of the results in terms of perfusion 
is discussed.
Preliminary studies are described, the results 
of which demonstrate that the clearance rate of 
133 Xe from the diseased joint greatly exceeds the 
clearance rate from the normal Joint.
It is more difficult to demonstrate the route 
of clearance of the isotope from the human than from
the animal joint. However, the dependence of
clearance on blood flow is demonstrated by simple 
tourniquet studies so designed as to exclude the 
possibility of appreciable clearance through osseous 
nutrient vessels and the qualitative identification 
of 133 Xe in femoral venous blood is described. The
results of a study in which the isotope was
introduced under direct vision into synovial tissue 
are also described and it is proposed that there is 
sufficient theoretical and factual evidence to 
support the conclusion that the route of clearance 
from the human joint is similar to that which obtains 
in greyhounds.
The clearance model is then applied to the 
results of the human studies and synovial perfusion 
is again derived from the clearance rate of the 
isotope and the diffusion rate and the partition 
coefficient of 1 3 3  Xe for human synovial tissue 
with respect to blood. Synovial perfusion in the 
rheumatoid joint was found to be of the order of 
five times the value obtained in the normal.
RADIOACTIVE XENON
Physical Characteristics
The Isotope employed in the studies which are the subject 
of the first port of this thesis was radioactive xenon (*^Xe).
The radioactive gas Xenon (^^Xe) has been employed 
previously in the measurement of blood flow through several 
organs (Bain and Harper* 1968). Xenon is a chemically inert 
gas* three times as soluble as oxygen and one seventh as 
soluble as carbon dioxide at body temperature. The Isotope 
^^Xe decays to stable <. cesium with a half life of 5*27 days 
emitting a negative beta particle of maximum energy 0.347 MeV. 
which is absorbed by less than 1 mm. of tissue. The nucleus 
formed by beta decay may reach a stable state either by 
emitting a gamma ray (0.081 MeV) or by the process of internal 
conversion with the emission of a K, X-ray (0.03 MeV) (Ball et 
al., 1962). These energies are sufficiently low to allow 
shielding with only 3A6th inch of lead. The low energy and 
short half life result in minimal radiation hazard to both 
patient and investigator.
poelne.t|-jf, .Estimates
Under the circumstances of the Isotope studies performed 
in the following human studies with 133 Xe, the mean energy 
deposited locally is less than 0.13 MeV. Assuming 133 Xe to
be uniformly distributed throughout the synovial membrane and 
assuming that the membrane Is of the order of 1cm. thick in 
rheumatoid arthritis, then the dose rate to the membrane 
will be 10 mllllrad/^ Cl of 133 Xe. The doses employed were 
of the order of lO^Ci (i.e. 100 millirads) and the effective 
biological half life of the Isotope proved to be only of the 
order of 45 minutes, leaving a wide safety margin (Harper 
et al., 1964)9 well beneath the radiation dose delivered 
during routine diagnostic radiology. The radiation dose 
delivered during a standard radiographic examination of chest 
is of the order of 200 millirads and comparative figures for 
an Intravenous pyelogram and for a screening examination of 
stomach without image intensification are 2.23 rads and 90 rads 
respectively. At the surface of bone the dose rates would be, 
at the very most, 30% of the dose to the synovial membrane.
The partial pressure of 133 Xe will be maximal at the surface 
of the membrane and will descend towards the bone because of 
the Intervening synovial blood vessels. One millimetre below 
the surface of bone or cartilage the dose rates will be less 
than 10% of the above value. Whole body and gonadal doses 
are negligible.
Biological Characteristic.
Xenon is thus a safe Isotope to employ in human studies.
Furthermore, its high solubility in air results in over
I"' ' *. . . ' ■. 1 Vi "' ' ' ■ ,
95% of the circulating isotope being discharged Into the 
alveoli in one circulation through the lungs (Ball et al., 
1962). Consequently only negligible amounts are 
available to re-clrculate Into the joint and counts 
recorded over the joint do not require to be corrected 
for this. This facilitates the calculation of perfusion 
(vide infra page At body temperatures, 133 Xe is
both chemically and biologically inert, which also 
facilitates the calculation of blood flow since no metabolic 
"shifts" or exchanges need be considered as are necessary 
with, for example, radioactive sodium (Oosselln, 1966).
Xenon (133 Xe), being lipid soluble and of small molecular 
weight, is freely diffusible in biological media and is not 
limited by membrane permeability. Its distribution in the 
body is therefore subject only to physical laws of gas 
transfer.
'ANIMAL EXPERIMENTS
Feasabillty Studies
The following preliminary animal experiments were 
undertaken to study the clearance of intra-articularly 
administered 133 Xe.
Approximately\100fCl of 133 Xe dissolved in 1 ml. of 
0.9% sterile sodium chloride were Injected into the medial 
aspect of the stifle joint of an anaesthetised adult 
greyhound dog. A lightly collimated directional counter 
was then placed six Inches from the lateral aspect of the 
joint. The directional counter (Ekco N599D) incorporated 
a 1" x H " thallium activated sodium iodide crystal and 
photomultipliert and was connected through an Ekco 
raterneter (Ekco 1750) to a double channel chart recorder 
(B24) which recorded the count rate per minute graphically 
at a paper speed of 20 mm. per minute. Monitoring began 
two minutes after injection and was continued for 45 minutes. 
The graph was sampled at one minute intervals and the 
absolute count rate was plotted on to semllogarlthraic graph 
paper as a function of time. Straight lines were obtained 
in this way from which the halving time (Ti value, mlns.) 
could be easily determined. The count rate was noted to 
fall exponentially following injection of the isotope,
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Legend: The leg was severed at the level of the
femoral trochanter leaving only the femoral artery 
and vein connecting the hind limb to the trunk.
The count rate following intra-articular injection 
of 133 Xe was monitored by external directional 
counting and plotted semilogarithmically against 
time. When the femoral vein was clamped no 
further appreciable clearance occurred.
demonstrating that the isotope was leaving the joint.
This experiment was repeated on a further two occasions 
employing different doge and the Ti value (mine.) was 
calculated in each case. The same experimental method 
was employed in a fourth dog. However, on this occasion, 
prior to the injection of the isotope, the relevant hind 
limb was disarticulated at the hip and all the tissues 
were severed, with haemostatic control, leaving only the 
femoral artery and vein connecting the hind limb to the 
body (Fig. 1). The isotope was injected and counting 
performed in the usual manner. After 15 minutes, when 
the rate of clearance was established, the femoral vein was 
clamped# After a further 15 minutes inguinal and para­
aortic lymph nodes were removed and placed in a well type 
scintillation counter.
Results
The T£ values calculated in each study were 65* 73>
58 and 90 minutes from the four graphs. Figure 1 shows 
the result obtained in the fourth experiment when the 
femoral vein was clamped. It can be seen that the 
clearance, which had been proceeding at a constant rate, 
stopped abruptly at that point and no further appreciable 
loss of radioactivity occurred. When the lymph glands
were placed In a well type scintillation counter, no 
activity was detectable.
Discussion
Total cessation of clearance of the radioisotope 
when the circulation ceased implies that, under the 
conditions of this experiment, the route of clearance 
of intra-articularly administered 133 blood flow
dependent. Failure to detect activity in the regional 
lymph nodes suggests that no significant radioactivity was 
lost to the lymphatic system in this experiment. The 
latter point is less securely based than the former since 
it may be argued that, whereas alternative vascular routes 
were ligated and thus closed, this was not true of the 
alternative lymphatic channels. A point against this 
objection is that at least some activity might have been 
expected to clear through the main lymphatic channels, 
although from the design of this experiment it is not 
possible to answer this objection fully. Further animal 
studies were therefore undertaken.
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MEASPREMENT OF SYNOVIAL PERFUSION IN DOGS 
Introduction!
Most methods for the determination of blood flow 
measure total flow to or from an organ or tissue. It 
is more difficult to derive a measure of flow through 
the capillary bed which reflects effective tissue 
perfusion (Friedman, 1968). The only acceptable 
methods of assessing flow through any particular 
capillary bed are to observe it directly or to employ 
some flow dependent process which takes place only in 
the microcirculation (Gosselin, 1966).
In the present study, an attempt was made to 
validate the use of the isotopic clearance method as a 
measure of synovial tissue perfusion in animals. 
Clearance of a small molecular weight substance by a 
tissue is mediated by several variables including the 
chemical and physical properties of the substances 
(Kety, 1951 2 Jacox et al., 1952 : Laing and Kim, I960 : 
Hollander et al., 1961 : Perl et al., 1965) and the 
structure and perfusion of the tissue (Kety, 19^9 2 
Pappenheimer et al., 1951 2 Pappenheimer, 1953 2 
Renkin, 1955 2 Barlow et al., 1961 2 Perl, 1962 !
Landis and Pappenheimer, 1963 2 Thorburn et al., 1963 : 
Perl and Chinard, 1968)* When an inert lipid soluble gas
k l
is employed particularly relevant measurable variables 
include the diffusion rate of the gas in the tissue 
(Krogh, 1919 : Kety, 1951 : Renkin, 1955 t Perl et al,, 
1965 J Unsworth and Gillespie, 1969), the partial 
pressures developed (Gillespie, 1968) and the solubility 
of the gas in the tissue with respect to its solubility 
in blood (Conn, 1961). Many workers (Thorburn ot al., 
1963 t Lassen et al., 1964 : Larsen et al., 1966 and 
Sjersen, 1967) have employed the clearance method to 
derive tissue perfusion. In each case those variables 
which affect clearance other than perfusion are either 
minimised or are incorporated into the method. In the 
present study three factors in particular are 
quantitated namely, the route of clearance of the 
tracer from its site of injection, the diffusion rate 
of the tracer and the partition coefficient of the 
tracer in the relevant tissue.
Uk
MATERIALS AKP METHODS
The in vivo studies were conducted in a surgical 
theatre in the Wellcome Surgical Research Centre,
Glasgow. Studies were performed on the stifle joints 
of adult greyhound dogs weighing from 25 to 31 kg. 
Anaesthesia was induced with thiopentone sodium (20 mg./ 
kg.) and a cuffed endotracheal tube was passed into the 
trachea. Outflow was connected to a Starling 
respiratory pump and inflow to a Boyle*s anaesthetic 
machine. Anaesthesia was maintained with a 5:3 mixture 
of nitrous oxide and oxygen and was monitored by periodic 
determinations of blood gases. A catheter placed in the 
brachial artery was connected to a three way mercury 
manometer which provided continual recordings of blood 
pressure and pulse rate and a slow intravenous infusion 
of 0.9& NaCl was continued throughout each experiment. 
Monitoring Technique
Exercising care to avoid the presence of air bubbles, 
one al. of 133 Xe (approximately 100y Ci) was withdrawn
from the isotope reservoir into a syringe. Another one
15”ml. syringe was fitted with a guage needle and the 
needle was carefully inserted into the lateral aspect of 
the stiffle joint. Confirmation of the siting of the
needle was achieved by the aspiration of synovial fluid*
To minimise the effects of injection trauma (page c^5’), 
the needle point was left in situ for five minutes. The 
syringe was then removed and replaced with the syringe 
containing the isotope solution which was slowly injected 
into the Joint cavity. In no case was the injection volume 
in excess of 0.5 ml. The empty syringe was then removed 
and that containing synovial fluid was again fitted to the 
needle and remained in place throughout the study.
Counting Technique
The count rate was monitored and graphed semilogarith- 
mically in the same manner, employing the same equipment as 
in the previous experiment (page 3 T ),
ROUTT: OF CLEARANCE
Tourniquet Studies
In one study a tourniquet^placed around the thigh^was 
inflated 15 minutes after injection, on one occasion to 
mid-pulse pressure and on another to a level greater than 
the systolic blood pressure. On each occasion the 
tourniquet remained inflated for 8 minutes and the count 
rate was monitored for ten minutes following deflation.
A similar protocol was followed in three further 
studies when a narrow (2”) tourniquet was placed immediately
proximal to the stiffle joint and therefore distal 
to the site of emergence of the femoral nutrient 
vessels from bone.
F em oral V a in  S am p lin g  and F ree  F low  D e t e r m in a t io n s  o f  
F em oral F low
Two isovolumetric isotope solutions were withdrawn 
from the isotope reservoir and the count rate of each 
was determined. One dose was added to a known volume 
of 0.9% NaCl in a glass flask. The count rate of the 
empty syringe was immediately determined and the activity 
added to the flask was calculated by subtraction. The 
flask was sealed with all air excluded and the contents 
thoroughly mixed. Two mis. of the standard were 
pipetted into a 2 ml. counting vial which was sealed.
The count rate was obtained by placing the vial in a 
well type scintillation counter (Ekco M5400AA) and 
background count rate was subtracted. From the count 
rate^and from a knowledge of the activity delivered into 
a known volume of 0.9% NaCl^a figure for 100% dose could 
be easily obtained, in units of counts per ml.
When the dog was in position following induction of 
anaesthesia, the femoral vein was exposed in the groin. 
Careful blunt dissection was employed and no major vascular 
tributaries were severed. A ^ 2 W diameter plastic T-tube 
fitted with a three way tap was introduced into the vein
■kif
and secured. At this point the dog received 10,000 
units of heparin intravenously. Femoral flow was 
determined by collecting all the blood flowing through 
the T-tube in 30 seconds. A mean of three readings was 
taken and the blood was immediately replaced. At the 
conclusion of the study femoral flow rate was again 
determined in the same manner.
The isotope solution from the second syringe was 
injected into the stiffle joint. Immediately following 
injection the count rate of the empty syringe was 
determined employing precisely the same counting geometry 
as had been utilised in counting the other syringes. The 
activity delivered into the joint cavity could be obtained 
by subtraction. The detector was then positioned over 
the joint and counting commenced in the usual manner 
(page 3 ) .  The clearance curve was plotted on to 
semilogarithmic graph paper. From 2 to 46 minutes after 
injection femoral vein samples were obtained at two minute 
intervals. Two syringes were connected to the three way 
tap. 4 mis. of blood were withdrawn into one and 2 mis. 
into the other. The 2 mis. volume was removed and 
pipetted into the standard 2 mis. counting vials which were 
immediately sealed with all air excluded. The blood 
withdrawn was isovolumetrically replaced with 0.9% NaCl
and finally the 4 mis. of blood in the opposite syringe 
was flushed through the T-tube. The counting vials were 
placed in the well type scintillation counter and the 
activity, corrected for background, was determined in 
counts per ml. Multiplying by femoral flow rate, these 
counts could then be expressed as % of 100% dose per 
minute and cumulative % per minute could be determined.
To relate these figures to the activity lost from the 
joint the straight line obtained on semilogarithmic graph 
paper was produced back to time zero. This figure was 
designated 100% and the absolute count rate obtained at 
any time thereafter could be expressed as a % of 100% dose. 
This could easily be converted to % per minute and could 
then be compared with the femoral vein activity.
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CALIBRATION CURVE
Ii£L*_2
L egend} C a l i b r a t i o n  c u r v e  f o r  fe m o r a l  f lo w  r a t e *
The difference in height of the blood columns in the 
inflow and outflow tracts (difference B-A Fig*3) is 
plotted on the vertical axis. The femoral flow rate 
measured by free flow (mean of duplicate readings at 
flow increments of 20 ml*/mln* over the range 50 to 
IfOO ml./min.) is plotted on the horizontal axis.
CONSTANT MONITORING OF FEMORAL VEIN ACTIVITY AND FLOW RATE
Twelve inches of /^l*" brass tubing was shaped into a 
coil with a single loop of 2" internal diameter. Two 
inches from each free end a vertical sidearm was inserted 
and each of these was connected to 18" of graduated plastic 
tubing. The coil was slllconlsed before each experiment 
and was calibrated in vitro using heparinised dog's blood 
(P.C.V.JfO) at 37°C. The blood was conducted through the 
coil from a reservoir placed two feet above the coil and 
collected in a graduated measuring cylinder from the coil 
outflow tract. By partially clamping the tubing proximal 
to the coil the flow rate could be adjusted. The flow 
rate was measured by collecting all the blood flowing into 
the graduated cylinder in a known time, the mean of 
duplicate readings being taken at each flow rate. While 
free flow was established, the difference in height of the 
columns of blood in each vertical sidearm of the coil was 
recorded and these were plotted against the flow rates to 
derive a flow curve (Fig. 2). Each set of readings shown 
were determined at flow increments of 20 ml./min. over a 
range of 50 to 2f00 ml./min.
The coil, with its polythene tubing extensions, was 
fitted around a 2" thallium activated sodium iodide crystal 
and photomultiplier (Ekco P1062) with the inflow and outflow
EXPERIMENTAL MODEL
He* 2
Legends The experimental model employed for continuoui 
recording of femoral vein activity and flow rate throu, 
the coil and isotope clearance from the Joint* Femora! 
venous blood was conducted through the siliconised brai 
coil which was moulded round a scintillation detector* 
A linear plot of femoral venous activity against time : 
shown in the top graph* A second detector was employ< 
to monitor activity over the Joint and a semilogarithm: 
plot of activity against time is shown in the lower gri
tracts with their vertical eidearms emerging through 
apertures in the lead* Pul6es were fed from the 
photomultiplier to a pulse height analyser and rate- 
meter (Ekco N600B) and recorded on the Rikadenki chart 
recorder. The coil was filled with standard isotope 
solution made up as previously described (page 4-U ) 
and the count rate, less background was determined*
This was expressed as 100% dose in the coil* The coil 
was emptied and washed and the inflow and outflow tracts 
were carefully inserted and advanced at least 3" 
proximally and distally into the exposed femoral vein.
The arrangement was checked to ensure that blood would 
flow horizontally and that no acute angles were presented 
to impede flow.
The femoral flow rate could be derived in vivo by 
reading the difference in height between outflow and 
inflow blood columns and from the flow curve and could 
be monitored continuously (Fig* 3)» The absolute coil 
count rate was also monitored continuously following 
injection of 133 Xe into the stiffle Joint and could be 
expressed as % of 100% dose by multiplying by 
contemporaneously obtained femoral flow rate* Comparison 
with decrement in knee activity was obtained as 
described previously (page 4*8). 8 studies were
£1
conducted with the coil in place.
At the conclusion of six experiments lymph glands 
were removed from the paraaortic and inguinal regions 
and placed in the well type scintillation counter. At 
the conclusion of three coil experiments the plastic 
tubing was removed from the proximal end of the femoral 
vein. Femoral flow after its passage through the coil 
was measured by free flow» while the height difference 
between inflow and outflow blood columns was noted.
Thus the in vitro calibration curve could be checked in 
vivo.
MEASUREMENT OF DIFFUSION AND PARTITION COEFFICIENTS
Specimens for the determination of the diffusion 
and partition coefficients of 133 Xe in synovial tissue 
were obtained from the opposite stifle joints of the 
dogs at the conclusion of the experiments with the coil. 
The joint was exposed through an elliptical incision and 
the patello-tibial ligament was divided. The patella 
was reflected and blocks of tissue 1 to 2 cm. in area and 
5 mm. in depth were removed from different areas within 
each joint. Synovial fluid specimens were removed from 
the aspirate obtained at the beginning of the experiments. 
Diffusion Coefficient
The diffusion coefficient was determined by the 
method of Unsworth and Gillespie (1969)* If one face of 
a medium of thickness L cm. containing a dissolved gas at 
uniform partial pressure Po is suddenly exposed to and 
maintained at zero partial pressure, it can be shown by 
simple diffusion theory that the partial pressure P(xt) 
at a point x cms. from the other face after t seconds is 
given by:-
(1)
-k TT2 
1|L«!
and = ~1T
2L
P -1and k(cm sec ) is the diffusion coefficient of the gas
51
in that medium*
For large values of t only the first term is important 
and the partial pressure is given by:-
^  u *^2 Q cos<*x (2)
Thus for large values of t the partial pressure has a 
cosine profile decreasing exponentially* The halving 
time is given bys-
Ti _ -en 0.5 „ 2,,77-Lf _________  (3)
If the gas is a radioactive gamma emitter, the 
mean partial pressure can be monitored with a collimated 
scintillation detector* Samples were introduced into a 
temperature controlled vessel* For the synovial fluid 
samples a level pool 2 to 3 mm* deep was employed. For 
synovial tissue, slices of the order of 1 mm. were placed 
on an impermeable glass base*
133 Xe (approximately 100 ^ Ci) was introduced into 
the vessel and, after sufficient equilibration time, the 
space above the samples was flushed continuously with 
humidified air. A collimated sodium iodide detector 
monitored the remaining activity in the sample*
From the Ti value of the semilogarithmic plot of the 
count rate against time and the sample thickness, the 
diffusion coefficient was determined (Equation 3)•
1 L
P a r t i t i o n  C o e f f i c i e n t
The partition coefficient (A) of 133 Xe for animal 
synovial tissue with respect to blood, that is the ratio 
at equilibrium in vitro of the concentration of 133 Xe 
(^Ci/ml.) in tissue to its concentration in blood 
(yCi/ml.)f was determined in the following manner.
Each sample was placed in a solution of 133 Xe in 
saline in an air free glass test tube. The test tubes 
were sealed and left at 37°C. for 2l\ hours to 
equilibrate. The sample was then removed, freed of 
excess liquid and at the same time 2 mis. of saline 
were also removed from the test tube. Each was then 
placed in a sealed counting tube and their relative 
activities determined. The concentration of activity 
was calculated and from these results and from 
published data (Conn, 1961) the partition coefficient 
of 133 Xe for synovial tissue with respect to blood 
was calculated.
CALCULATION OF PERFUSION
In each study clearance from two to forty-five 
minutes after injection was monoexponential and is 
given by:-
Q = Qoe ^  — —  ........... . ' (1)
This result was predicted theoretically and confirmed 
experimentally by Kety (1949) studying radioactive 
sodium clearance from muscle.
From the general form of the Fick equation
rjj2 9 P(Ca-Cv) '..... ' 1 (2)
where « moles removed from the tissue of unit at
volume v in unit time t.
P = Perfusion (ml*/min.)
and Ca ^ Cv » concentration in pre- and post-capillary
blood in molee/ml.
Since recirculation of 133 Xe is negligible (Ca^O) and:
^2 e . pCv —  (3)
There is evidence that equilibration is rapid and that 
the venous exit condition (Cv * holds (Perl, 1962) 
and Ci « ^ where Q * number of moles in tissue, there­
fore by substitution:-
Rearranging and Integrating
q s Qoe ~ —-----------------  (5)
and P * k.A.v. ■ ■■— —      (6)
The slope of the eemilogarithmic plot (k) * 
loge ci - log© eg 
0.4343 (ti - t2)
where ci and c2 &re counts at ti and t2 respectively
,  P ,i §22 Ti
therefore:-
p s ml.AOOml./min.
* nl. AOOml./min. — —  (7)
TABLE I
T-J values obtained from the senilogarithmlc plots 
of activity recorded over the joint against time
before and after the intervention of tourniquet 
inflation. The studies in which a narrow 
tourniquet was employed are depicted by an asterisk
Tf Values (mine.)
Before After
72 70
7 k 72
91 90
82 81
6k 60
56 ' 58
69* 73*
55* 50*
7km 75*
78* . 76*
71* 68*
88* 85*
* D e n o te s  t h e  e x p e r im e n t s  i n  w h ich  a narrow  t o u r n i q u e t  
was a p p l i e d  im m e d ia t e ly  p r o x im a l  t o  t h e  j o i n t .
SlI
RESULTS
Route o f  C le a r a n c e
In Tour preliminary studies, clearance commenced
■y') , • " ^  r'<
within seconds of injection and could be described by a 
single exponential over the time period 30 secs, to 
mine, after injection. The half lives (T$ values, mine.) 
of the 8emilogarithmic plots of count rate against time 
were 65* 60, 68 and 72 minutes.
When a tourniquet was inflated either to mid-pulse 
or to over-systolic blood pressure clearance ceased, and 
recommenced at the original rate on release of the 
tourniquet. The T} values before and after inflation 
of the tourniquet were closely similar. This experiment 
was repeated on six occasions and the results were found 
to be consistent (Table 1). Precisely similar results 
were obtained when the narrow tourniquet was placed 
immediately above the joint, namely cessation of clearance 
on inflation of the tourniquet and recommencement at the 
original rate on release (Table 1)•
The results obtained when the percentage of 100% 
dose leaving the stiffle joint was compared with the 
percentage of 100% dose recovered either in samples or in 
the coil experiments are shown in Table 2. Only the 
figures for 10, 20, 30 and 40 minutes are shown, results
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at other times being entirely in accord with these.
At ten minutes after injection the mean cumulative 
percentage of 100% dose cleared from the joint (7*9) 
was closely similar to the mean value obtained for 
femoral venous activity (7.2). Similarly, at 20 mine, 
the respective values were 18*4 and 16.8; at 30 mins.
30.8 and 27*2 and at 1*0 mins. i*0.5 and 37*5* The 
percentages of activity cleared from the joint which 
could be accounted for in the femoral vein at 10, 20, 30 
and /*0 minutes were 92%, 91%, 88% and 93% respectively.
The results for femoral flow rate when determined 
by free flow at the beginning of the experiment were 
120, li*2, and 135 ml. per minute and at the end of the 
experiment the values were li*5, 168 and lif6 ml. per 
minute. A mean of all six values was employed in 
calculating the results in that experiment. However, it 
was clear that the femoral flow rate was not constant and 
accordingly the method of continuous recording of flow 
rate was developed. In calculating the results in the 
coil experiments the individual flow rates obtained 
contemporaneously with the respective coil count rates 
were employed. The flow curve obtained when the difference 
in height of the inflow and outflow vertical sidearm blood
columns was plotted against the experimentally determined
flow rate is shown in Fig. 2. Each point shown
represents the mean of duplicate readings at each flow rate.
When the femoral flow rate derived from the height
difference in vivo was compared with free flow
determinations of femoral flow rate at the conclusion
of the experiments, the derived values were 110, 160 and
12*0 ml./min. and the corresponding free flow readings
were 100, 155, and 11*5 ml. per minute respectively.
Diffusion and Partition Coefficients
The valueB obtained for the diffusion coefficient of
133 Xe in animal synovial tissue were of the order of
1.0 x 10-5 cm2 86C-1 gt 37°C, the range of values obtained
—5 p —1being 0.8 to 1.3 x 10 y cm sec , whereas values for the 
diffusion coefficient of the isotope in synovial fluid 
were of the order of 1.5 x 10*^ cm sec* (range 1.3 to
P i  A1.6 cm sec- at 37 C.). These values are similar to 
those obtained in other biological tissue and fluid media 
(Unsworth and Gillespie, 1969)*
The values obtained for the partition coefficient of 
133 Xe for synovial tissue with respect to blood ranged 
from 0.87 to 1.1 (mean 1.0) and this value also accords 
with partition coefficients obtained in other biological
tissues (Conn, 1961 : Larsen et al., 1966).
C a l c u l a t i o n  o f  S y n o v i a l  P e r f u s b n . i n Animal. S y n o v ia l  
T i s s u e
From Equation 7 (page ), utilising the value
1.0 for the partition coefficient and the T-J- values 
obtained in these studies, synovial perfusion rates 
in these experiments ranged from 0.72 to 1.26 
ml./100 ml./min. (mean 0.91 ml.AOO ml./min.) •
DISCPSSIOW
These results support the conclusion that lntra- 
articularly administered Xenon ( ^Xe) diffuses into the 
synovial membrane and is cleared by the subsynovial blood 
vessels to the femoral vein.
Thus the results of the preliminary tourniquet 
studies demonstrated that no clearance occurred when the 
tourniquets remained inflated. Furthermore, no clearance 
occurred when the narrow tourniquet placed distal to the 
site of emergence of the fanoral diaphyseal vessels was 
inflated. Had any significant clearance been occurring 
through cartilage and thence through the blood vessels in 
bone, it is unlikely that a tourniquet in this position 
would completely arrest clearance. Further evidence 
that clearance does not occur through cartilage is 
provided by the slow diffusion rate of the isotope. 
Cartilage is avascular and it has been shown that in the 
absence of flow the diffusion of 133 Xe in tissue over 
2 mm. distance takes longer than the time Involved in these 
studies (Sjersen, 1967). Cartilage is over 2 mm. in 
thickness and should therefore present a formidable barrier 
to the isotope. On the other hand, since the capillaries 
of the synovial membrane are only microns removed from the 
surface (Schumacher, 1969 t Norton and Ziff, 1969), it can
easily be shown that over 50% of the Injected isotope 
would diffuse across this distance in the time of these 
studies. That this is Indeed so, is demonstrated by 
the fact that clearance commences within seconds of 
injection.
In the sample and coil experiments approximately 
90% of the activity clearing from the joint could be 
accounted for at any time up to 40 minutes of injection 
in the femoral vein. Thus, at most, only 10% is 
available to clear by all other channels. The 
discrepancy may be partly attributable to clearance 
through other venous channels and to loss of isotope by 
diffusion from vessels between the joint and the 
monitoring system. Passive diffusion out of the area 
under the counter is invalidated by the slow diffusion 
rate of the Isotope and since the needle was allowed to 
remain in situ closed by synovial fluid passage up the 
needle track is unlikely to have been a major factor.
That clearance in lymphatic vessels is not a major factor 
is suggested by the work of Hollander et al. (1961) and 
of Stone and Miller (1949) and in this study no activity 
was detected in excised lymph nodes. Those instances 
in which femoral vein accountancy exceeded joint 
clearance are almost certainly related to lack of
L3
quantitative precision in this relatively crude 
biological system. In two experiments (Dog 6 and 
Dog 18), the discrepancy persists throughout, 
suggesting a systematic error.
It would appear, therefore, that the clearance 
of intraarticularly administered 133 Xe is mediated by 
and subject to, similar conditions which apply to any 
clearance model. One advantageous difference 
encountered in the present system however is that 
tissue distension due to deposition of the tracer 
solution is unlikely to be a major factor when the 
solution is introduced into the synovial cavity.
The clearance method for the determination of 
capillary flow has been employed by many workers (Kety 
1949 5 Thorburn et al., 1963 * Lassen et al., 1964 s 
Larsen et al., 1966 I Sjersen, 1967)* Since it is an 
indirect method, certain assumptions are necessary. 
Criticism has been levelled at those assumptions, 
(Qosselin, 1966). Clearance can easily be shown to 
be flow related but to what extent is it mediated by 
partial pressure gradients, diffusion or membrane 
permeability?
Qillespie (1968) has studied the influence of 
partial pressure gradients on tissue clearance of an
*1
inert radioactive gas. Ho concluded that in an 
infinite homogeneous tiesue the partial pressure at 
any stage during clearance could be assumed to be 
approximately uniform, except at relatively tiny 
regions surrounding the arterial ends of the 
capillaries. He also noted that significant errors 
could arise if tissue adjacent to the region under 
study possessed markedly different flow rates, for 
example grey and white matter in brain. This 
situation does not obtain in the case of the synovial 
tissue. As to the question of tissue homogeneity, 
this is a more complex problem. No tissue is 
histologically homogeneous. Accordingly, homogeneity 
in the context of clearance studies must be defined 
functionally. A small (ra.m.) section of tissue which 
possesses a characteristic diffusion and partition 
coefficient and from which inert gas clearance is 
monoexponential is assumed to be functionally 
homogeneous (Perl et al., 1965)*
The extent to which inert gas clearance is 
diffusion dependent over micron distances has been 
closely studied. Pappenheimer (1953) demonstrated 
very rapid equilibration rates for small molecular
weight substances* Kety (1951) also concluded that 
diffusion was not a limiting factor and he derived 
equilibration rates for inert gases in tissue to be of 
the order of seconds* Perl and Chinard (1968) have 
studied this problem and noted that under certain 
circumstances "large scale diffusion" (over mm*) could 
exert an appreciable effect* "Small scale diffusion" 
(over microns) is allowed for in the clearance model 
by the inclusion of A (the partition coefficient).
He proposed a method for calculating the importance 
of large scale diffusion and employing this method and 
the relevant values for diffusion coefficient, partition 
coefficient, flow rate and other system parameters 
employed in the present model, large scale diffusion 
is not a major factor in the clearance of 133 Xe from 
the joint cavity.
Membrane permeability is also an important aspect 
of clearance. In particular lipid insoluble substances 
such as radioactive sodium are likely to be affected by 
this (Qosselln, 1966). However, for inert freely 
diffusible lipid soluble small molecu lari tracers such
as radioactive 133 Xe, on current concepts of membrane
permeability, the predominant process is likely to be
one of passive diffusion.
Thus It would seem reasonable to accept the 
assumptions involved in the clearance method in the 
context of this study. Figures for synovial 
perfusion of the order of 1.0 ml./100 ml./min. seem 
reasonable in the light of flow in other supporting 
connective tissues (Sjersen, 1967 : Lassen et al., 1964 
Larsen et al., 1966). However, since this is the 
first time that it has been possible to measure this,
no direct comparisons are possible.
' * • • .
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HUMAN STUDIES
Preliminary Studies In Normal and Diseased Human Subjects 
Studies were then performed in normal volunteers 
and in patients afflicted with rheumatoid arthritis to 
determine the clearance rates from the human knee joint. 
Patient Studies
133 Xe studies were performed on 14 clinically 
active knee joints of six patients with "definite” or 
"classical" rheumatoid arthritis (Ropes et al.1959 )•
In all but one knee joint articular erosions were present 
on radiological examination and all had marked synovial 
hypertrophy clinically. At aspiration none had more 
than 5 ml. of synovial fluid in the joint. The mean age 
of these patients was 56.8 years (range if6 to 62 years). 
Four were male. Seven studies were performed on four 
healthy male volunteers aged between 22 and 26 years.
None had a history of disease or trauma of the knee joint 
and in all the knee X-rays and sheep*s cell agglutination 
tests (Ziff, 1957) were normal.
Injection Technique
All injections were performed in a surgical theatre, 
with the patient lying supine. The knee was extended 
and immobilised with sand bags. The room temperature 
ranged from 65 to 70°C. and an extraction fan was 
constantly in operation to reduce the concentration in
air of the radioactive gas exhaled by the patient.
A fine guage needle was introduced into the joint 
cavity by a lateral infra-patellar approach and when 
an effusion was present this was aspirated as fully 
as possible. A prepared syringe containing the 
isotope dissolved in less than 1*5 ot 0.9% sterile 
sodium chloride was then attached to the needle and 
the solution was introduced into the joint cavity.
In one normal volunteer the volume of diluent was 
20 al. to examine the effect of volume on the 133 Xe 
clearance. The needle was withdrawn and the wound 
was sealed with adhesive.
Preparation and Dose of 133 Xe
The reservoir of 133 Xe (Amersham) was kept 
outside the surgical theatre. In the first experiment 
on the human knee (tho author’s) a dose of 100 *^Ci was 
chosen. In this experiment it was found that 
sufficient counts should be present with the 
directional counter touching the skin over the patella, 
employing only lO^Ci and this dose was used successfully 
in all studies thereafter. The dose was prepared 
directly from the reservoir for each study and air 
bubbles were carefully excluded from the syringe owing
r
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Legendi Semilogarithmic plot of the disappearance 
curve of 133 Xe from the knee Joint cavity of a 
patient with rheumatoid arthritis. Activity is 
plotted semilogarithnically on the vertical x-axls, 
against time in minutes on the horizontal axis.
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Legend: Semilogarithmic plot of the difference
between the pointe plotted in the first fifteen 
minutes after injection of 133 and the straight 
line produced back to the vertical axis in Flg.l.
-Eta, J6
Legends Semilogarithmic plot of a disappearance 
curve of 133 Xe from the normal knee joints.
The graph can be described by a single exponential.
to the high solubility of the radioactive gas in air* 
Counting Technique;
Counting was performed using a lightly collimated 
1« x thallium activated sodium iodide crystal 
connected to an Ecko ratemeter and direct writing pen 
recorder. The crystal was directed at the medial 
aspect of the joint using the upper border of the 
patella as a reference point. Counts per minute were 
within the range 1,000 to 10,000 the back ground being 
of the order of 10 to 30 counts per minute. Counting 
commenced two minutes after injection and was continued 
for 30 to 45 minutes at a paper speed of 600mm/hour.
The graph was sampled at one minute intervals for 
count rate and the results, minus the background, were 
transposed onto semilogarithmic graph paper as a 
function of time. The biological half life (Ti value 
in minutes) was then calculated from the semi­
logarithmic plots of the results.
Results
The results are shown in Table 3 and Figs. 4 to 6.
A slow monoexponential clearance pattern (Fig. 6) was 
observed in all but one normal subject. In that subject 
the volume of diluent was 20 ml., to determine the effect
70
of the volume injected and the Tj value obtained in 
that case was 66 minutes. This was by far the lowest 
value obtained in any normal subject. In that normal 
volunteer the shape of the curve obtained also 
differed from the pattern of clearance of the other 
normal subjects. When plotted onto semi-logarithmic 
paper, two exponential functions could be clearly 
discerned. . . The Ti value of the initial fast
component was 3*6 minutes (henceforth designated T^i) 
and that of the slower second component was 66 minutes. 
The slower Ti value was included in the calculation of 
the mean (217»85 mins.) and standard error (72.6 
minutes) of the results obtained in normal subjects.
The results in the rheumatoid subjects differed 
markedly from the results obtained in normal subjects. 
Whereas only one normal subject displayed a bi­
exponential clearance, the results in all the 
rheumatoid subjects could be resolved into two 
exponentials very similar in pattern and in order of 
magnitude to the bi-exponential graph obtained in the 
normal subject. The short Initial component could 
be described by a T1^ value. The straight line of 
the second component was extrapolated back to the
TABLE III
Biological half lives (Ti values in minutes) of 
disappearance curves of 133 Xe from Human Knee
Joint Cavities
Patients with Rheumatoid Arthritis Normal subjects
Biological 
Ti 
veauee 
(mine.)
Range
Mean
Standard Error
T1* ♦ Ti * Ti
3.0 42.0 630
3.4 61.2 120
3.6 19.2 150
2.0 24.5 66(T1i*-
3.2 40.0 264
3.0 57.0 120
3.2 (3.0) 29.5 (28.0) 175
2.6 (2.4) 35.0 (30.0)
1.8 50.0
6.4 50.0
2.7 26.6
2.2 27.0
1.8 - 6.4 19.2 - 61.2 66-630
3.09 38.5 217.85
0.34 3.97 72.6
0.01 > p  3^0.001
tH  ie the biological half life of the fast exponential curve 
in patients with rheumatoid arthritis.
* Ti is the biological half life of the slow exponential curve 
in patients with rheumatoid arthritis and the slow mono­
exponential curve in normal subjects.
vertical axle. The count rate in the initial minutes, 
minus the corresponding figure on this extrapolated 
line, was then plotted semilogarithmically against 
time and yielded a straight line from which the T^-J- 
value could be readily calculated (Fig. 5)* This is 
the same technique as was employed for the bi­
exponential normal graph. The mean and standard
ierror of the T i values obtained in the rheumatoid 
patients was 3«09 - 0.34 minutes. The T£ values of 
the slower component in the rheumatoid subjects,
' ' - .. * V f • L • . ' ‘ .
obtained directly from the first semilogarithmic 
plots, gave a mean value of 3o*5 minutes, (- standard 
error 3*97 minutes) and the results obtained in the 
rheumatoid patients for this slow component were 
significantly faster ( O.O^ b-p>0.001) by a student 
t-test) than the values obtained in normal subjects 
(Table 3).
Discussion
Thus the rate of clearance of intra-articularly 
administered 133 Xe from the knee joint is considerably 
faster in rheumatoid subjects than in normal volunteers. 
Indeed, inspection of the results shows that there was 
no overlap whatever between the groups. It was
possible that the difference observed was explicable 
on the basis of the difference in the mean ages of 
the groups studied. However, in view of the 
magnitude of the difference, this seemed unlikely.
In normal subjects the semilogarithmic plots 
obtained yielded a straight line and could therefore 
be described by the equation:
- k ty b Ke
where l « 0.693
^ Ti
However, in rheumatoid subjects the graphs obtained 
were bi~exponential, i.e.:-
„ kt *y * Ke ♦ K e
where £  * 0,$92
•rH
The reason for this discrepancy was not immediately 
apparent and furthermore the constancy of the 
difference could not be assumed since the results 
obtained in the normal subject injected with 20 ml. 
of diluent was bi-exponential. It was also noteworthy 
that the T-J- value obtained in that normal subject was 
very much less than those obtained in all other 
normal subjects. This value was included in the
calculation of the mean of the normal results because
the numbers studied were so small and since it could
only militate against over-optimistic interpretation 
of these early results. However, this one result did 
suggest that the volume of diluent had an effect on 
the result and prompted further studies to elucidate 
this problem (page )•
Scholer et al., (1959) demonstrated a rise in 
the concentration of deuterium and of radioactive 
sodium (2**Ha) in the blood during the clearance of 
these substances from the joint. Accordingly, in 
one rheumatoid patient, femoral vein blood was removed 
during the 133 Xe study and placed in a well type 
scintillation counter. 133 Xe was qualitatively 
identified in this sample. From thi6 and from 
previous experimental work in animals (page 51), it 
seemed reasonable to propose that the monoexponential 
clearance of 133 Xe from the joint was accounted for 
by passage of the isotope into the blood stream. It 
also seemed likely that the faster clearance rates 
observed in rheumatoid patients could be accounted 
for by a similar mechanism and that the shorter 
biological half life represented greatly enhanced 
perfusion of the inflammed synovium.
itk
DERIVATION OF SYNOVIAL PERFUSION IN THP HUMAN JOINT
It Y/as not possible to employ the same 
experimental protocol to demonstrate the route of 
clearance of 133 Xe in the human. Furthermore, it is 
impossible to extrapolate directly from the results 
obtained in normal dogs to the diseased human 
diarthrodial Joint. Accordingly, studies were 
designed in an attempt to obtain some evidence, albeit 
indirect, that the route of clearance in the human was 
also blood flow dependent and that the clearance model 
could be applied to results obtained in human studies.
ROUTE OF CLEARANCE OF 133 Xe FROM THE PIARTHRODIAL
JOINT CAVITY IN MAN
TOURNIQUET STUDIES 
Method
133 Xe studies were conducted in the usual manner 
in ten patients with "classical" rheumatoid arthritis 
(Ropes et al., 1959), five of whom had been subjected 
to the operation of anterior knee synovectomy more than 
one year prior to these 133 Xe studies. The mean age 
of these patients was 63*2 years (range 42-71 years). 
Two were male and all had articular erosions on 
radiological examination. When the clearance rate
EFFECT of a TO U R N IQ U E T  on CLEARANCE  
of 133Xe from the KNEE
COUNT RATE
5 10 15 20 25 30 35
TIME in MINUTES
Etei 7
Legend: The effect of tourniquet inflation on the
clearance of intra-articularly administered 133 Xe 
from post-synovectomised knee joint of five 
patients with rheumatoid arthritis. The Ti values 
prior to inflation were 20, 19, 24, 30 and 14 
minutes and the corresponding Ti values following 
deflation were 19, 17, 24, 28 and 16 minutes.
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Legend: The effect of tourniquet inflation on the
clearance of intra-articularly administered 133 Xe 
from the unoperated knee joints of five patients 
with rheumatoid arthritis. The T-J values before 
inflation were 70, 16, 46, 40 and 26 minutes and 
following tourniquet deflation the corresj^onding 
values were 72, 14, 49, 36 and 23 minutes respectively.
had been established a narrow (2M in width) tourniquet, 
positioned immediately above the upper border of the 
joint, was inflated to a pressure mid-way between the 
individuals systolic and diastolic blood pressure*
After an interval of 5 to 10 minutes, the tourniquet 
was deflated and the clearance rate monitored for a 
further 20 minutes*
Results and Interpretation
The TJ values obtained before and after the 
intervention of the tourniquet are shown in Figs. 7 
and 8* The values obtained beforehand in both 
operated (20, 19, 24, 30 and 14 minutes) and unoperated 
(70, 16, 46, 40 and 26 minutes) knees were similar to 
the corresponding values obtained following tourniquet 
deflation (19, 17, 24, 28 and 16 minutes and 72, 14, 49, 
36 and 25 minutes respectively) and in each individual 
study the two values obtained were closely similar.
In no case was appreciable clearance of the isotope 
observed during the time of tourniquet inflation.
These results show that isotope clearance can be
' 1
interrupted by venous occlusion in both synovectomised 
and unoperated knees of patients with rheumatoid 
arthritis. The position of the tourniquet, below the
exit from bone of the nutrient vessels allowed 
separation of clearance in diaphyseal vessels from 
clearance superficial to bone. No appreciable 
clearance was occurring through the diaphyseal 
vessels, since flow in these veins would not have 
been affected by occlusion below the nutrient foramen 
(page II ).
INJECTION OF 155 Xe UNDER DIRECT VISION INTO HUMAN
SYNOVIAL TISSUE
Method
A 52 years old female patient with "classical11 
rheumatoid arthritis (Ropes et al., 1959) whose knee 
Joint exhibited marked involvement with clinically 
obvious synovial hypertrophy agreed to participate in 
this study. She had previously accepted the 
recommendation that she would benefit from synovectomy 
Preoperatively, her knee score (page III) was +12 and 
the T£ value obtained four days preoperatively was 
23 minutes. At the operation of anterior knee 
synovectomy, the joint cavity was opened. A solution 
of 133 Xe (20pCi in 0.1 ml. of sterile 0.9% NaCl) was 
injected under direct vision approximately 2 to 3 cm. 
into synovial tissue at the periphery of the joint, as
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Legend: 133 Xe was injected at operation under
direct vision into synovial tissue* During 
monitoring of clearance rate a narrow tourniquet 
placed around the lower third of thigh was 
inflated for 8 minutes* The T-J- value prior to
inflation was 20 minutes and following deflation 
22 minutes*
22
far removed from cartilage as possible* The cavity 
was quickly packed with saline soaked swabs and the 
capsule and skin wounds were approximated and clamped* 
The swabs employed were placed under the directional 
counter at the conclusion of the experiment and the 
count rate obtained was less than k% of the count rate 
obtained over the joint* The isotope clearance rate 
was monitored in the usual manner and when this was 
established a narrow tourniquet placed round the lower 
third of thigh was inflated to 90 mm. Hg. Inflation 
was maintained for 8 minutes and the clearance rate 
was monitored throughout this time and for 20 minutes 
following deflation*
Results and Interpretation .
The semilogarithmic plot of count rate is shown 
in Fig* 9* The Ti value of the initial period is 
20 minutes* No appreciable clearance occurred during 
tourniquet inflation and the Ti value following 
deflation is 22 minutes*
Both of these Ti values accord well with results 
obtained in other patients exhibiting a similar degree 
of clinical involvement and with the value obtained
preoperatively* Cessation of clearance on venous
occlusion implies that clearance is flow dependent.
In this experiment the isotope was introduced 
directly into synovial tissue whereas in all other 
studies injection is intra-articular. In the latter 
situation diffusion must occur across an intervening 
avascular layer prior to clearance in small blood 
vessels. The similarity between the clearance rates 
obtained by these different methods is accounted for by 
proximity to the surface of these small vessels with 
consequent reduction in the intervening distance to be 
traversed by the isotope (Norton and Ziff, 1969).
Clearance through cartilage and diaphyseal vessels 
was totally excluded by the design of this experiment. 
Indeed, clearance by all routes other than the synovial 
vessels was excluded since the wound was closed through­
out the study.
DIFFUSION RATE AND PARTITION COEFFICIENT IN NORMAL AND
DISEASED HUMAN SYNOVIUM
Methods
Specimens of synovial tissue, synovial fluid and 
cartilage were obtained at the operation of synovectomy 
from eight patients with rheumatoid arthritis and from 
seven necropsies in young patients who had never been 
noted to have articular disease. The superficial
1 to 2 mm. of synovium were carefully dissected from 
each specimen and the synovium, synovial fluid and 
cartilage were separately homogenised. Thereafter the 
methods employed for the determination of diffusion and 
partition coefficients were those previously described 
(pages s"1- ^  ^  ) •
Results and Interpretation
The values for the partition coefficients of 133 Xe 
in all the specimens were closely similar, the ranges of 
values obtained being almost identical. The mean value 
for both normal and rheumatoid synovium was 1.0 (range 
0.87 to 1.1) and the mean value for all of the cartilage 
and synovial fluid specimens was 1.02 (range 0.91 to 1.22). 
These accord with values obtained in similar biological 
tissue (Conn, 1961). The mean value of 1.0 was employed 
in the derivation of synovial perfusion throughout this 
thesis. It should be emphasised that since it is not 
possible to determine individual partition coefficients 
in each 133 Xe study, the assumption that this narrow 
range of values obtains throughout is necessary.
Although this assumption is commonly accepted (Thorburn 
et al., 1963 s Lassen et al., 196^ J Larsen et al., 1966 : 
Sjersen, 1967), absolute values quoted for perfusion must 
be interpreted with this in mind.
£0
The values obtained for the diffusion rate of 133 Xe
in synovial tissue were within the range of values obtained
-5 2in the animal tissues. The mean value was 1.0 x 10  ^cm
1 ~5 2 -isec" for synovial tissue, 1.5 x 10* cm sec" for
synovial fluid and 0.8 x 10 cm ' sec" for cartilage.
These values are similar to those obtained in other
biological tissue. The same arguments which apply in
considering diffusion in the animal model obtain
therefore in man (page ki+). The proximity of
capillaries to the cavity allows rapid equilibration and
the early establishment of clearance. On the other hand
the slow diffusion rate renders clearance by any other
route unlikely on theoretical grounds alone.
DERIVATION OF SYNOVIAL PERFUSION IN MAN
Method
133 Xe studies (page ) were conducted in 18 
healthy male volunteers. Particular care was 
exercised to exclude a history of disease or trauma to 
the knee joint. Careful clinical examination of the 
knee joint revealed no abnormality. Radiological 
examination of knees, hands and feet and serological 
tests for rheumatoid factor were negative. Their ages 
ranged from 20 to 68 years. Twelve were male 
University students between the ages of 20 and 28 years 
and the remaining six had non-articular complaints, 
their ages ranging from /f2 to 68 years (mean 52.2 years).
Twelve further studies were conducted in patients 
with "classical” rheumatoid arthritis (Ropes et al.,
1959)» all of whom had severe clinical involvement of 
the knee and in all of whom articular erosions were 
present on radiological examination. None were 
receiving corticosteroid therapy. All were post­
menopausal females, their ages ranging from 58 to 6lf 
years (mean 60.3 years). As is the case with all 
studies reported in this thesis, both patients and 
control subjects volunteered to participate with full 
knowledge of the content and implications of the proposed
V* • • TABLE IV
Synovial Perfusion (ml./lOO ml./min.) in 
12 Patients with Rheumatoid Arthritis and 
in 18 Normal Subjects
Rheumatoid Arthritis Normal Subjects
» " ■ -* ‘ - 1" r *’ • • t  - ■* .' "  « * •' * - * V- -***’• '* - v- ‘ - «-Vl "* • A '-■* V, 4 ** * *■ >*
Age Range 
58-64 yearsn s 12
. Age Range '  
20-28 years 
n =  12■ - iv* . * ,yt. * •  ^‘ •, - ■ *■<* vw V ■ •* •' 4
Age R* 
40-68 
n at \
1.22 0.49 0.2]
. 0.81 0.36 0.2'
1.69 ' 0.15 0.5<
2.10 0.11 0.6:
2.31 O .58 0.4:
2.77 0.11 0.3c
A .08 0.26 0.3c
1.92 0.46
1.51 1.05
2.0^ 0.58
1.39 " 0 0.40
1.82
U* . »■* *’»
1.00. - * .. s*i
Mean 1.97 
♦
0.46 0.3!
S.E.M. 0.24 0.09 O.Oi
0.001 o.6 > p ^ o .5
All normal > As V > ’•* 4*-~* V • - V; 'subjects v • rheumatoid arthritis p<0 .001.
study.
The relationship employed for the derivation of
synovial perfusion (S.P.) wasi (Equation 7» page ^k )#
S.P. * 69.3 k X ml.AOO ml./rain, 
vThe value employed for A was unity.
Results
The results are shown in Table 4. The synovial 
perfusion values obtained in the two groups of normal
subjects (mean O .46 i S.E.M. 0.09ml./100 ral./min. and
,0.39 +raean/ral.AOO ral./min. - S.E.M«0.06ml. A 0 0  ral./min.) were
not significantly different ( 0.6 7 P ? 0.5 ), The mean
value of all normal subjects ( O .43 i S.E.M. 0.06
ml.AOO ml./min.) was, however, significantly lower
( p-C0.001 ) than the mean value obtained in the
patients with rheumatoid arthritis ( 1.97 1 0.24
ml.AOO ml./min.).
Discussion
The evidence presented in this section supports the 
conclusion that intra-articularly injected 133 Xe is 
cleared from the joint cavity in man, as in the greyhound, 
by the synovial vessels.
Apart from theoretical considerations based upon the 
site of injection (page U  ), the diffusion rate of the 
isotope in tissue (pages Uy  ^ ) and the proximity to
the joint cavity of the capillaries, certain facts 
support this assertion. The isotope has been 
qualitatively identified in femoral venous blood. 
Tourniquet studies (page “74) confirm that clearance 
is flow dependent and that no appreciable clearance 
occurs through diaphyseal vessels. Furthermore, 
when other routes are excluded (page~7 4 ) clearance 
occurs at a rate consistent with that obtained in 
similarly afflicted joints. The relevant values for 
diffusion rate and partition coefficient have been 
determined and accord with those obtained in similar 
tissues by other workers. Whereas the order of 
magnitude of the diffusion rate is such as to render 
extremely unlikely any effect of biological variation 
of diffusion upon clearance, the same is not true of 
the partition coefficient. Although the range of 
partition coefficient values obtained in these studies 
is small, the acceptance of uniformity of partition 
coefficient must be more cautious. This point must 
be constantly remembered in assessing the validity of 
absolute values of perfusion in all clearance models.
The clearance method for the derivation of 
perfusion is indirect, and therefore certain assumptions 
are necessary. In the present context no other method
is available with which to compare the results.
The values obtained for normal synovial perfusion 
are of a realistic order of magnitude when compared 
with perfusion rates of other supporting connective 
tissues (Lassen et al., 1964 i Larsen et al., 1966 
Sjersen, 1967). The difference obtained between 
normal perfueion and perfusion of rheumatoid 
synovium accords with the pathology of the disease. 
It would seem reasonable to accept comparative 
figures for perfusion in normal and diseased states 
as being biologically meaningful and to cautiously 
accept the absolute values obtained until another 
method becomes available for confirmation.
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SUMMARY
1* 133 Xe studies are simple to perform and expose
neither patient nor investigator to undue 
radiation hazard,
2, 133 Xe is cleared from the joint cavity by
synovial vessels to the femoral vein in animals 
and probably also in the human subject.
3* The diffusion and partition coefficients of
133 Xe in synovial tissue have been determined.
4. Clearance can be described by a single
exponential for the first 40 minutes following 
injection and the rate of clearance is 
proportional to the synovial perfusion rate.
5* Synovial perfusion rates in the stifle joint 
of dogs, in normal human knee joints and in 
the knee joints of patients with rheumatoid 
arthritis have been derived.
6. The synovial perfusion rate in patients with 
rheumatoid arthritis greatly exceeds normal.
CHAPTER 3
It is mandatory to establish the confidence limits 
which can be ascribed to any new technique. Particula 
problems associated with the 133 Xe clearance method, 
highlighted in the preliminary studies reported in 
Chapter 2, were the variability of the clearance rate 
in the first few minutes after injection and the effec 
of large diluting volumes on the clearance rate. In 
Chapter 3 the results of studies designed to 
investigate these problems are reported. In 
particular, the influence of the method and of the 
site of injection and the effect of the diluting 
volume injected and of the presence of a knee joint 
effusion are reported.
The reproducibility of the derivation of T-Jr value
ex. dl
is quantitated,^the results obtained by prolonged 
monitoring of the count rate are recorded. The 
variability of clearance rate with time and with the 
age and sex of the subject is examined.
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TABLE I
Values Derived 
and from 90 to 120
; from 5 to i|0 rains, 
rains, after Injection
Rheumatoid Arthritis Normal Does
5-40 mins, 90-120 mins. 5-40 rains. 90-120
18 70 89 90
32 96 70 72
tt 7k 82 80
45 88 42 41
51 90 46 46
54 59
59 63
63 97
61 85
68 111
81 98
43 81
42 102
50 79
35 65
73 91
78 88
66 106
68 92
62 95
The paired values below the line represent those 
studies in which a separate late exponential was 
detected.
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PROLONGED MONITORING OF CLEARANCE RATE
In one normal subject (the author’s) the 
clearance rate was monitored for over four hours.
The T4- value obtained from both the early and late 
segments of the graph were identical (600 mine.).
In five male patients with "classical” or
r . v'vM *•
"definite" rheumatoid arthritis (Ropes et al., 1959) 
the clearance rate was monitored for over IPO minutei 
In each one the early clearance rate (T£ values 18, ■ 
41, 45 and 51 minutes) persisted for approximately 4< 
minutes. Thereafter the clearance rate gradually 
altered the change being discernable between 50 and I 
minutes after injection. The T£ values of the latci 
exponentials were 70, 96, 74, 88 and 90 minutes 
respectively (Table 1).
In twenty experiments in normal dogs monitoring 
was continued for over four hours. In five of those 
studies no late exponential could be separately 
discerned. In thirteen studies a late exponential 
could be clearly defined which was characterised by a 
different T£ value (Table 1). In the remaining two 
studies the T£ value calculated from the later phases 
was greater than the original T-J- but could not be 
clearly defined as significantly different (i.e. with
nfcf fry ' ' i . V ^ .. ’ -•w*- \ * VV ' r ' r'
the range of the reproducibility studies - Table 10).
It is possible that these slower late 
exponentials represent clearance from more peripheral 
areas of the synovium, but there is insufficient 
information to assert this confidently. Clearly, 
however, the term "synovial perfusion" in the context 
of this thesis can only be ascribed to clearance 
within 40 minutes of injection.
STUDIES TO INVESTIGATE THE PATTERN OF CL)ARANCE GRAPHS
OBTAINED
It has previously been noted (page 7o) that on 
some occasions only a single exponential could be 
fitted to the results whereas on other occasions an early 
separate exponential could be clearly discerned. Two 
clues were offered by the pilot studies performed 
(page ~lv). In the normal subjects when the volume of 
isotope diluent was 20 ml. the resulting semilogarithmic 
plot could be described by two exponentials whereas 
when the volume was less than 2 ml. only a single 
exponential was observed. Secondly, two exponentials 
were found more frequently in studies on diseased 
joints than in normal joints. In further studies it 
was also noted, in a qualitative uncontrolled manner, 
that whenever difficulty was experienced with the 
initial injection and whenever the initial synovial 
fluid aspirate contained fresh blood, then the result 
was more likely to be biejq>onential. The first 
exponential in these studies could be either slower 
or faster than the second but was always of less than 
15 minutes’ duration. To investigate this, further 
studies were conducted to examine the effect of volume 
and the effect of injection technique on the clearance
rate of intra-articularly administered 133 Xe.
THE EFF ECT OF VOLUME OF INJECTION ON THE CLEARANCE 
OF INTRA-ARTICULARLY ADMINISTERED 133 Xe
Introduction
Rupture of the joint cavity following injection 
of large volumes intra-articularly is not uncommon 
(Jayson, 1970) and although this is not usually 
accompanied by clinical disability, nevertheless it 
was felt necessary to conduct further studies in 
animals rather than in human subjects.
The effect of the volume of Injection was studied 
in different ways. One experiment was performed 
during which 133 Xe was injected consecutively on four 
occasions into the same joint cavity. On each 
occasion the identical dose of isotope was employed 
but the diluting volume was progressively increased.
As a control for this experiment identical doses with 
constant diluting volumes were employed in the opposite 
joint on four successive occasions. In a further 
experiment femoral vein samples and the femoral venous 
flow rate were obtained in addition to clearance rate 
from the Joint following the injection of a large 
diluting volume and the results were compared with 
those obtained previously (page 5*5) when a smaller 
volume of diluent was employed.
Materials and Methods
Four experiments were conducted on the stifle 
Joints of adult greyhound dogs weighing 29* 27, 33 
ahd 28 kg. The anaesthetic employed and the injection 
(page 34 ) and counting (page ^4 ) techniques have 
been described. The clearance rate from one joint 
was monitored on four successive occasions. The 
dose of 133 Xe administered on each occasion was 
closely similar but on the first occasion the diluting 
volume was 0.5 ml*» on the second 2.5 ml., on the third 
4 ml. and on the fourth 6 ml. The half lives (T-J- 
values, mins.) were calculated from each of the four 
15 minute monitoring periods following injection. In 
the opposite joint the same protocol was followed but 
on each occasion the volume injected was only 0.5 ml* 
Four experiments were conducted employing this protocol. 
In a further six studies a standard volume (6 ml.) of 
0.9% sterile NaCl was injected on four successive 
occasions without the addition of 133 Xe. This 
sequence was adhered to in all six experiments.
In one additional experiment in which the diluting 
volume was 4 ml., a T-tube placed in the femoral vein 
allowed the determination of femoral venous flow rate 
prior to injection. By removing venous samples at
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Figure 2 .
Legendt Effect of repeated injections of a constant 
dose and volume of 133 Xe and of injections of a larg 
volume of 0*9% NaCl with additional isotope.
' • a
TABLE II
Effect of Increasing Volumee of Diluent on 
the Clearance of 133 Xe.
133 Xe ins-
T£ values 
(mins.)
Exp. 0.5 ml. 2.3 mis. 4 mis. 6 mis
1. 78 46 22 12
2. 55 43 34 20
3. 6if 56 38 25
4. 52 43 26 17
TABLE III
Effect of Repeated Administration of 133 Xe 
in a Constant Volume on the Clearance Rate
133 Xe in:-
(mine.)
Exp. 0.5 mis. 0.5 als. 0.5 mis. 0.5 IB
1. 75 71 74 70
2 . 6 2 6 2 60 58
3. 60 63 58 55
4. 47 45 45 48
5, 10, 15» 25* 30, 25 and 40 minutes after Injection 
femoral venous activity could be compared with the 
activity lost from the joint (page 5‘s ).
Results
The results are shown in Figs, 1 to 3 and Tables 
2 to 5.
In all four experiments, when the diluting 
volume was increased so also was the clearance rate 
(Fig, 1). The T*3r values at each monitoring period 
are shown in Table 2, The baseline T-J- values were 
78, 55» 64 and 52 minutes. The respective values 
following injection of 2.5 ml, were 46, 43, 56 and 
43 mins.; following injection of 4 ml. were 22, 34i 38 
and 26 minutes and following the injection of 6 ml. 
were 12, 20, 25 and 1? minutes respectively (Table 2). 
Two exponentials could be fitted to the semilogarithmic 
plots of the experiments in which 4 ml. and 6 ml. were 
injected (Fig. 1 )•
In the control studies, where the diluting 
volume was constant, no alteration in clearance rates 
wan observed. The T£ values obtained throughout each 
experiment were closely similar (Fig. 2 : Table 3).
On each occasion when 6 ml. of 0.9% NaCl alone were injec 
during monitoring of the clearance rate, no marked or 
consistent alteration in the T£ values before and after
TABLE IV
Effect of the Intra-articular Administration of a 
Constant Volume of 0.9% NaCl without Additional 
133 Xe on the Clearance Rate
Volume Injected:-
(nins.)
Exp. 6 mis. 6 mis. 6 mis. 6 mis
1. 60 56 58 61
2. 45 43 45 40
3. 76 79 74 80
4. 54 54 47 46
TABLE V
Cumulative % of 100% Dose Cleared from the Stifle Joini
and
Cumulative % o f  100% Dose Accounted for in Femoral Vein*
Time after
% of Counts 
cleared which 
can be detecte<Injection Joint Femoral Vein in Femoral
5 20.7 3.6 17
10 32.8 5.9 18
15 43.1 8.5 20 .
25 60.3 12.3 20
30 64.7 20.9 32
35 67.0 35.3 53-
40 72.4 36.8 51.
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Figure 3
Legend: The graph obtained following injection of
ml. of I33 Xe solution intro-articularly.
1 2
injection was observed (Fig* 2 : Table If).
Table 5 shows the results of femoral venous 
activity and activity lost from the joint each 
expressed as % of 100% dose as has been described 
(page The activity lost from the joint which
could be accounted for in the femoral vein at 5, 10,
15, 25, 30, 35 and 40 minutes was 17%, 18%, 20%, .
20%, 32%, 33% and 51% . The percentage obtained
in previous experiments (page ' S ' S ) at 10, 20, 30 and 
40 minutes were 92%, 91%, 88% and 93% respectively.
The semilogarithmic plot of count rate against time 
(Fig* 3 ) differs from the plots obtained in other 
studies with lower diluting volumes* Two exponentials 
can be detected as is shown in Fig. 3, the second 
commencing between 30 and 45 minutes after injection. 
The first exponential is markedly faster than is 
commonly encountered and the second is of a similar 
order of magnitude to the first exponential usually
s'*1.observed (pages ^2-).
Discussion
It is clear from these results that whereas volume 
alone does not affect the clearance rate within this 
experimental design, the combination of isotope and 
high diluting volume does exert a profound influence on
°Lh-
the clearance rate. It Is possible that one of the 
non-perfusion variables which affect clearance is 
affected. For example, higher hydrostatic pressures 
and partial pressures may individually or collectively 
contribute to the increased clearance rate in the 
early stages after injection resulting in an additional 
exponential. It seems more likely, however,that 
perfusion itself is Indeed increased. It is 
extremely interesting that the activity lost from the 
joint which could be accounted for in the femoral vein 
was markedly lower than in all other studies in which 
the injection volume was 0.5 ml. In addition, the 
clearance rate from the joint is notably faster over 
the first 30 minutes following injection and only 
thereafter does the slope accord with those obtained 
in the other studies (Fig^ cuAi). The shape of the 
graph is similar to that obtained in the human subject 
in whom the Injection volume was 20 ml. (page (/| ).
These findings suggest that clearance is occurring 
through unusual routes under these circumstances. One 
possible explanation would be that additional vascular 
channels become available in response to either higher 
pressure or higher volumes within the joint cavity. 
Alternatively, it is possible that rupture of the
joint cavity occurs in response to the increased 
volume and that the isotope is then "leaking" from 
the area under the counter. If this were truo,
- v .. >  ’ • •' * \  \ •* • • f: v- * - *♦ v /  , • y  * * * .
• > v 'w ‘V  ' avT .  *  J ;  ( V  / • * *  \  ' '> .  * . ** i * * . W  !* ■ ■?' - •however, a similar result should have been obtained 
when a large volume of saline (Fig. 2) was injected aloi 
Regardless of the precise mechanism involved, it■ . ’ - h
is clearly necessary to maintain the diluting volume
* ... T* . • •
*’ »' ■ •** . - ■ * . • i ’employed in clearance studies to a minimum.
EFFECT OF THE METHOD OF INJECTION OK THE CLEARANCE 
RATE OF IKTRA-ARTICULAHLY ADMINISTERED 133 Xe
The qualitative observation that an early 
exponential, variable in time and direction, might be
V.  -*• V ' ■ » . ' 4 - ^ ’ f ' . *• ' *. . . ’* * ■ ’ • *• - - s '  • "
related to the facility of injection prompted the
’» • * . u * f* ' • > > *■ ' . if*'’' ' . ' . •'following study*
v  . . . .  • . ■* .• * •  y  ' ' .Method r • .
The method of injection was altered. The needle
was introduced into the joint cavity and any free fluid
- ' . • * •
present was aspirated. If no free fluid was present, e
• *. •
very small (less than 1.0 ml.) amount of sterile 0.9%
Na Cl was injected and immediately withdrawn to check
that the needle point was free in the joint cavity. A
-n
period of five minutes (more than the mean T v valucb we
then allowed to elapse, with the patient lying comfortat
• *• r ' * ;■ v* :: } '•** . * -  * . * 'v “V* \ rv*'^  uto allow recovery from the immediate effects of knee 
injection. The knee was then immobilised with sandbags 
and the isotope was introduced very gently and slowly
The T
Mean
i values obtained by the original and by the 
amended method of injection
TABLE VI
Original Method 
n c 12
3.0
3.4
3*6
2 .0
3.2 
3.0
3.2 
2.6 
1.8
6.4
2.7
2.7 
3.09
Amended Method 
n « 8
1.3
i.i
0.8
1.4
1.4 
0 .8
1.3
1.5
1 . 2
(mean injection time 60 seconds) into the joint 
cavity. The needle was carefully withdrawn and 
counting commenced in the usual manner. This procedure 
was followed in thirty consecutive, normal (3) and 
rheumatoid (27)# 133 Xe studies.
Results
No T^-Jr value was calculable in 2 normal and in 
19 rheumatoid subjects.
The T^J value in the remaining normal subject was 
0.8 minutes.
The mean and standard error of the T1^ values in 
the other 8 rheumatoid subjects was 1*2 - 0.096 minutes. 
This differs significantly (p (0.001) from the 
values obtained previously (page1 \ ) by the original 
method (Table 6).
Discussion
Some workers (Harris and Millard, 1956 : Harris et 
1958 : Scholer et al., 1959 i Scoccianti, 1966 : 
Hernborg, 1969) have observed a monoexponential 
clearance pattern of different substances from the 
rheumatoid knee joint, whereas in other studies the 
pattern of clearance curve obtained was similar to the
biexponential curves reported in this thesis (Harris 
et al., 1958). As a further complication, the 
clearance rate in the first few minutes following 
injection may be not increased but almost horizontal, 
thereafter clearance becoming established in the 
usual manner.
In other tissues including skin (Sjersen, 1967)» 
brain (Harper et al., 1964 s Hoedt-Rasmussen et al., 
1966) and kidney (Thorburn et al., 1963) bl- or 
multi-exponential clearance patterns have been 
obtained consistently and found to be biologically 
meaningful. Andersson et al. (1967), studying 
prostatic blood flow, have employed the early fast 
component in the calculation of their results.
Sjersen (1967) considered that the initial fast 
component obtained following intradermal injection of 
133 Xe is an injection phenomenon. Larsen (1966), 
in the study of adipose tissue, supports this 
assertion and he stated that the slope of this early 
fast component could be altered by alteration in 
injection technique. Ho evidence to explain this 
initial fast component has been advanced in any tissue 
as yet and therefore great caution is required in its 
interpretation.
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It seeme unlikely that the T^-J* value obtained 
in these articular studies has any biologically 
important meaning* It is inconstant in time and 
in direction and can be altered by alteration of the 
method of injection.
The precise explanation of this phenomenon is 
not immediately apparent. One possibility, 
suggested by the relationship to freshly blood­
stained aspirate, is that some 133 Xe was being 
introduced directly into small blood vessels.
However, the effect of such a "bolus" injection 
woul^ d probably have been of extremely brief duration. 
A second possibility is that the isotope was 
introduced into a relatively high pressure area, 
for example fibrous capsule, and that elevated local 
hydrostatic pressure was resulting in early 
acceleration of the rate of clearance of the isotope. 
That this is unlikely in the human studies is 
suggested by the ease of injection which was 
mandatory in every case for verification of the 
position of the needle. Also in many cases synovial 
fluid was aspirated from the joint. However, the 
results of the succeeding study shows that this is 
indeed a possible mechanism. A further possibility
discussed in a later part of this thesis (page 
is that local histamine or catecholamine release 
consequent upon tissue damage accelerates or retards 
the early phase of clearance. Early diffusion and 
mixing of the isotope may also be important.
Although T1! values were much lees frequently 
obtained and were of markedly reduced duration in 
later work reported in this thesis, the only points 
on the clearance graphs which were utilised in 
deriving T-J- values were those following injection by 
over three minutes.
THE EFFECT OF THE SITE OF INJECTION ON THE 
CLEARANCE OF 133 Xe
At the conclusion of one 133 X© clearance study 
in a greyhound, while the animal remained under 
anaesthetic, the patello-tibial ligament was severed 
and the patella was reflected, exposing the Joint 
cavity. 133 Xe (0.1 ml.) was then injected 
successively into four separate areas adjoining the 
Joint cavity. Between each injection, saline soaked 
swabs were packed into the joint cavity, the patella 
was replaced and the wound approximated with artery 
forceps. The 133 Xe clearance rate was then
■vtf
-r ? •<?
vr
Figure t„
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Legondt Clearance rates of I33 Xe injected into 
adipoee tissue, liganent fibrous tissue and bone
monitored for 20 minutes before the wound was 
again opened and the experiment repeated employing 
a different site of injection. The sites selected 
for study were the medial femoral condyle, the patello~ 
tibial ligament, an area of fibrous tissue and an 
area of adipose tissue. The injected area was 
removed at the conclusion of the study and the tissue 
identity confirmed histologically in each case. The 
pressure required to inject the isotope solution into 
the first three areas was noticeably greater than the 
pressure required to inject the isotope into the 
joint cavity.
Results
The half lives of the initial clearance rate is 
designated T^i and that of any succeeding exponential 
is recorded as Ti value (page "To) •
The results of the T^i and of the Ti values are 
shown in Fig. In the case of bone, ligament and
fibrous tissue, the early clearance rate was markedly 
faster than the results commonly obtained when the 
isotope is introduced into the joint cavity. In the 
case of clearance from adipose tissue, fibrous tissue 
and ligament, the Ti values are greater than those
U2i* \
obtained in clearance from the joint cavity (pages 
S T  ), denoting a slower clearance rate. The Ti 
value of clearance from adipose tissue accords with 
133 Xe clearance rates obtained in studies on human 
adipose tissue (Larsen et al.f 1966). The initial 
fast clearance rate in adipose tissue was considered 
to be insufficient duration to justify calculation of 
a T^i value. The Ti value of clearance from bone is 
markedly less than all other clearance rates. Bone 
blood flow is of the order of 10 ml./lOO ml./min. 
(Copp and Shim, 1963) which is in accord with the Ti 
value obtained in this study (8 mine. = 8.3 ml./
100 ml./min.).
There being only one study in each group limits 
the confidence which can be employed in interpreting 
these results. The T i values obtained in fibrous 
and ligamentary tissue does suggest an association 
with tissue composition. The early faster clearance 
rate may well be associated with a local increase in 
hydrostatic pressure. These results do, however, 
underline the importance which must be attached to 
ensuring that the needle point lies free in the joint 
cavity when performing the 133 Xe clearance studies. 
Whereas the facility of injection will assist in
L02
excluding injection into bone, ligament or fibrous 
capsule, it is not possible to exclude injection into 
adipose tissue in this way. Aspiration of synovial 
fluid will certainly confirm the intra-articular 
position of the needle point but whereas this is not 
difficult in the dog and commonly in rheumatoid 
joints, the same can not be said for normal human 
subjects. When this is not possible the injection 
and easy withdrawal of a volume of sterile 0.9% NaCl 
will assist in localisation and was mandatory in the 
studies reported in this thesis.
Thus three possible mechanisms which may affect 
the pattern of clearance have been to some extent 
characterised. It is possible that many other factors 
may contribute to clearance in the early period 
immediately following injection. However, the 
remaining studies in this study were conducted with 
particular attention to the technique of injection which 
was standardised throughout, and any free fluid in the 
joint cavity was removed prior to the injection of 133 Xe.
Studies were then designed to examine the possible 
effects of certain other factors which might be 
expected to exert an influence on the 133 Xe clearance 
rate.
Mean
S.E.l
The T-J- values obtained prior to anJ following 
aspiration of a knee effusion in lit rheumatoid 
patients. The volume aspirated in each case i 
noted. The correlation coefficient between the 
volume aspirated and the difference in T-J- value
; TABLE VII
was 0. 3>5'i+ ' - if ►*..' .
Tt Value (mins.)
Before After Volume
Aspiration Aspiration Difference Aspirat
72 60 12 44
58 50 8 52
52 48 4 v- 63
32 28 52
152 125 27 61
34 14 2° 70
k9 29 20 * . 72
k3 36 , 7 55
27 - 23 4 12
63 35 28 35
39 37 2 21
56 38 " 18 6o
69 66 3 38
68 30 18 30
58.14 *5.64 12.50 47.:
(. 8.19 7.19 2.449 4.8'
T (paired) « 5.104 r = 0.354 : •. ~v •
EFFECT OF A KNEE JOINT EFFUSION ON THE CTJA3AWCE OF 
INTRA-ABTICPLARLY ADMINISTERED 133 Xe
The following study was conducted to determine the 
effect of the presence of a knee joint effusion upon 
the 133 Xe clearance rate.
Subjects and Methods
Fourteen post-menopausal female patients were 
selected who were suffering from "classical" or 
"definite" rheumatoid arthritis (Ropes ct al. 1959) 
and who had clinically obvious knee effusions. Their 
mean age was 50.8 years and the age range was 46 to 60 
years. All patients were informed of the object of 
the study prior to seeking their agreement to 
participate. The 133 Xe studies were performed in 
the manner previously described (page S ) and one 
hour later the knee joint was aspirated to completion 
with full aseptic precautions. The volume of aspirate 
was measured. On no occasion was fresh blood observed 
macroscopically in the aspirate. The 133 Xe studies 
were then repeated in an identical manner.
Results
The values obtained on the two occasions are 
shown in Table 7 together with the volume of synovial 
fluid aspirated from each knee joint. It can be seen 
that the mean T-J- value obtained prior to aspiration
101*
(mean 58.14^ S.E.M. 8*19 minutes) was significantly 
higher ( p. (  0.001) than the mean value obtained
ffollowing aspiration (mean 45*64- S.E.M. 7*19 minutes). 
The reduction in Ti value in each patient was not 
related to the amount of fluid aspirated. The 
correlation coefficient was 0.354 (p =^0.1).
Discussion
These results show that the presence of a knee 
joint effusion reduces the rate of clearance of 133 Xe 
from the knee joint. This accords well with 
theoretical considerations. Thus, the further the 
isotope is from the effluent blood flow the more the 
diffusion coefficient will operate. Since the 
diffusion rate of 133 Xe is slow (page 5^ ), the rate 
of clearance will be reduced.
Of practical importance however is the fact that 
relationship between the volume of the aspirate and the 
degree of reduction in clearance rate is not 
significant (r * O.354), Thus, the presence of a 
knee joint effusion introduces an avoidable variable 
into the 133 Xe studies. Accordingly, wherever 
possible, an effusion which was present was aspirated 
as completely a6 possible prior to the 133 Xe studies 
reported hereafter.
REPRODUCIBILITY OF 133 Xe CLEARANCE RATE
Variability of results is encountered in any 
biological system whether the method of monitoring is 
subjective or objective. Whereas it is certainly 
possible to reduce biological variation by attention 
to technique, it is not possible to remove it. The 
only alternative, therefore, is to examine the 
variation encountered, to quantitate it and to interpret 
all future results accordingly. The following 
studies were designed to examine the inherent 
variability of the 133 Xe clearance rate in normal 
and diseased human subjects and in the greyhound.
RI PRODUCIBILITY OF LINE-FITTING
The only aspect of the calculation of the Ti 
values which is open to inter- and intra-observor error 
is the process of fitting a straight line to the seai- 
logarithmic plots of the results. It became obvious 
in the course of these 133 Xe studies that, provided 
the knee remained absolutely immobilised throughout the 
monitoring period and the counting geometry was 
maintained, semilogarithmic plots of the count rate 
clearly described a straight line. However, in 
several cases, doubt existed and accordingly the inter-
The T-J- values (mine*) obtained when the same results 
were calculated by the same observer on different
TABLE VIII
occasions
INTRA^OISERWR error
Occasion 1 Occasion 2
65 60
30 32
10 12
Results from 46 42
rheumatoid 22 20
knees 27 25
n s= 9 21 24
36 32
46 41
Standard Error of the difference 1.07 mins.
260 245
170 185
Results from 220 265
normal knees 125 150
n ss 9 360 290
125 145
330 195
250 235
265 270
Standard Error of the difference 18 P 7 mine.
TABLE IX
The Tf values (nine*) calculated from the same results
by two different observers
-----
Observer 1 Observer 2
Results from 
rheumatoid 
knees 
n e 14
17
69
17
17
17
50
9
17 
23 
47 
40
18 
42 
20
18
62
15
18
15
50
13
17
17
52
46
22
31
17
Standard error of the difference 1.51 mins.
Results from 
normal 
knees 
n s 10
130
170
260
150
190
280
310
220
265
110
145
130
190
180
160
330
250
210
180
125
Standard error of the difference 14.44 alns.
ijQh
and the intra-observer errors were quantitated.
Method
To determine the inter-observer error, the counts 
recorded in J 1+ rheumatoid subjects in whom the 
semilogarithmic plots of count rate against time did 
not describe a straight line were re-plotted and the 
Ti values calculated separately by two different 
observers. Similarly, Ti values were determined by 
two observers from the counts recorded from | Q  
normal subjects which likewise did not describe a 
straight line when plotted serailogarlthmically against 
time. To quantitate the intra-observer error, the 
results obtained in 9 studies of patients with 
rheumatoid arthritis and in Cj studies on normal 
subjects were plotted "blind" on two occasions, one 
week apart, by the same observer.
Results
The results of the Ti values obtained are shown 
in Tables 8 and 9. The standard error of the 
difference of the inter-observer was 1.31 minutes and 
that of the intra-observer error was 1.07 minutes for 
the rheumatoid graphs. However, the standard error 
of the difference of the inter-observer error was 
minutes and that of the intra-observcr error was 18.7 
minutes in the case of the normal graphs.
±01
Discussion
It can be seen from these results that the int«?r- 
and intra-observer for the normal graphs is greatly 
in excess of that recorded in the case of the 
rheumatoid graphs• This is closely related to the 
position of the graphs on the semilogarithmic scale 
(Fig. £> : page ^ ) . To determine the of the 
normal subjects the graph, running almost parallel to 
the horizontal axis, must be produced for some 
considerable distance and this is not the case in tie 
faster clearance graphs of the rheumatoid subjects 
(Fig^jl^. Also it must be appreciated that the 
graphs employed to determine these errors were the 
most irregular graphs obtained in the course of these 
studies. However, the wide variation found in the 
normal subjects must be constantly remembered in 
considering the results of the succeeding studies. The 
error is very small in the case of tho results obtained 
in studies on patients with rheumatoid arthritic.
EFFECT OF REPEATED ADMINISTRATION OF ISOTOPI INTO TflF 
SA.ME JOINT CAVITY
In experiments previously reported (page °lo),
133 Xe was injected consecutively four times into the 
stifle joint and the clearance rate monitored between
TABLE X
Reproducibility of Ti values of 133 Xe clearances 
12 studies ehof/ing the effect on Ti values of a 
second injection of 133 Xe given about 15 minutes 
after the initial dose.
Ti (minutes) after 
1st injection of 
 L21.Xe
150
150
100
63
55
55
41
32
30
28 
28
13
Tf (minutes) after 
2nd injection of 
______133—Xe
150
150
100
56
51
52 
39 
27 
27 
27 
25 
16
Standard error of the difference * 0.82 minutes
(Calculated from lower 10 figures in the Table).
1 Q
»
each injection for 15 minutes. This experiment was 
repeated four times and on each occasion the Ti values 
obtained (Table 3) were similar.
The same protocol was followed in twelve 
rheumatoid patients. In each patient approximately 
10jCi of 133 Xe dissolved in 0.2 ml. of 0.9% NaCl were 
injected into the joint cavity on two consecutive 
occasions with an intervening control monitoring period 
of 15 minutes. Again the Ti values obtained following 
each injection were similar (Table 10). The standard 
error of the difference was only 0.82 mins. However, 
clearly no result can be considered to be significant 
unless it is at least outwith the range of the 
difference of the values quoted (7 minutes). This is 
particularly relevant in the studies on the effect of 
pharmacological agents reported later in this thesis 
(pages 1 * 5 * .
VARIATION WITH TIME OF INJECTION ON THI CLEARANCE OF
S P i |
Morning and Evening Studies
In eight rheumatoid subjects studies were performed 
at 9 a.m. and again at 6 p.m. The T£ values obtained 
are shown in Table 11.
TABLE XI
v ' V
T£ values obtained when 133 Xe studies were performed 
at 9 a.m. and at 6 p.m. in six patients with
rheumatoid arthritis
Ti values (minutes)
Patient
1
2
3
h
5
6
mean
♦
Standard Error
9 a.a.
46
62
39
56
54
60
52.8
3.58
6 p.a.
42
60
38
59
58
65
53.6
4.46
Standard error of difference = I .49 minutes.
TABLE XII
Ti values obtained when 133 Xe studies were performed 
on separate occasions, Zb hours apart, in 7 
rheumatoid patients and in one nomal subject.
T-J- values obtained (minutes)
Subject Day 1 Day 2
1 (R.A.) 30 25
2 (R.A.) 50 W)
3 (R.A.) 30 28
b (R.A.) b3 b7
5 (R.A.) 3b 30
6 (R.A.) 30 25
7 (R.A.) 30
8 (normal) 120 135
Standard error of the difference of the values 
obtained in the seven rheumatoid subjects = 1.93 mine.
The standard 
error of the difference was only 1.49 minutes.
Thus no circadian rhythm was detectable in these 
abnormal subjects.
Day to Day Variation
In seven patients with rheumatoid arthritis and 
in one normal subject 133 Xe studies were performed 
on two occasions twenty-four hours apart. The TJ 
values obtained are shown in Table 12. The standard 
error of the difference was 1.93 minutes.
VARIATION WITH SITF. OF INJECTION
Since the diffusion rate of 133 In tissue is 
slow (1.0 x 1<T5 cm2/sec. in tissue - page the
rate of clearance of the isotope is probably relevant 
only to the areas anatomically closely related to the 
site of deposition of intra-articularly injected 133 Xe 
The histology of synovium is by no means uniform 
(Chap. \ : page and accordingly it was considered 
necessary to investigate the variation in clearance 
rate from different sites within the joint.
Method
Six patients with "classical" or "definite" 
rheumatoid arthritis were selected. All of these 
patients had clinical involvement of the knee joint
The Ti values obtained when the isotope was 
introduced into the joint, on one occasion by a 
medial approach and on the second occasion by a
lateral approach
TA5LB XIII
■La-Umt Score Medial Approach Lateral Approac
1 12 28 27
2 12 46 49
3 12 33 30
4 4 68 65
5 4 57 59
6 4 78 78
Standard error of the difference 1»Q2 mins.
but the degree of Involvement was not uniform.
Thus three patient© had clinical knee scores (page 1*2.) 
of +12 and the other three had knee scores of +!*• 1.11
were female and their mean age was 60,2 years (range 
55 to 61\ years). In all patients their arthritis rae 
in a "stable" state at the time of study and no 
alteration in their clinical state or regimen of 
therapy was noted during this study,
133 Xe studies were performed on two occasions 
within 2l\ hours. On the first occasion the isotope 
was introduced by a medial infra-patellar approach snd 
on the second occasion by a lateral infra-patellar 
approach. Otherwise the method of injection and the 
counting conditions were identical.
Results
The TJ values (in minutes) obtained on the two 
occasions in each patient are shown in Table 13. It 
can be seen that the values obtained on each occasion 
were closely similar regardless of the degree of 
involvement in the inflammatory process. The 
standard error of the difference of the values 
obtained on the two occasions was 1.02 minutes.
Discussion
Thus these results show that the clearance of
intra-articularly administered 133 Xe is similar, 
regardless of the site of injection. This suggests 
that, although the pathological process is not uniform, 
the changes affect the parts of the synovium subserving 
isotope clearance sufficiently severely to render the 
rate of clearance of 133 Xe abnormal and sufficiently 
uniformly to give similar clearance rates.
VARIATION WITH SEX 
Method
The results obtained in over 800 studies 
performed on patients suffering from "classical" 
rheumatoid arthritis from the inception of the 
technique until May 1969 were surveyed. From these 
results, fourteen male and fourteen female subjects 
were selected who were age-weight- and as far as 
possible disease-matched. The parameters of disease- 
matching included evidence of systemic disease by 
disease duration ^ erythrocyte sedimentation rate, 
articular index (Ritchie et al., 1968 - page Hi), 
sheep1s cell agglutination titre (Ziff, 1957)# 
haemaglobln and white cell count and evidence of local 
disease in the Joint studied. For the assessment of 
local disease, a knee score was employed which is 
utilised throughout the succeeding studies in this thesi
TABLE XIV
The T-J- values obtained when 133 Xe studies were 
performed in lit male and lit female patients who 
were suffering from rheumatoid arthritis
Male Female
56 J?
48 5 2
62 64
38 36
26 25
Ti values 81 86
obtained 63 60
(minutes) 59 61
32 31
38 35
46 43
42 45
58 61
72 73
Mean 51.6 52.1
Standard Error 4.21 4.59
0.9> p>0.8.
TABLE XV
The ciean and standard error of the parameters 
employed in comparing the Ti values obtained in 
male and in female subjects
Male Female
Disease duration (yrs.) 5,6 ^ 1*04 5.5 - 1.12
E.S.R. 52 i 3.6 50 - 4.1
Hb 10.8 - 0.8 10.9 - 0.7
w.b.c. 6.5 - 1.1 thousand 6.7 - 2.06t
SCAT titre 138 128
Articular Index 56 i 3.6 52 t 4.i
Knee Score 7.0 i 1.14 7.5 - 1.06
(years) 55 - <t.2 57 - 3.8
Weight (Kg) 78 - 5.6 72 - 6.1
LLi
r
A history of pain and of tenderness was elicited 
and graded* The knee was then subjected to firm 
pressure over the joint margin and the response 
graded* Finally the knee was palpated and the 
degree of swelling was graded. Grading was on a 
0 to 3 basis where 0 * "absent" 1 «= "slight"
2 - "moderate" and 3 85 "severe". The maximum score 
for any individual Joint was therefore *12.
Results
The results are shown in Tables 14 and 15* The 
values obtained are similar in the female and male 
subjects when the other variables are stabilised.
The values obtained in male 
subjects (mean 51*6 minutes i S.E.M. 4*21 minutes) 
werenot significantly different (0.9>*P >0.8) from 
the values obtained in female subjects (mean 52*1 
minutes i S.E.M. 4*59 minutes) by a student t-test.
The mean and S.E.M. of the parameters employed in 
comparing the groups of patients are shown in Table 13* 
It can be seen that the groups of patients were closely 
similar in all respects. Thus no sex difference is 
encountered in these 133 Xe studies such as has been 
reported with radioactive sodium (Jacox et al., 1952).
The Tj values obtained in 16 rheumatoid patients 
within the age range 30 to i*0 years and in a 
further 16 patients within the age range 55 to
65 years.*      1     ■        — ..
Age Group 
30A O  years 55/65 years
TABLE XVI,
*f9 47
76 77
71 75
82 80
26 28
36 39
32 31
T£ values kk 42
obtained
(minutes) 4129
43
32
57 53
53 53
67 68
■ . *>
39 37
51 55
43 42
Mean 49.75 50.13
Standard Error 4.21
e.9?> p> 0.95
TABLE m i
The mean and standard error of the mean of the 
parameters employed in comparing the T£ values obtained 
from the different age groups studied.
Age Group
Matching Parameter
30 to 40 years 
n g 16_____ 55 to 65 years n g 16_____
Disease duration (yrs.)3.1 - 1.01
E.S.R.
Hb
w.b.c.
SCAT titre 
Articular Index 
Knee Score
Weight (Kg)
3.3 - 0.81 
♦39 - 2.9 
♦
36 - 4*2
1 1 .1 ~ 0.9 11.4 - 0.8
6.9 - 1.6 thousand 6.2 • 1.1 
128 128
48 - 4.2 W7 - 3.9
5 - 1.2
82 - 4.2
5 .3  -  1.01
79 - 3.6
L\Jl
VARIATION WITH AGE
133 Xe clearance studies have been previously 
reported (page 82.) which show that no variation could 
be demonstrated in normal subjects within the age 
groups studied. The following investigation was 
undertaken to exclude the possibility of variation 
with age in diseased subjects.
Method
In a similar manner to that described for 
investigation of sex difference, all the results were 
again scrutinised. Thirty-two patients were selected 
who were weight-matched and disease-matched. Sex 
matching was omitted and disease matching was performad 
on the same basis as has been described above. Sixteen 
of these patients were between the ages of thirty and 
forty years and sixteen were between the ages of fifty- 
five and sixty-five years.
Reeults
The results are shown in Tables 16 and 17# The 
TJ values obtained in the patients aged thirty to 
forty years (mean 49*75 - S.E.M. 4*24 minutes) did nob 
differ significantly ( 0.97>P>0.95 ) from the values 
obtained in the patients aged between fifty-five and 
sixty-five years (mean 50.13 * S.E.M. 4.21 minutes)
Jlh
by a paired student t-test. The mean and standard 
error of the parameters employed in comparing these 
results are shown in Table 17 where it can be seen that 
the two groups were similar in other respects. Age, 
therefore, within the limits of the study, does not 
seem to influence the clearance rate of 133 Xe,
The rate of clearance of intra-articularly 
administered 133 Xe from the joint cavity possesses 
an acceptable degree of inherent biological variation 
provided that the isotope is delivered in a small 
diluting volume, that the injection is carefully and 
accurately accomplished and that any free fluid is 
aspirated before the commencement of the study.
Clearance is then monoexponential for approximately 
40 minutes after injection and there is little variation 
with age, sex, time or site of injection. The error 
of calculating Ti values is small in the case of 
relatively fast clearance rates but becomes considerable 
when the clearance rate is slow.
t
SUMMARY
1* Clearance is monoexponential for approximately 
If0 minutes after injection. Thereafter a 
slower exponential may occur.
2. Early fast clearance rates may be related to volume 
of diluent employed or to the method or site of 
injection. Clearance under these circumstances 
may occur through routes other than the femoral 
vein. This inconstant transient phenomenon is 
unlikely to be biologically important in these 
studies.
3. The clearance rate is increased following 
aspiration of an effusion but not in proportion to 
the volume of aspirate.
4. Reproducibility of line-fitting to derive Ti 
values is considerably higher when the clearance 
rate is fast than when it is slow.
5. Inherent biological variation within short time 
limits and with age and sex of the subject is 
small.
± i£
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CHAPTER h
The change in the rate of clearance of 
intra-articularly Injected 133 Xe from the normal 
canine joint following external heating and with
local administration of vaso-reactive drugs is
'
reported in this chapter.
The response to the intra-articular injection 
of exogenous catecholamines and their respective 
blocking drugs was studied in an attempt to 
demonstrate the presence of and ^ adrenergic
receptors in normal synovium. A similar but
limited study was conducted in joints which were 
the seat of experimentally induced osteoarthritis 
and synovitis and the results of both are 
reported in this chapter.
The change in clearance rate resulting from 
the local administration of methacholine and of 
atropine was studied to investigate the effects of 
parasympathetic stimulation and studies were 
conducted to characterise the effects of 
histamine and of serotonin on the clearance rate. 
The results of these studies are also reported in 
this chapter.
. 133vt  Xe HEAT
^ APPLIED
 ..
\   <
-7 7
2  7
2 6
° 5
»- 4 O
si
0
1  3Z
boc<
8
3E 2UJ(/)
• • • # HEAT
V DISCONTINUED
T 2 « 46 |
...........
..........
r^2
10 20 30 40 50 60
TIME IN MINUTES
Figure 1
Legend: The effect of externally applied heat
on the clearance rate of 133 Xe.
EFFECT OF KXTJv HAL HSATING OK THE 133 Xe 
GUIDANCE RATE
Introduction
The effect of the application of external heat on 
the rate of clearance of intra-articularly injected 
133 Xe from the stifle Joint was determined in 
anaesthatised adult greyhound dogs.
Materials and Methods
Twelve experiments were conducted employing both 
stifle Joints of six greyhounds weighing from 2i* to 30 kg 
The anaesthetic (Chap."2-: page the injection
(Chap. “b : page ^to) and the counting (Chap. ”2- : page Z*\ 
technique have been described. The baseline clearance 
rate was monitored for 20 minutes in each study and 
thereafter the Joint was exposed to external heating 
with a Philipp short-wave diathermy lamp. The detector 
was protected from the heat source and the count rate 
was monitored throughout the heating period (30 minutes) 
and for a further 20 minutes following removal of the 
heat source.
Results and Interpretation
An example of the semilogarithmic plot of the 
result is shown in Fig. 1. Five minutes following the 
application of heat the clearance rate accelerated and
TABLE I
Ti values (minutes) before during and after the 
exhibition of external heat to the canine stifle 
joint* The time intervals between the application 
or removal of the heat source and the subsequent 
change in clearance rate are shown*
Ti (mins.)
Before
Heating
Time (mins.) 
to 
Change
Ti (mine.)
Daring
Heating
Time (mine.) 
to 
Change
Ti (
Aft
Heat
68 4 42 9 6$
4 9 3 31 11 4£
52 6 40 20 51
54 5 32 15 50
77 5 46 17 74
70 8 53 16 72
42 8 25 13 42
55 4 20 8 55
54 6 36 20 57
65 9 51 12 67
67 9 50 12 64
60 7 36 14 56
59.4 5.8 38.5 13.9 58
42-77 3-9 20-53 8-20 42
\similarly there was a delay of 8 minutes following 
the removal of the heat source before the clearance 
rate began to decelerate and return to its pre-heating 
value. The TJ values (mins.) derived from the pre­
heating, heating and post-heating periods are shown in 
Table 1.
These results indicate that the exhibition of 
external heating results in an increase in clearance 
rate and therefore in synovial perfusion rate in 
canine synovium. The increase, while persisting 
during heating, is transient lasting only from 8 to 
20 minutes following the removal of the heat source.
ADRENERGIC CONTROL OF SYNOVIAL FliRFPSION
TIIE PRESENCE OF * AND P> RECEPTORS 
Introduction
Both functional (Kellgren and Samuel, 1950) and 
histological (Gardner, 1950 : Boyd, 1954 : Skoglund, 
1956 : Polacek, 1961 s Goldie and Wellisch, 1969) 
techniques have been employed to demonstrate the 
presence of nerve fibres in human synovial tissue.
In addition, Cobbold and Lewis (1956|)have studied 
the response of ”Joint blood flow” to both physical 
and pharmacological agents in an Isolated perfused 
animal preparation and demonstrated the presence of 
both sympathetic and parasympathetic responses.
The experimental model employed in the study of 
the route of clearance of 133 Xe (p a g e  iTo j Fig* 3* )
is particularly suited to the study of the physio­
logical responses of the synovial vasculature to 
pharmacologically active agents. The only 
interference with normal mechanisms in the Joint is 
anaesthesia and the introduction of minute volumes of 
isotope and compounds. In the present study, the 
monitoring system employed for the detection of the 
vascular effects of the compounds administered was 
the 133 Xe clearance rate. The femoral venous flow
!£C
rate and femoral venous radioactivity were also 
monitored.
It is currently believed that a "receptor site” 
is a specialised area on the protein surface of a muscle 
cell. When the fibre of the nerve cell is stimulated, a 
chemical mediator is released across the myoneural 
junction and combines with this specialised area 
producing an effect. Adrenergic receptor sites may be 
demonstrated hietochemically ( Falck and Owman, 1965) 
or their presence may be inferred from the effects of 
selected adrenergic agents and their antagonists on a 
suitable monitoring system. The latter method is 
employed in the present study. The compounds employed 
were selected from the point of view of both specificity 
and duration of action. Whereas few compounds have 
exclusively either c* or ^ effects, the peripheral 
effect of noradrenaline is mainly on oC and of isoprenalir 
mainly on ft receptors. Similarly, phentolamine and
propranolol act principally as oi and p  receptor 
blockers respectively although a direct action of 
phentolamine on email blood vessels has been demonstrated 
(Goodman and Gilman, 1965)*
The present study was designed to demonstrate the 
presence of at and £ receptors in synovial tissue by
monitoring the effect of both c< and 
stimulation and inhibition on the 133 
rate*
1 2 1
j? receptor 
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MATERIALS AND METHOD
A series of experiments was undertaken on the 
stifle joints of adult greyhound dogs at the Wellcome 
Surgical Research Centre, Glasgow,
The anaesthetic procedure, the injection technique 
and the counting and monitoring of clearance rate, 
femoral flow rate and femoral venous activity have 
been described (Chap, 1 : page (+L). The needle 
remained in place throughout each experiment, closed 
by a syringe containing sterile 0,9% NaCl, thus 
providing a convenient route for the administration of 
the active compounds.
The experimental protocol is shown in Table 2. 
Fourteen groups of studies were conducted. In all 
but two groups the experiment commenced with a control 
period of 15 minutes duration during which baseline 
values were obtained. The active compounds were 
administered in the order shown in Table 2 and a 
monitoring period of 15 minutes was allowed following 
administration of each compound. In at least one 
study in each major group > in addition to blood 
pressure pulse rate and clearance rate from the joint, 
the femoral venous flow rate and activity and clearance 
from the opposite stifle joint were also monitored 
continuously. Clearance rates are expressed as
JJLZ
Ti values (minutes). In two studies the effect 
of administering the isotope and active compound 
simultaneously without a preliminary control 
monitoring period was studied. The compounds 
employed on these occasions were isoprenaline (Spg) 
and noradrenaline (5yg)«
The pharmacological agents employed in this 
study were:
Isoprenaline sulphate in normal saline (Boots Pure 
Drug Co.)f .
Phentolamine mesylate BP ("Rogitine", Ciba 
Laboratories Ltd.),
Propranolol hydrochloride ("Inderal", Imperial 
Chemical Indutries), and
1-noradrenaline acid tartrate ("Levophed”, Bayer 
Production Co.).
These preparations were diluted in normal saline to
achieve a concentration of 5 ^ g/0.25 nl. for
isoprenaline and noradrenaline and 20^g/0.25 ml.
for propranolol and phentolamine.
Fifcure Z
Legend: The effect of intra-articular isoprenaline
(Jt'g*)* Blood pressure, pulse rate and the 
clearance rate from the opposite joint remain 
unchanged.
The rate of clearance from the injected join 
the femoral flow rate and femoral venous activity 
are all increased following injection.
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Figure 3
Legend: The effect of intra-articular noradrenaline
Blood pressure, pulse rate and clearance 
from the opposite joint remain unchanged*
The rate of clearance from the injected joii 
the feioral flow rr»te and femoral venous activity ar< 
all reduced following injection.
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Legend: The effect of intra-articular propranolol
(20HS«)» Blood pressure, pulse rate, clearance rate 
from both opposite and injected joints, femoral flow 
rate and femoral venous activity all remain unchanged 
following injection.
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Legendj The effect of intra-articular phentolaraii 
(IfO y £•)• Blood pressure, pulse rate and clearai 
from the opposite joint remain unchanged*
The rate of clearance from the injected 
joint, femoral flow rate and femoral venous activ; 
are all increased following injection.
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Legend: The effect of intra-articular noradrenalir
(5 ug.) following the prior administration of 
phentolamine (4
Blood pressure, pulse rate and clearance 
from the opposite joint remain unchanged throughoul 
the experiment.
Although the clearance rate from the 
injected joint, the femoral flow rate and femoral 
venous activity are all increased following the 
injection of phentolamine (40*» g«)f there is no 
subsequent change following noradrenaline (5 V £•)•
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Legendt The effect of intra-articular isoprenaline 
(5yg*) following the prior administration of 
propranolol (20^ g*).
Blood pressure, pulse rate, the clearance 
rate from opposite and injected joints, the femoral 
flow rate and femoral venous activity remain unchan# 
throughout the experiment*
RESULTS
The effectsof intra-articularly administered drugs 
on the clearance of 135 Xe are shown in Figs. 2 to 7 and 
Tables 3 to 7*
In Figs. 2 to 7 the values obtained for pulse rate, 
blood pressure, clearance rates (Ti values) from both 
control and test stifle joints, femoral venous flow 
rate and femoral venous count rate before and after the 
administration of each drug are shown. It can be seen 
that there was no alteration in blood pressure, pulse 
rate or in the clearance rate from the opposite stifle 
joint in any of these studies. Whenever a change in 
clearance rate from the test joint was observed, the 
femoral venous flow rate and femoral venous count rote 
altered in the same direction.
Following the intra-articular administration of 
isoprenaline (5^g)» the clearance rate, femoral flow 
rate and femoral count rate were all increased (Fig. 2). 
However, no change occurred when isoprenaline (Spg) 
was administered after the prior administration of 
propranolol (20^ g) (Fig. 7).
Following the intra-articular administration of 
noradrenaline (5^g)» the clearance rate, femoral flow
LF: ! CT o f  ^  ('ICEFIT)" STIMULATION (ISOPRENALINE) OH 133X<
CLEARANCE RATE - I
* r * ' l . *
TABLE III
Isoprenaline (5Pg) 
______Alone______
Ti before Ti after
. 90 21
72 7
35 12
200 80
200 11
100 28
95 23
66 9
107 21f
Range 35-200 7-80
8/8
Isoprenaline (5y g) aft 
. Propranolol (20h x)
Ti before Ti after
74 74
60 60
110 110
80 80
51 51
76 76
75 75
51-110 51-110
No. of experiments showing 'change
0/6
wt.
I %
r
■ u
IPS
V
. 1 <■ .t
•*. --A:
TABLE IV
SIT.L1?.?. 1£ ^
Isoprenaline (5*> g) after Isoprenaline (5m g) afl
  PfeeqtoJ.ftmlne g)   Noradrenaline (5f *)
before Ti after Ti before Ti after
100 100 
110 110
80 21 110 110
66 UZ 200 200
58 11 . 52 52
56 22 120 100
6i* 31 20 20
48 27 56 56
■ 120 51
. . 1 
Mean 62 25.5 99 89
Range lt8-8o 11-1*2 20-200 : 20-200
No. of experiments showing change
6 /6  2/9
• ■ ■ . !
> : \  • • • • • *  / •  v . . \  t  . . . . . .  . • x
b . . . ' . . . • - . - ' - -
f c . . ;* V- ,  ,  • t  " • ■ v - ~ .  - * • * < •  . * . - '  4 ;  v .  • . . T V  ‘ . .
TABLE V
gfT.CT OF oi RECEPTOR STIMULATION (TORADREKALIHE) OH 1?33
CLEARANCE WTE - I
Noradrenaline (5* g)
 AAone_______
Noradrenaline (5pg) After 
Teoprcnallac (5f ft)
T} before Ti after Ti before Ti after
, /, .*•* * *
60
• V*. . ■ • • *
. 200 21 100
72 250 17 110
t* n *>.• C* V- • * f* 4’.^ 85 280 53 110
55 300 12 : 52
’■ *; ‘ V ./ 76 210 34 100
V ‘-*V Y- *■*. -O'-/.; 9 45/ -*9?"* *,^ V • * « V M- 28 150
23 44
>" *%£ ' • V.‘- ; *• 11 . 20
Mean 69.5 248 23 81
Range 55-85 200-300 9-53 20-150
-A’* . ♦ % . - ' . ,
Ro. of experiments showing change
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rate and femoral count rate were all decreased (Fig, 3)* 
However, when noradrenaline (5^ g) was administered 
following the prior administration of phentolamine 
(40 ye) no change in these parameters was noted (Fig* 6).
When phentolamine (40 y g) was injected into the 
joint the clearance rate, femoral flow rate and femoral 
count rate were all increased (Fig. 5)» However, when 
propranolol (20 y g) was injected no change in these 
parameters was noted (Fig. 4)*
The Ti values obtained before and after the 
administration of each drug in the other studies of 
each group in which no coil was inserted are shown in 
Tables 3 to 7* In all experiments the direction of 
change was identical to that noted above with the 
exception of the results obtained when noradrenaline 
(5 ye) *<*8 administered following the prior administration 
of phentolamine (20 ye)* In of eight instances there 
was a distinct alteration with noradrenaline which did 
not occur when the dose of phentolamine employed was 
40 y>e (Table 6). When isoprenaline (5 j^ g) was injected 
following the prior administration of phentolamine (40^ g) 
the T-J values were markedly reduced and when noradrenaline 
(5 ye) was administered following the prior administration 
i of propranolol the Ti values were greatly increased
(Tables 4 and 6 respectively). When isoprenaline 
(5j/g) was injected after noradrenaline (5j/ g) the 
isoprenaline effect was obtained in only two of nine 
experiments, whereas when noradrenaline (5 fg) was 
injected following isoprenaline (5yg)$ the 
noradrenaline effect was noted on all occasions 
(Tables 4 and 5)*
The TJ values obtained when isoprenaline (5y &) 
was administered mixed with 133 Xe and when 
noradrenaline (5 y g) was administered with 133 Xe 
were 16 minutes and 170 minutes respectively.
DISCUSSION
The responses obtained in this study are 
qualitatively similar to those obtained in other 
tissues (Goodman and Gilman, 1965 ? Glover and 
Hutchison, 1965 i Gosselin, 1966 : Brick et al., 1968). 
Thus, clearance rate, femoral venous count rate and 
femoral venous flow rate are all increased following 
the intra-articular injection of isoprenaline, 
suggesting an increase in synovial perfusion. These 
effects are not apparent following the prior 
administration of propranolol denoting the f receptor 
blocking action of this substance (Brick et al.,
1966). However, the isoprenaline effects are 
demonstrable following the prior administration of the 
blocking drug phentolamine (Eisenfeld et al., 1967 : 
Foster, 1969)* Conversely the clearance rate, 
femoral venous flow rate and femoral venous count rate 
were all reduced by noradrenaline, demonstrating 
predominant c* effect of this drug at the dose level 
of 5^ g» Again these effects were noted following 
the prior administration of propranolol. The results 
when noradrenaline was administered following the prior 
administration of phentolamine were of interest.
\ •
m• • . , t ’
When the dose of phentolamine was 20 f g six of eight 
studies showed some response to noradrenaline.
However, when the dose of phentolamine was 40^ g 
no response to noradrenaline was observed. These 
findings suggest that the blocking action of 
phentolamine on the <v effect is dose related. 
Phentolamine given intravenously produces vaso­
dilatation and cardiac stimulation (Goodman and 
Gilman, 1965)* The blood pressure response varies 
with the relative contributions of the two effects. 
This drug also increases the peripheral blood flow, 
predominantly in the skin, but with the doses usually 
employed in man this is often much less than that due 
to local anaesthetic nerve block. The dilatation is 
due primarily to a direct action on vascular smooth 
muscle; however, with higher doses of phentolamine 
c* adrenergic blockade may also be involved, thus 
demonstrating a dose related effect. It would appear 
therefore that in low dosage phentolamine probably 
acts mainly on vascular smooth muscle while in 
high dosage it acts as an o< adrenergic blocker.
When isoprenaline (5^g) was injected following 
the prior administration of noradrenaline (5^6) the 
effect of isoprenaline was only rarely apparent.
However, when noradrenaline (5 p g) was injected 
following the prior administration of isoprenaline 
(5^6) the effect of noradrenaline could be clearly 
demonstrated. No conclusion can be drawn as to the 
relative potency of these substances from this data, 
however, since the molar concentrations at the receptor 
sites are not known. Isoprenaline, for example, by 
increasing flow will tend to reduce its local 
concentration, the converse effect obtaining in the 
case of noradrenaline. It has been suggested 
(Stephenson, 1956) that the population of receptors 
is not homogeneous in its interaction and that in spite 
of its higher affinity, isoprenaline has a lower 
efficacy than noradrenaline. Alternatively, it may be 
that low concentrations of noradrenaline may be taken 
up more avidly than any concentration of isoprenaline, 
or indeed, than a higher concentration of noradrenaline 
itself (Foster, 1967).
There was no response to the intra-articular 
administration of propranolol however when phentolamine 
(40 y B) m s  injected, the clearance rate, femoral flow 
rate and femoral count rate were all increased. This 
suggests that the synovial vessels possess a vaso­
constrictor tone, supporting the conclusions of Cobbold
. : ' l2£L
f
and Lewis (1965abc).It remains possible however that 
phentalomine exerts a direct effect on peripheral 
vessels in these circumstances*
Criticism has been levelled at the use of a control 
period prior to the administration of a drug. Gosselin 
(1966) states that if the control period is employed 
one must then propose that all of the injected drug 
reaches the isotope-containing tissue quickly and 
uniformly. To Investigate this criticism, in two 
studies the isotope was injected simultaneously with 
the drug. In both studies the effect of the drug 
could be clearly seen to be established within ten
iminutes after injection. Furthermore, the resulting 
T$ values were in the same range as those obtained in 
the other studies in which the drug was injected only 
after a control period. It would seem therefore that 
diffusion of the pharmacological agents employed in this 
study was not a limiting factor.
The results obtained in this study of the response 
of synovial blood vessels to the sympathomimetic agents 
support the conclusion that the synovial blood vessels 
are under sympathic control and also suggest the 
presence of both<*- and £ -receptor sites in the synovium
Although no final conclusions regarding the relative 
importance of ex' and receptors in synovium, it is 
interesting that noradrenaline appeared to be more 
potent than isoprenaline and that phentolamine, but 
not propranolol, exerted an effect alone* This may 
indicate that receptors predominate in the control 
of synovial blood vessels.
/
1. Local injection of isoprenaline results in an 
increase in clearance rate which is abolished by 
pre-treatment with propranolol but not with 
phentolamine demonstrating the presence of ^ receptors 
in synovium*
2. Local injection of noradrenaline results in a 
decrease in clearance rate which is abolished by 
pre-treatment with phentolamine but not with 
propranolol demonstrating the presence of V  receptors 
in synovium.
3« Femoral venous accountancy of activity lost from 
the joint persists through pharmacologically induced 
changes in the clearance rate.
If. At the doses employed in these studies no systemic 
effects were observed.
5. Phentolamine injection causes an increase in 
clearance rate which may tie due either to its direct 
effect on small blood vessels or to its receptor 
blocking action.
sttkmaRY
JADmiiERGIC CONTROL OF CANINE SYNOVIAL PERFUSION IN 
EXPERIMENTALLY INDUCED OSTEOA: :flTfRITIS AND SYNOVITIS
Introduction
In the course of clinical, radiological and 
pathological studies conducted in collaboration with 
Mr. M. Pond at the Veterinary Hospital, Glasgow on 
experimental osteoarthritis in dogs, observations were 
made which throw some light on the adrenergic control 
of Inflaramed synovial tissue.
The joint disease is produced in a normal stifle 
joint by surgically dividing the anterior (cranial) 
cruciate ligament through a two millimetre (2 mm.) 
incision alongside the straight patellar ligament.
The opposite stifle joint serves as a control. No 
splint is applied to the limb and the dogs are allowed 
to exercise for three hours each day.
The immediate result of the surgical procedure 
is gross joint inability which is followed very 
rapidly by a synovial effusion. This effusion is 
readily appreciated as a warm fluctuant swelling on 
either side of the straight patellar ligament but 
after about one month it becomes obscured by thickening 
of the joint capsule and periarticular soft tissues.
As the disease process continues into the third month 
an irregular proliferation of osteophytes can be
juik
palpated along the attachments of the joint capsule.
The degree of lameness and joint instability 
steadily decreases after a two to three week period 
following the surgery#
Histologically, in addition to marked osteophyte 
formation, a progressive vascular synovitis is observed 
from the second to the sixth post-operative month.
MATERIALS AND MTTHOP
The animal© were anaesthetised with sodium 
thiopentone and a 5:3 mixture of O^iNO^ with 
supplementary trilene. A fine gunge needle was 
inserted into the Joint cavity and the position 
confirmed by aspiration of synovial fluid. The needle 
remained in place, closed by a saline filled syringe, 
throughout each study. Approximately 50 Ci of 133 Xe 
(Amersham) in an air free solution of 0.9% NaCl were 
injected into tho Joint cavity. Volume accountancy was 
strictly adhered to throughout each experiment and at no 
time did the volume exceed the amount of synovial fluid 
initially aspirated by more than 50%. The counting 
techniques and derivation of Tj values has been 
described (Chap. Z : page
Both the diseased and the contralateral control 
Joints of each dog were studied. Following the 
determination of baseline count rate, various adrenergic 
compounds were administered intra-articularly through the 
indwelling needle. Each time an active compound was 
administered, a small volume of isotope solution was 
administered with it. The pharmacological agents 
employed in this study weret-isoprenaline sulphate B.P. 
(Boots Pure Drug Co. Ltd.); 1-noradrenaline acid tartrate
("Levoph* d1* Bayer Product* Co.); propanolol hydrochloride 
("Inderal" Imperial Chemical Industries Ltd.) and 
phentolamine mesylate B.P. ("Rogitine" Ciba Laboratories 
Ltd#). These compounds were diluted in 0.9% SaCl to 
achieve the desired concentration.
Baseline Tf values and duration of disease
TABLE VIII
Dog
1
2
3
4
T-Jr values (mins.)
Normal «Jt# 
140 
68 
120 
89
Diseased Jt 
49 
14 
23 
9
Duration of 
disease 
(mnths.)
7 
6 
5
4
1£L
RESULTS AND INTERPRETATION
The baseline T-J- values obtained in each 
experiment were markedly reduced on the affected 
side, regardless of the duration of the disease*
This implies an increased synovial perfusion rate.
The fastest clearance rate was obtained in the stifle 
Joint showing the most acute disease when this was 
judged clinically by assessing the degree of lameness! 
joint instability, warmth, soft tissue hypertrophy 
and bony proliferation. This was the Joint studied 
after the shortest post-operative period. The slowest 
clearance rate in a diseased joint was found in the 
one judged clinically to be the least acutely affected 
This was the joint studied after the longest post­
operative period (Table 8).
Although higher doses of active compound were 
required the response of the clearance rate to the 
intra-articular administration of the pharmacological 
agents was qualitatively similar in both the normal 
and the affected Joints. Thus the clearance rate was 
increased by isoprenaline in a dose of 2.5 f7 S *ke 
normal and 10 in the affected joints. Conversely, 
the clearance rate was reduced by noradrenaline in a
TABLE IX
T4- values (mins«) obtained before and after drug administration,
Normal Diseased
Isoprenaline: Pro iranplol 
Normal Diseased
Dose 2.5 ug 10 ug Dose 2.5 ug:80 ug 10 ug:40 u*
Before After Before After Before After Before Aft<
IPO 15 23 13 19 22 105 lie
26 13 19 12 59 57 20 2C
140 14 28 10 30 30 140 14C
65 20 49 17 21 20 60 6C
88 24 20 7 46 46 45 42
loo 30 50 14 32 30 48 4*
Noradrenaline Noradrenaline1Phentolamine
Normal Diseased Normal Diseased
Dose 125 ug 10 ug Dose 2.5 ug:40 ug 10 ug: 80 v
Before Alter Before After Before After Before Afte
25 70 29 150 50 52 20 22
80 150 42 150 40 41 42 4C
65 90 22 60 38 39 60 6C
58 60 10 70 52 54 38 3£
33 75 15 51 26 28 38 3S
48 73 35 68 64 62 30 34
TABLE X
T^ values (mins.) obtained before and after the 
administration of Phentolamine
Normal Diseased
Dose 40 ug 80 ug
Bofore After Before After
68 26 57 40
60 32 60 24
lltO 72 26 30
8a 51 14 19
76 43 9 7
91 64 30 28
88 52 21 22
110 80 19 9
73 36
75 42
66 38
71 41
* Studies in which phentolamine did not cause 
an increase in clearance rate.
I Aft
dose of 2.5^ 6 in the normal and 10 yg in the affected 
joint. A dose related effect was observed in one 
study in which first 2.5 and then 10 y g of noradrenalin 
were administered consecutively. The T£ value was 
increased from 29 to 35 minutes on the first occasion 
and from 35 to 68 minutes on the second. These 
responses were not obtained when the catecholamines 
were administered following an adequate dose of their 
respective blocking agents, propanolol and phentolamine 
(Table 9). Again, however, the dose of the blocking 
agent required was higher on the inflamed side. When 
phentolamine (i*0 yg) was administered to the normal 
joints the clearance rate was increased. However, in 
5 of 8 studies in inflamed joints, employing 80 y g of 
phentolamine, no increase in clearance rate was observed 
(Table 10).
Thus, although quantitative differences between 
the responses to isoprenaline, noradrenaline and the 
combination isoprenaline:propanolol and noradrenaline: 
phentolamine were obtained, qualitatively the responses 
were similar. The positive responses to these agonists 
and the abolition of these responses by specific blockin 
agents, suggests the presence of both of and ft
adrenergic receptors in the control of normal and 
inflamed synovial perfusion. Increase in clearance 
rate following phentolamine may be related to a 
direct effect of the compound upon small blood 
vessels, or to abolition of a resting adrenergically 
mediated vasoconstrictor tone. Failure of this 
response in the inflamed joints may indicate loss 
of basal vasoconstrictor tone.
SUMMARY
1. Quantitative differences in the dose of agonist 
or blocking agent required to produce the same 
effect in normal and inflamed synovium were 
discovered, higher doses being required in the 
case of the latter#
2. Qualitatively similar responses to isoprenaline 
and propranolol and to noradrenaline and 
phentolamine as agonist and blocking agents were 
obtained in normal and inflamed synovium, 
demonstrating the presence of both and j>
receptors.
3. Qualitatively different responses to the 
injection of phentolamine alone were obtained.
In the normal joints an increase in clearance 
rate was obtained but no change occurred even with 
the exhibition of larger doses in five of the 
diseased joints suggesting loss of ^  adrenergicall 
mediated basal vasoconstrictor tone in these 
inflamed joints.
PHARMACOLOGICAL STUDIES ON THE EFFECT OF 
THYMOXAMIKK OH PERIPHTRAI BLOOD VSB3ELSI 
MONITORING BY THE 133 Xe CLEARANCE TECHNIQUE
Introduction
Since Alquist coined the terme o< and p receptc 
in 1948, a great deal of work has been performed on 
the adrenergic control of peripheral blood vessels ir 
many tissues. It has been established that skin anc 
other superficial tissues contain predominantly X  
receptors (Brownlee, 1966) whereas in the heart, and 
in muscle vessels, (3 receptors are most conspicuous 
(Brownlee, 1966). The recent availability of a 
specific <x: adrenergic blocking agent, thymoxamine
("Opilon", Wm. Warner and Co. Ltd.) which acts 
reversibly by competitive inhibition (Birmingham and 
Szolcsanyi, 1965 : Birmingham, Ernest and Newcombe, 
1969) affords the opportunity of selectively studying 
receptor function. Thymoxamine, unlike 
phentolamine, has not been shown to possess a 
direct effect on small blood vessels. Whereas, in 
the previous section (page\i7.)» increased clearance 
rates produced by phentolamine could have resulted 
either from the blocking or the direct effect of the 
compound, similar results obtained with thymoxamine 
could more confidently be related to the blocking 
action thereby strengthening the case for the existent
of basal vasoconstrictor tone. In the present study 
this compound has been employed in the study of 
adrenergic control of the peripheral blood vessels in 
canine synovium.
The acquisition of intimate knowledge of the 
peripheral circulation has been limited by the 
availability of suitable monitoring techniques. The 
introduction of radioisotopes has greatly extended the 
monitoring techniques available. The system for the 
detection of drug induced changes in the peripheral 
blood vessels used in this study was the rate of 
clearance of intra-articularly injected Xenon (153X«). 
The effect of thymoxamine alone was studied and 
thereafter to further characterise the result the 
effects of isoprenaline and noradrenaline alone and in 
combination with thymoxamine were examined.
MATERIALS AND METHODS
The experiments were conducted in a surgical 
theatre in the Wellcome Surgical Research Centre,
Glasgow. Both stifle Joints of adult greyhound dog£
♦
weighing from 20 to 28 Kg. were studied. Anaesthesia 
was induced with sodium thiopentone (20 mg.Ag*) 
maintained with a 5.5 mixture of nitrous oxide and 
oxygen and additional (1%) trilene. A catheter 
placed in the brachial artery permitted continuous 
recording of blood pressure and pulse rate.
Inlection Technique
A 15/16*1 guage needle was inserted into the 
Joint cavity by a medial infra-patellar approach and 
confirmation was achieved by aspiration of clear 
synovial fluid in every case. If the aspirate was 
blood stained, no further studies were performed in 
that Joint. An air-free volume of less than 0.5 ml, 
of isotope solution was carefully injected into the 
Joint cavity and the needle remained in situ 
throughout each experiment closed by a syringe 
containing 0.9% sodium chloride, thus providing a 
convenient route for the administration of the 
pharmacological agents. Each time an active compoui
The 
experimental 
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showing 
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order 
and 
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was administeredf a small (^0.25 ml*) volume of 
133 Xe was injected with it and throughout each 
experiment volume accountancy was scrupulously 
adhered to* At no time did the total volume injected 
exceed the amount of synovial fluid aspirated initially 
by more than 3 0%.
The counting techniques and derivation of TJ 
values have been described (Chap* Z : Page ).
As the clearance rate becomes slowerf the semilogar- 
ithraic plots approach the horizontal and the errors of 
calculating the T-J values become magnified. Accordingly 
all values in excess of 150 mins. are recorded simply 
as T} e>150 minutes in this paper.
The experimental protocol is shown in Table11.
The effects of thymoxamine, isoprenaline and 
noradrenaline alone were studied (Groups 1 to 3)• 
Isoprenaline was administered following the prior 
administration of thymoxamine (Group l\). Increasing 
doses of noradrenaline were administered following a 
fixed dose of thymoxamine (Group 3), and increasing 
doses of thymoxamine were administered prior to a 
fixed dose of noradrenaline (Group 6). Increasing
• • ' * ” ... - *. . *..,v v? < r ‘ - ;  . •' . . . . . .  *• *■ \ „ • •* » v  V
doses of thymoxamine were also administered following 
a fixed dose of noradrenaline (Group 7).
\ 1.5
' . • ' .
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Pharmacological Agents
The pharmacological agents employed in this 
study were: thymoxamine (OPILON, Wm. Warner and Co.
Ltd.), 1-noradrenaline acid tartrate (LKVOPHED, Bayei 
Production Co.) and isoprenaline sulphate in normal 
saline (Boots Pure Drug Co.). These compounds were 
diluted in sterile 0.9% sodium chloride solution to
• • jr.* \ £. ' *
achieve the desired concentrations.
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TABLE XIII * ry*
133_.X_e_ CLEABAWCE RATE (OROuFTT
Baseline
56
72
39
*6
68
Mean
Fange
55
54
39-72
No* showing 
change
Ti (mins*)
FollowinK Thymoxamine
‘V . k 'f' •><.' *’ -vj/i•* •* •* vv
37 )
)
46 ) 40 g« 
)
28 )
31 )
)
38 ) 200 g. 
) .
34 ) .
36
28-46
6/6 6/6
THE
Following
Isoprenalin
(2*5ug.)
20
26
9
16
21
22
19
9-26
RESULTS . l'
The results are shown in Figures 8 to 10 and 
Tables 12 and 13*
In eleven of the twelve studies in Group I 
(thymoxamine alone) the clearance rote following drug 
administration greatly exceeded the baseline value 
(Table 12)* No clear relationship to the dose 
employed was noted. An equivocal result was obtained 
in the remaining study, the Ti values prior to and 
following injection being 34 and 30 minutes 
respectively. In Groups 2 and 3 the results were 
consistent throughout: in all six studies with
isoprenaline (2.5 the clearance rate following
drug administration exceeded the baseline values and 
in all six studies with noradrenaline (2.5^6*) the 
clearance rate was reduced following injection 
(Table 12)• Change in clearance rate was abrupt and 
marked in every instance. When isoprenaline 2.5 fc* 
waB administered following thymoxamine (Group 4) a 
marked increase in clearance rate ensued in all 
studies (Table 13)* In three of these studies the 
dose of thymoxamine was 40 ^ g. and in the remaining 
three studies the dose employed was 200^ g.
The results obtained when increasing doses of
t im e
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Legend: The effect of increasing doses of ti
prior to a fixed dose of noradrenal: 
(Qroup 6).
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Figure 10
Legend: The effect of increasing doses of thymoxaraj
following a fixed dose of noradrenaline 
(Group 7).
noradrenaline were administered following a fixed 
dose (60^ g.) of thymoxamine (Group 5) are shown in 
Figure 8. A dose related response was obtained.
Thus when the dose of noradrenaline was 0.5» no change 
in clearance rate was obtained. When the dose of 
noradrenaline was 2.5* or 10 yg. the clearance rate 
was reduced following the injection of noradrenaline. 
(Variable responses were obtained at a dose of ly g.). 
When increasing doses of thymoxamine v/ere administered 
prior to a fixed dose (2.5 yg*) (Group 6) of 
noradrenaline again a dose related response was 
obtained (Fig. 9)• Thus when the dose of thymoxamine 
was 10 or 20 yg. the clearance rate was subsequently 
abruptly and markedly reduced by the administration 
of noradrenaline. Howevert when the dose of
thymoxamine employed was 80 or 100 yg. no such 
subsequent noradrenaline response was obtained.
Variable responses were noted when the dose of 
thymoxamine employed was either ifO or 60 y g.
When increasing doses of thymoxamine were 
administered following the prior administration of 
noradrenaline (1.0 ^ g.) (Group 7) no response was 
noted until the dose of thymoxamine employed was 200y g 
In two studies in which this dose was employed the 
clearance rate was abruptly and markedly increased 
following thymoxamine injection (Fig. 10).
L L 1
The monitoring system employed in this study to 
demonstrate pharmacologically induced changes in the 
peripheral vasculature was the rate of clearance of 
intra-articularly administered 133 Xe. Although the 
confidence which can be ascribed to the expression of 
results in absolute units of perfusion cannot be complete 
since the method is indirect and since no other method 
is available to.confirm the results, major changes in 
clearance rate such as are encountered in the present 
study, occurring coincidentally with drug administration, 
may be justifiably attributed to pharmacologically 
induced changes in perfusion (Gosselin, 1966). The 
results of the present study may be interpreted to 
indicate that whereas noradrenaline reduces synovial 
perfusion, the intra-articular administration of both 
isoprenaline and thymoxamine arc attended by an increase 
in clearance rate and therefore in 6ynovial perfusion 
rate. The results with noradrenaline and with
isoprenaline, are easily understood in terms of the
■ / ■ ■ • ■ known effects of these compounds on other vascular beds
(Goodman and Gilman, 1965)* However, interpretation of
the effect of thymoxamine is less obvious. Increase
in clearance rate and in perfusion rate may be the
DISCUSSION
result of a direct effect of the compound on email 
blood vessels. Although thie effect has been 
demonstrated with phentolamine however^no conclusive 
evidence is available to support thie assertion in the 
case of thymoxamine. The more likely possibility 
supported by the conclusions of other workers 
(Birmingham, Akubne and Szolcsanyi, 1967 t Turner, 
Harrison and Schoenfeldt, 1969) ic that the compound 
releasee these peripheral vessels from a basal 
adrenergically mediated vasoconstrictor tone.
The results of this study also demonstrate that 
wheroas thymoxamine has no.influence on f? adrenergicali 
mediated isoprenaline response, the compound will 
abolish the mediated effect of noradrenaline. The 
effect is dose related and can be modified by either 
increasing the dose of the agonist or reducing the 
dose of the blocking agent. Furthermore, the 
noradrenaline effect can be reversed by theV * , '*■» * * ' S' '* * S-* ‘ ^ r
administration of a large dose of thymoxamine. These 
results may be adduced in support of the contention 
that the mode of action of thymoxamine is by 
competitive antagonism (Birmingham and Szolcsanyi, 
1965)* The dose ratio at which the modifying effect
of thymoxamine was demonstrable varied in the 
different groups of studies. When thymoxamine was 
administered first (Groups 5 and 6) the dose ratio 
obtained was of the order of 60 (thymoxamine) to 
1 (noradrenaline). However, when the compound first 
administered was noradrenaline the corresponding ratio 
was 200:1. Variation in affinity of the compounds 
for the receptor binding sites may explain this 
discrepancy.
It would seem from the results of this study 
that the 133 Xe clearance technique provides a suitable 
model for the in vivo study of pharmacologically induced 
changes in perfusion. The method is particularly 
attractive since it involves only minimal interference 
with the physiological state of the animal.
Ul L
• SUMMARY
1. The rate of clearance of intra-articularly 
injected 133 Xe provides a simple model for the 
in vivo study of drug induced changes in synovial 
perfusion.
2. Intra-articularly administered thymoxamine 
results in an increased clearance rate. This may 
be the result of a previously undetected direct 
effect of the compound on peripheral blood 
vessels but is more likely to be due to abolition 
of resting adrenergically mediated basal vaso­
constrictor tone.
3. The increase in clearance rate mediated by 
receptor stimulating compound (isoprenaline) 
persists following the prior administration of 
thymoxamine.
If. Thymoxamine prevents, and reverses, the
reduction in clearance rate mediated by an ^  
receptor stimulating compound (noradrenaline).
This effect is dose related.
PHARMACOLOGICAL STUDIES WITH PARASYMPATHETIC COMPOUNDS.
HISTAMINE AND SEROTONIN ON CANINE SYNOVIAL PERFUSION 
MONITORED BY THE 133 XENON CLEARANCE TECHNIQUE
The effect of parasympathetic compounds, histamim 
and serotonin upon peripheral blood vessels has been 
intensively studied particularly in pharmacological 
test systems which are more or less divorced from the 
in vivo situation. The opportunity of following 
peripheral circulatory events in vivo by external 
monitoring of /ninute volumes of radioactive tracer 
substances is now available (Chap. 2). Following the 
intra-articular injection of radioactive 133 Xe the 
clearance rate from the joint provides an index of 
synovial tissue perfusion with minimal further 
interference to the anaesthetised animal.
This monitoring system was utilised to determine 
the effects of methach oline, isoprenaline, mepyramine 
malleate, histamine, serotonin and noradrenaline on 
canine synovial perfusion measured by the 133 Xe 
clearance technique. The effect of atropine, a 
substance which antagonises many of these compounds, 
was also studied. .
Experiments were conducted on both stifle joints 
of anaesthetised adult dogs weighing from 20 to 35 kg* 
at the Wellcome Surgical Research Institute, Glasgow. 
Twenty-two of the dogs were greyhounds and 10 were 
mongrels. Anaesthesia was induced with sodium 
thiopentone (20 mg./kg.) and maintained with a 5*3
i
mixture of N02:02 and additional 1% trichloroethylene.
Injection and counting technique
A 15/l6th" gauge needle was inserted into the 
stifle joint by a medial infrapatellar approach and 
confirmation of the position of the needle point was 
achieved by the aspiration of synovial fluid in all 
studies. Any experiment in which the initial aspirate 
was macroscopically blood stained was abandoned. The 
needle remained in place throughout each study, closed 
by a syringe containing 0.9% NaCl, thus providing a 
convenient route for the administration of isotope and 
active compound solutions. On each occasion that an 
active compound was administered a small volume 
( <0.2 ml.) of 133 Xe solution was injected with it.
The counting techniques and derivation of Tj values 
have been described (Chap. 2 : page 1+) •
TABLE XIV
133 Xs
nS8S!S?ln
Period First Compound
Oroup Studies Injected (15 mins.J Admlnlstsred (pg.)
1 10 ----------- Ms thacholins 
(0.1 to 5.0)
2 9 ----------- Noradrsnallns 
(0.25 to 2.5)
3 6 ----------- Isoprenaline
(2.5)
k 19 ----------- Thymoxamine
(10 to 200)
5 7 ----------- Histamine
(0.025 to 2 5 )
6 10 ----------- Serotonin 
(0.1 to 5.0)
7 9 ----------- Atropine 
(0.1 to 10.0)
8 10 ----------- Msthacholins 
(0.1 to 5 0 )
9 6 ----------- ‘Vasodilator*
10 6 ----------- Atroplna
(0.5 to 5.0)
11 6 ----------- Serotonin 
(0.1 to 10.0)
12 10 ----------- Methachollne
Monitoring 
Period 
(15 to 20 m i ne.)
Second Compound 
Administered (pg.)
(1.0 to 10O)
Methachollne 
(0.5 to lOO) 
Isoprenaline 
(2.5 to 3 0 ) 
Atroplna 
(0.5 to 5.0)
Atroplna 
(0.1 to 120)
Atroplno
(0.5 to 10)
TABLE XIV (contd.)
Croup
No. of 
Studio•
133 Xo
Injoctod
Control
Monitoring
Period
( 1 5  m i n s . )
First Compound 
Administered (ug, )
Monitoring 
Period 
( 1 5  to 20 m i n s . )
Second Compound 
Administered (|ig.)
13
Ik
15
16
17
18
19
20
35
7
5
6 
lit 
12 
17
Atropine 
(2.5 to 10.0)
Methachollne 
(5.0)
♦
Atropine 
(1.0 to 100) 
Atropine 
(5.0 to 120) 
Atropine 
(2.5 to 5.0) 
Atropine 
(1.0 to 5.0) 
Atropine 
(1.0 to lOO)
Thymoxamine
(5.0 to 2 5 0 ) 
Mepyramine 
(5 . 0  to 1 0 0 )
Methachollne 
(1.0 to 2 5 0 0 )
Noradrenaline 
(0.25 to 2.5)
Isoprenaline 
(2.5 to 5.0) 
Serotonin 
(0.1 to 10.0)
Hie tamine 
(0.1 to lOO)
His tamine 
(0.025 to 25) 
Hittaalne(1.0)
Monitoring 
Period 
(15 m l n a . )
Monitoring 
Poriod 
(15 mlna. )
■>
Legend »
The dose ranges employed and the order oi' administration of tho compounds studied.
T£ values derived from almost horizontal slopes are 
unreliable and accordingly all values in excess of 
150 mine, are simply described as T-J =^150 mine. 
Experimental protocol
The experimental protocol with the concentration 
of active compounds and their order of administration 
is shown in Table 12. Twenty groups of studies were 
conducted. In groups 1 to 7, the effects of atropine, 
methacholine, serotonin, histamine, isoprenaline, 
noradrenaline and thymoxamine on the clearance rate of 
133 Xe were monitored following a control monitoring 
period. In groups 8 to 20 the effects of combinations
*" - - ' ‘ V.* '* ■ ■ . % -
of those compounds were studied in the dose ratios 
indicated.
Pharmacological agents
The compounds employed in this study weres 
atropine sulphate (Antigen Ltd.), methacholine chloride 
(HAmecholM Macarthy*s Ltd.), serotonin creatinine 
sulphate (Glasgow Royal Infirmary Pharmacy Department),
V J .
histamine acid phosphate (Evans Medical Ltd.), 
isoprenaline sulphate OSuscardia", Boots Pure Drug Co. 
Ltd.), 1-noradrenaline acid tartrate ("Levophed", Bayer 
Production Co. Ltd.), mepyramine raalleate ( Anthisan 
May and Baker) and thymoxamine ("Opilon*1, Wm. Warner & 
Co. Ltd.). These were diluted in sterile 0.9% NaCl
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RESULTS
The results are shown In Fig. 11 and Tables 15 
to 26. Fig. 11 shows a representative example of 
the alteration in clearance rate following intra- 
articular injection of methacholine, and the absence 
of change when methacholine was administered 
following a prior injection of an appropriate dose 
of atropine.
The Ti values obtained, before and after 
methacholine in doses ranging from 0.1 y g. to 5*0 ^g. 
are shown in Table 15. Although no significant 
change in the clearance rate attended the 
administration of 0.1 ^ g., a marked increase was 
observed at higher dose levels. In doses in excess 
of 0.1 ^g. no obvious dose related response was 
obtained. In all of nine studies in which 
noradrenaline (0.25 to 2.5 ys*) was administered, 
the clearance rate was markedly reduced following 
the injection, the degree of reduction again being 
unrelated to the dose administered (Table 15).
Indeed, a marked reduction in clearance rate was 
obtained with the lowest dose of the compound. In 
all six studies the clearance rate was increased
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following the Injection of Isoprenaline (2.5 pg.) 
(Table 15)•
The effect of thymoxamine (10 to 200|j g.) 18 
shown by an increase in clearance rate in all of the 
19 studies, the degree of change again being unrelated 
to the dose administered over the dose range studied, 
and similarly an increase in clearance rate attended 
the administration of histamine (0.025 to 25«OjJg., 
seven studies) and of serotonin (0.1 to 5*0 ^ >g., nine 
of ten studies) (Table 16)# In the remaining 
serotonin study the increase in clearance rate 
obtained was only 21%.
The two points on the graph immediately following 
the injection of methacholine are displaced from the 
straight lines obtained before and after injection. 
This was noted to occur frequently with all of the 
compounds studied and Ti values reported in all drug 
studies in this thesis refer to the steady state 
periods characterised by straight line graphs of more 
than 10 minutes duration.
The duration of effect of methacholine, 
isoprenaline, histamine and serotonin ranged from 10 
to 18 minutes whereas the duration of effect of 
noradrenaline ranged from 12 to 32 minutes. In all
TABLE XVII
j,? Tj* Values (nln.) V-,’ *, yii
Dose
) Before After % Change
10.0 34 34 0
5.0 *7 1? 21
5.0 27 51 49
2.5 56 54 3
2.5 56 50 lO
1.0 82 26 68
1.0 k6 24 1(8
1.0 72 ko 55
0.1 36 20 kk
0.1 88 31 6k
0.1 110 36 67
Legend I
Hie effect of atropine on the clearance rate of 133 Xe 
(croup 7).At doses of leea than 1.0 i&g. the clearance rate was 
increaeed ( 6 of 6)» Only one of five caeee with higher doeee showed a change In T} value In excess of 25^ and In that case the clearance rate was reduced.
Legendi 
Effect 
of 
methachollne 
following 
methacholine 
and 
of 
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following
vasodilator 
compounds 
on 
the 
133 
clearance 
rate 
(groups 
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studies the duration of effect was related to the 
administered dose of the compound, the effect being 
more prolonged with higher doses of each compound.
When atropine was administered in low doses 
(0.1 to 1.0 g.) the clearance rate was increased in
all of six studies whereas variable responses were 
obtained at higher doses. Increase, reduction or 
lack of change in clearance rate at doses in excess 
of 1.0 yg. did not seem to be related to the doses 
employed (Table 17). In only one of these studies 
employing doses in excess of 1.0 yg. was there a 
change in T$ value of more than 25% and in that study 
the Tjr value was increased, denoting a reduction in 
clearance.
When methacholine was administered following a 
prior injection of methacholine in the doses 
indicated (Table 18) the clearance rate was increased 
in eight of ten studies by more than 25%» however, in 
only one of six studies in which isoprenaline was 
administered following the previous injection of a 
vasodilator was there any reduction in Ti value. In 
that study a small dose of methacholine had been 
administered as the vasodilator drug*. The compounds
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TABU a
Tfc (min.) Tfc (min.) Results / Dose Ratio1 tropin* Methaoholin# After After Atropine/>•• (ug.) Doss (ug.) Atropine liethaoholine liethaoholine
5.0 1.0 150 150 B 5*1*5.0 1.0 80 80 B 5*1*5.0 1.0 31 33 B 5*1*2.5 1.0 50 48 B 2.5*1*10.0 5.0 44 48 B 2si*5.0 5.0 150 150 B lsl*5.0 5.0 80 78 B lsl*5.0 5.0 31 28 B lsl*2.5 2.5 68 70 B lsl*
2.5 2.5 36 37 B lsl*
2.0 2.5 70 24 VB 111.252.0 2.5 30 26 B lsl.25*2.5 5.0 70 . 51 VB ls210.0 25.0 48 48 B ls2.5*10.0 25.0 36 36 B ls2.5*3.0 10.0 47 45 B ls3.3*2.5 10.0 51 53 B ls4*2.5 10.0 53 42 B ls4*5.0 25.0 78 82 B Is5*
5.0 25.0 37 19 VB ls5
5.0 25.0 23 13 VB ls510.0 100.0 48 34 VB lslO
5.0 50.0 150 150 B lslO*
5.0 50.0 82 80 B Is 10*
3.0 50.0 45 35 B Is17*
5.0 100.0 80 35 VB ls2010.0 150.0 60 39 VB ls30
3.0 100.0 35 24 IB Is33
2.5 100.0 73 42 VB ls40
2.5 100.0 53 34 VB ls40
2.5 100.0 39 26 HB ls40
2.5 100.0 84 43 VB ls4010.0 500.0 69 37 HB ls5010.0 500.0 34 18 HB ls50
5.0
Vo. showing
2500.0 150 24 VB 1:500
ohange>25>
* Vo. showing 
ohange < 25?
/ Chang* in T& Talus of >25^ has boon arbitrarily designated "no block" 
(IB) and ohango of looo than 2% has bosn termed "block" (B), 0*0 text for explanation.
Legends The effect of methaoholin* following a prior dose of atropine 
(group 13) on the 133 Xe olearanoe rate.
and doses employed are shown in Table 18.
When atropine was administered following a prior 
dose of atropine in the doses indicated in Table 19 
there was no change in clearance rate in four of six 
studies. In the remaining two studies a slight 
increase and a slight decrease in Ti value was 
observed, neither change exceeding 25%» When atropine 
was administered following the prior administration of 
serotonin in the doses Indicated in Table 19 the 
clearance rate was markedly increased in four of six 
studies. In the remaining studies the changes in Ti 
value were less than 25%*
The results of the studies in which methacholine 
waG administered following atropine in varying dose 
ratios are shown in Table 20. In this, and in all 
other studies in which the blocking action of a 
compound was studied , change in Ti value of less than 
25% was deemed to indicate no change and was 
designated "block" (B). Conversely when the Ti value 
altered by more than 25% following drug administration 
this was taken to Indicate change and was designated 
"no block" (N.B.)• It can be seen from Table 20 that 
dose ratios of atropine to methacholine in excess of 
lsl resulted in no change in clearance rate, whereas
I
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following 
Mothaohollno 
Atropino 
and 
Mothaohollno 
Ad mini at prod Togothor
dose ratios of.lees than 1:17 resulted in all of ten 
studies In a distinct methacholine effect* Variable 
responses were obtained at Intermediate dose ratios.
In six studies (Table 21) methacholine and atropine 
were administered together in various dose ratios* In 
the studies in which the dose ratio of atropine to 
methacholine exceeded 1:1*7 no change in clearance 
rate of more than 25% was noted and in the study in 
which the dose ratio was 1:5 o distinct Increased 
clearance rate was obtained. . .
When atropine was administered following the 
prior administration of methacholine the T$ values 
following atropine were Increased in five of ten 
studies and reduced in the remaining three studies in 
which change of more than 25% was recorded (Table 21)* 
No obvious relationship to the respective doses of the 
compoundswas noted* When noradrenaline was injected 
following the prior administration of atropine in all 
dose ratios studied9 the noradrenaline effect of 
reduction in clearance rate was observed. Even in the 
study, in which the dose ratio employed was 400:1 a 
reduction in clearance rate was also noted following 
noradrenaline. In one study when isoprenaline was 
injected following atropine in the dose ratio of
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atropine to isoprenaline of 2:1 no response to 
isoprenaline was obtained (Table 22)* However, when 
that experiment was repeated on three occasions 
isoprenaline injection was followed by a marked vaso­
dilator response and when the dose ratio employed was 
1:1 or 1:2 the clearance rate was increased following 
isoprenaline.
When atropine was administered prior to serotonin 
in a dose ratio of atropine to serotonin of lees than 
5:1 the serotonin induced Increase in clearance rate 
was obtained. In dose ratios in excess of 5:1 there 
was an increase in clearance rate in only one of eight 
studies (Table 23). In three studies a distinct 
reduction in clearance rate was noted. When histamine 
was administered following the prior administration of 
atropine in dose ratios of atropine to histamine in 
excess of 10*1 no increase in clearance rate was 
obtained whereas in all studies in which the dose ratio 
was less than 1:1 the clearance rate was increased 
(Table 24)• Variable responses were obtained at 
Intermediate dose ratios. When histamine was 
administered following thymoxamine in the dose ratios 
of thymoxamine to histamine in excess of 100:1 no change 
in clearance rate was noted (Table 25). However, when
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Effaot 
of 
napjrramina 
mallaata 
and 
of 
hiatanina 
on 
tha 
133 
olaaranoa 
rata
«T 0
1
M!IK
o
rov/i
C A
VJI
•£-  OvOO vo o Ov V J I V J Ioo ro ■r* ov ON o o ^5-
H
S’
8  0 QO © ON r M H HO O O O O O O O VJI
o  o  o  o  o  o
ro
o
JTI
s
o o o o o o o o o o
S’
£ •• m
§M­s
.p- vji >£“ •£- o\ Ov VJI -P“ ov
0 0  Q  V > l V /I O  •£ " V O  0 0  V J I* * * * * * * * I s *3 » rfc»
oO
o o s v o o r o o o o - ^  o d  vj i  g  « r f l&$ S S f
the dose ratio was lees than 100:1 the clearance rate 
was increased in nine of eleven studies* When 
mepyramine malleate was administered prior to 
histaminet even in dose ratios of 100il the histamine 
effect was clearly apparent* Although no change 
attended the administration of low doses of mepyramine 
an increase in clearance rate was noted with doses of
• . w * • *.
80 and 100^ g. (Table 26) •
Although many variables may contribute to the 
clearance rate, including the physical characteristics 
of the tracer substance and the structure and perfusioi 
of the tissue (Chap* 2), it would seem reasonable to 
ascribe abrupt changes in clearance rate occurring
' . i ’  ^ - • r
reproducibly following drug administration to 
pharmacologically induced changes in perfusion 
(Gosselin, 1966)* The point is strengthened when 
predictable dose related responses of large dimensions 
can be demonstrated* Increase in T-J value and 
therefore reduction in clearance rate and perfusion 
rate are interpreted as vasoconstrictor responses and 
conversely reduction in T£ value is interpreted as 
vasodilator response in this study. As shown in 
Fig. 11 the points on the clearance graph immediately 
following drug administration may be erratically 
distributed and are neglected in calculating T-J values, 
All T£ values quoted in this thesis are calculated onlj 
from straight lines of at least 10 minutes* duration. 
The factors contributing to the points immediately 
following injection are complex and include Isotope 
and drug distribution, electronic adjustment to the
DISCUSSION
Ur. . .
new count rate and rate of onset of drug effect.
The reproducibility of the clearance rate of intra- 
artieularly injected 133 Xe has been determined 
(Chap. 3  ). In the present study change in excess 
of 25% was taken to be significant. Thie value is 
in excess of the rang© of the differences of 14 
duplicate T£ values previously obtained (Chap. 3> 2
Table I O ) .
The responses obtained with appropriate doses of 
methacholine, noradrenaline and isoprenaline 
administered alone are easily interpretable in the 
light of their effects on other vascular beds (Goodman 
and Gilman, 1965)• The methacholine effect was found 
to last from 10 to 15 minutes. In nine cases out of 
ten when methacholine was injected 15 minutes after a 
prior dose of methacholine, vasodilation occurred. 
However, in five of six cases when isoprenaline followed 
a previously administered vasodilator, no further 
increase in clearance rate attended the administration 
of isoprenaline. It is possible that maximal vaso­
dilation had occurred with the first drug administration. 
This is in accordance with the observation of Brownlee
(1966) that the vessels maximally dilated with a drug
• * ' . " v  * r- ■ . • * • • '' * i v . ’iV f  •’ *y * ,
could no longer respond to isoprenaline. It seems
" , .* “ 4&I . ~ :Jr - >rV.' -'VV -V ’-Vv.' " * ,vi.< • ■*. . ’ - ■ v
likely that failure of response to isoprenaline is 
fcelated both to the identity and to the dose of the 
compound previously injected. In the.single study in 
which a response was obtained, the compound previously 
administered was methacholine. The dose in that 
instance was only 2.5fg* whereas no further effect of 
isoprenaline had been demonstrable following a much 
larger dose of methacholine. It nay be that the 
duration of action of tho higher dose was more prolong* 
That thymoxamine administration causes an increase in 
perfusion has been interpreted by other workers as 
indicating the abolition of basal oc adrenergically 
mediated vasoconstrictor tone (Birmingham et al.f 1967s 
Myers et al., 1968)•
Similar conclusions are suggested by the decrease
1 * ' X \  \ y  ' * * r** \  • * r. . *• . , . ’ . 1 * * \
in T-} values occurring after thymoxamine in the present 
study. The vasodilator effect of histamine on the 
peripheral vasculature in other tissues (Dale and 
Laidlaw, 1919 • Diana et al., 1968) is reflected in
-V. f* * \ . • 1 .v ’ . A : \sgt 'I .,jy */%, / . v  1 • . * • rm *■ ’ . ’ ,r • •'»•* ' % * * ’
the increased clearance rates observed in the present
. *' • ! ■ ■ • . 
study. Results in other systems on the vascular
effects of serotonin have yielded conflicting
results in the past. In doses of the order
of 100 to 1,000 ^ g. subcutaneously Injected this 
compound caused intense vasoconstriction of skin blood 
vessels (Greaves and Shuster, 1967). When infused 
intra-orterially in doses of 2 to 16 y g./min. transient 
vasodilation for two minutes was followed by 
vasoconstriction and Walshe (1967) concluded that in 
muscle vessels both constrictor and dilator responses 
were present, the latter predominating* In the 
present study only vasodilator responses were obtained, 
clearance returning to the original rate after 15 to 
30 minutes*
The results with atropine are of particular interest 
In high doses variable responses were obtained whereas 
with lower doses vasodilation was noted in all studies* 
Though this is the opposite response which one would . 
expect with a muscarinic blocking agent, therapeutic 
doses of atropine may result in dilated skin blood 
vessels (Goodman and Gilman, 1965)• Ashford (1962) 
found that doses of atropine one-tenth of the dose 
required to block acetylcholine caused excitation and 
he suggested that atropine may be stimulating the 
receptors whon it first combines with them* When both 
high and low doses of atropine were administered
I (&k>
following atropine, no change in clearance rate was 
observed. It is possible that following the initial 
stimulatory dose of atropine, additional atropine in 
the receptor area might not be excitatory. V/hen 
atropine was administered after a previous dose of 
methacholine, vasoconstrictor responses were obtained 
in five of the 10 studies; but when atropine 
followed serotonin in four studies out of six 
vasodilation occurred. In the first set of 
experiments atropine could be reversing residual 
methacholine effects, while in the second set 
atropine could still be exciting the yet unstimulated 
parasympathetic receptors. Serotonin may have a  
sensitizing effect on atropine as it has been found 
to have with norepinephrine and histamine (De la 
Lande, 1966).
When methacholine was administered after 
atropine, the methacholine vasodilatory effect could 
be prevented consistently at dose ratios of one to 
one and greater while ratios of one to 17 or lees did 
not block. When atropine and methacholine were 
administered together a block occurred at dose 
ratios of two to one and greater. Atropine, a
muscarinic receptor antagonist, would be expected to 
block methacholine, and it acted as an effective 
blocker for at least 35 to 45 minutes. Any modifying 
effect of atropine on the vasoconstriction induced by 
noradrenaline must be extremely weak. Noradrenaline 
induced vasoconstrictor responses were obtained even 
at a dose ratio of 400 to one. Interestingly, atropine 
was found to inhibit in a dose ratio of two to one the 
vasodilatory effect of the adrenergic receptor 
stimulator isoprenaline. This result however was 
unrepeatable and did not occur at other dose ratios. 
Although the explanation of this unusual response is 
not immediately apparent, the other results suggest 
that atropine does not exert a modifying influence on 
isoprenaline. Atropine may, however, abolish the 
vasodilator effect of histamine on peripheral blood 
vessels (Goodman and Gilman, 1965)• When administered 
prior to histamine in a dose ratio of ten to one or 
greater, no increase in clearance rate subsequently 
attended histamine administration. This result may be 
interpreted to suggest that at least some component of 
the histamine response is mediated by receptors 
susceptible to atropine blockade. It is extremely 
interesting that the histamine effect persisted despite
- / * * * ' *  V* ' ' *v'.V*J'V. " ■ r  -*£x\
the prior administration of large doses of antihistamine.
■ r
again suggesting that histamine ia not acting simply 
through "histamine receptors". Increase in clearance 
rate with large doses, of mepyramine may be the result 
of histamine release by this compound. A modifying 
effect of thymoxamine on the histamine vasodilator 
response in a dose ratio of greater than 100 to 1 was 
noted. Thie weak histaminolytic effect has been 
noted by other workers (Brownlee, 1966 : Birmingham 
et al., 1967). Atropine is the stronger blocking 
agent of the two because the dose ratio of atropine 
necessary to block histamine was at least ten times 
lower than the ratio of thymoxamine needed to block 
histamine. Atropine war also found to block serotonii 
at dose ratios higher than 5 to 1, which is the same 
order of magnitude as the dose ratio required to 
block histamine. It is possible that atropine blocks 
through the same pathways for both drugs. The 
methacholine blocking action of atropine is clearly 
more efficient than its weak effect on histamine and 
serotonin. It is interesting that vasoconstrictor
responses were obtained when serotonin was injected
■ ■ ' * \ . - - * . following atropine. This may indicate that serotonin
constrictor responses are also present in synovial 
tissue, but are only seen when the over-riding 
vasodilatory responses are blocked.
The results of this study suggest the presence
of muscarinic receptors in canine synovial tissue.* . ‘ ■ . y ' • ' ■
Both histamine and serotonin elicit vasodilator 
responses, which are modified by the prior 
administration of atropine, A weaker histarainolytic 
effect of thymoxamine has beon demonstrated but 
mepyramine malleate failed to modify the effect of
* r  4 '  ‘histamine. This suggests that histamine may be 
acting through muscarinic receptors rather than 
specific "histarainic" receptors in canine synovium. 
The methacholine vasodilator response may be inhibitei 
either by prior administration or concurrent admini­
stration of atropine. The administration of atropin 
alone, in low doses excites a vasodilator response 
but variable results are obtained with higher doses. 
Noradrenaline induced vasoconstriction occurs despite 
prior treatment with atropine and atropine failed to 
exert a modifying affect on isoprenaline induced 
vaso-dilation.
SUMMARY
1. The effect of various compounds on the rate of 
clearance of intra-articularly administered 
133 Xe as an indirect measure of synovial 
perfusion was studied.
2. Vasodilator responses were obtained with 
methacholine, histamine, serotonin, thymoxamine, 
isoprenaline with high doses of mepyramine and 
with low doses of atropine. Higher doses of 
atropine yielded conflicting results. Vaso­
constrictor responses were obtained with 
noradrenaline•
3« Atropine injected following serotonin commonly
resulted in vasodilator responses whereas following 
methacholine variable results were obtained.
4. Atropine abolished the response to methacholine
and to a lesser extent, to serotonin and histamine. 
Thymoxamine was weakly histarainolytic. Mepyramine 
failed to prevent histamine induced vasodilatation. 
It is proposed that histamine may be acting through 
cholinergic rather than specific fthistaminictf 
receptors in canine synovium.
Ill
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5. Atropine did not modify the vasodilator response 
to isoprenaline and did not affect the vaso­
constrictor response to noradrenaline.
6* The results suggest the presence of muscarinic 
receptors in canine synovial tissue.
‘ ' 4 ’ •' ,r j -.. ‘J  •
CHAPTER 5
PHYSIOLOGICAL AND PHARMACOLOGICAL STUDIES IN 
NORMAL AND INFLAMED HUMAN KNEE JOINTS
In this chapter the physiological responses 
of human synovial vasculature to physical agents and 
to pharmacological stimuli are documented. Most 
of this work is founded upon results obtained 
previously in animal experiments reported in 
Chapter /*.
The changes in synovial perfusion induced in 
both normal and inflamed joints by external 
heating, exercise and the intra-articular injection 
of histamine are discussed.
The presence of adrenergic receptors in both 
normal and inflamed human synovial tissue is 
demonstrated and the differences between the 
responses of the normal and diseased joints are 
discussed.
m
mSTUDIES OH THE SYMPATHETIC CONTROL OF NORMAL AMD DISEASED 
SYNOVIAL BLOOD VESSELSl THE EFFECT OF AND RECEPTOR 
STIMULATION AND INHIBITION. MONITORED BY THE 135 XENON
CLEARANCE TECHNIQUE
ADRENERGIC CONTROL OF HUMAN SYNOVIAL PERFUSION
Introduction
This study represents an attempt to define
functionallyt by the response of the 133 X® clearance
rate to intra-articularly administered exogenous
catecholamines, the presence of adrenergic receptors
in both normal and abnormal human synovial tissue. The
work is a logical extension of previous work performed
in animals (Chap. ^ s page I'll.) and the methods
employed are similar• In particular, the similarities
between the responses obtained in normal human and
canine and in inflamed human and canine joints were
studied.
TABLE I
Numbers of Studies using Different Drugs 
Injected into the Knee Joints of Normal 
Subjects and of Patients with Osteoarthritis (O.A.) 
______and Rheumatoid Arthritis (R.A. )_____________
Isoprenaline 2.5 g. 
Fropranolol 40 g.
Propranolol 40 g. 
with isoprenaline 2.5 g*
Noradrenaline 2.5 6*
without prior heating
Noradrenaline 2.5 6*
after application of external 
heat to joint
Phentolamine If0 g.
Phentolamine 40 g. 
with noradrenaline 2.5 g*
Phentolamine 40 g. 
with noradrenaline 5 g*
Normal
8
8
8
7
8
5
3
0 »A a Rj
25
17
15
6
4
20
20
0
2
2
MATERIALS AND METHODS
Patients and Control Subjects
In all, 275 studies were performed (Table 1).
Sixteen normal subjects volunteered to participate. All 
were male University students between the ages of 22 and 
30 years and none gave a history of disease or of trauma 
to the knee joint. Careful clinical examination of the 
knee joints revealed no abnormality. Thirty-nine 
patients who had clinical and radiological evidence of 
osteoarthritis of the knee joints were studied. Their 
ages ranged from 39 to 72 years (mean 58.2 years) and 12 
were male. Serological tests for rheumatoid factor were 
negative and in all the erythrocyte sedimentation rate 
was less than 15 mm* per hour (Westergren). Sixty-four 
putients with "classical" rheumatoid arthritis (Ropes et 
al*i 1959) were studied. In all, serological tests for 
rheumatoid factor were positive and the erythrocyte 
sedimentation rate exceeded 20 mm. per hour (Westergren). 
All of these patients had clinical and radiological eviden 
of knee Joint involvement by the disease process at the 
time of study. Their mean age was 42.3 years (range 28 
to 69 year^)5 nineteen were male.
All patients and control subjects volunteered to 
participate in the study with full knowledge of its conten
Infection and Counting Technique
The method of injection, with aseptic precautions, 
has been described previously (Chap. 3 t page ^ U )• To 
obtain reproducible results, it is of particular 
importance to ensure that the needle point is free in 
the Joint cavity and to wait for approximately five 
minutes following the insertion of the needle before 
injecting the Isotope solution. In the present study 
the Joint was not exercised following injection and the 
dose of 133 Xe administered was approximately 20y Ci.
The needle, which between injections was attached to a 
sterile syringe, containing either sterile 0.9% Wa Cl 
or synovial fluid, remained in situ throughout the study 
providing a convenient route for the repeated intra~ 
articular administration of drugs with minimal discomfort 
to the patient.
In feasibility studies on normal subjects the drugs 
were administered without additional isotope. The 
expected responses to exogenous catecholamine injection 
were not obtained consistently but when these studies 
were repeated employing the same dose of the drug but 
with the concurrent administration of a small amount 
(less than 0.03 ml.) of additional Isotope solution
! ' • .a change in clearance rate was observed in every case#
I. ‘ • . ■ ■
The problem is discussed by Qosselin (1966) and is due 
to the placement of isotope and drug in different 
sites# In the present study, whenever a drug was 
administered a small amount of isotope solution was 
injected with it# In twelve studies on knees with 
different clearance rates, including two normal
subjects, following the control monitoring of clearance
■rate a second dose of 133 Xe was injected and the count 
rate again monitored for fifteen minutes# The Ti 
values obtained on each occasion are shown in Table 2#
. . . ,, -v*• * ‘ * . * ‘ *. .. , . " , >
The standard error of the difference was 0.87 minutes.
The count rate was monitored using a collimated 
detector (EKCO M5^00AA) incorporating a lf» x liM T.I. 
sodium iodide scintillation crystal which was aligned 
2M from, and directly above, the patella. Pulses were 
fed into a pulse height analyser (EKCO M5010) and 
ratemeter (EKCO M5183A) and recorded on a direct 
writing pen recorder (Goerz Servoecribe RE511). At 
the completion of each study the count rate minus 
background (of the order of 0.1% count rate) was plotted 
\ onto semilogarithmic graph paper as a function of time.
The halving times (Ti values, minutes) were obtained
i
mfrom these straight line graphs.
Pharmacological Agents
The pharmacological agents employed in this study 
were Isoprenaline sulphate B.P. in normal saline (Boots 
Pure Drug Co.), Phentolamine mesylate B.P. ("Rogitine"
CIBA Laboratories Ltd,), Propranolol hydrochloride 
("Inderal" Imperial Chemical Industries Ltd.) and 
1-nor-adrenaline acid tartrate ("Levophed" Bayer 
Products Co,). These preparations were diluted in 
sterile 0,9% NaCl to give a final concentration of 
5 f-'g/ral. for isoprenaline and noradrenaline and 80 g^/ral. 
for propranolol and phentolamine. In three studies on 
normal subjects the dose of noradrenaline employed with 
40^ g. of phentolamine was 5 yg* whereas in the other 
five in that group the dose of noradrenaline was reduced 
to 2.5 ^ g* (Table 1). Otherwise, and with the 
exception of the repeat studies in which the doses 
employed are separately recorded, the doses of drugs 
used were as follows:-* isoprenaline 2.5 j'g** noradrenalin* 
2.5^g*» propranolol 40 ^g, and phentolamine 40 ^ g. 
Experimental Protocol
In all cases, a control monitoring period of 
approximately 15 minutes followed the intra-articular
Injection of the isotope. Thereafter a catecholamine 
was administered, together with a further small amount 
of isotope and the count rate monitored for another 
15 minutes.
In the normal subjects both knees were studied.
In the first knee either isoprenaline or noradrenaline 
was Injected as described and then the opposite joint 
was studied using the appropriate blocking drug. 
Following the control period, either propranolol or 
phentolamine was administered and the count rate 
monitored for 10 to 15 minutes; finally the stimulating 
and corresponding blocking agent were administered 
together and the clearance rate followed for a further 
15 minutes. Thus, If isoprenaline was administered 
into the left knee joint, then first propranolol and 
then a mixture of propranolol and isoprenaline were 
Injected into the right knee.
In the case of arthritic patients It was frequently 
not possible to study both joints, either because the 
patients found it uncomfortable to remain immobile for 
the necessary time or because of asymmetry of joint 
involvement. Accordingly, the administration of 
isoprenaline, noradrenaline, propranolol or phentolamine
alone was considered to represent a separate study. 
Likewise, the administration of a blocking agent, 
followed later by a mixture of blocking agent and 
catecholamine was considered to represent a separate 
study and the results are expressed in this way. In 
all, isoprenaline alone was administered in eight 
studies of normal subjects, in 25 studies of patients 
with osteoarthritis and in 24 studios of patients with 
rheumatoid arthritis (Table 1). The number of studies 
in each group in which propranolol, propranolol with 
isoprenaline, noradrenaline, phentolamine and nora­
drenaline with phentolamine were administered is 
similarly shown in Table 1*
One limitation inherent in the 133 Xe clearance 
technique is the difficulty of demonstrating a 
reduction in an already slow perfusion rate. The 
semilogarithmic plots tend towards the horizontal and 
the error of plotting and of determining the Ti value 
increases. Accordingly, all Ti values in excess of 
150 minutes in this study are simply recorded as > 150. 
For the same reason it was not possible to demonstrate 
directly the effect of noradrenaline in normal subjects 
and in some diseased patients whose baseline Ti values
ISO
were high. In such Instances9 therefore, prior to 
injection of noradrenaline, the knee joint was 
subjected to external heating* Following the control 
monitoring period the subject was placed in a sitting 
position with the knee joint equidistant between the 
electrodes of a short wave diathermy machine (Siemens 
Ultratherm 6089B)* The control was set to maximum 
heat for between five and ten minutes* When the 
subject began to feel uncomfortably warm, heating was 
discontinued and the patient returned to the original 
counting position. In no case did the time to return 
to the original position exceed 1 minute* The count 
rate was monitored for over 10 minutes and, thereafter 
noradrenaline was injected and the study continued*
In one subject the waning of the increased clearance 
rate due to heating was followed without interference 
for twenty minutes* The semilogarithmic plot obtained 
is shown in Fig* 2.
LOG
Time a fte r  Initial 133Xe Injection (min)
><
Legendt Semi-logarithmic plots of count rate per
second against time showing, in normal subjects,
the effects of intra-articular isoprenaline,
propranolol and isoprenaline with propranolol on 
the clearance of 133 Xe from the knee*
LOG
(Counts/Sec) Heat
Time after Initial 133 Xe Injection(min)
fJrilt ?
Legend! Semi-logarithmic plots of count rate per 
second against time showing, in normal subjects, t] 
effects on 133 Xe clearance from the knee of exten 
heat, intra-articular noradrenaline, phentolamine i 
phentolamine with noradrenaline in different dose ratios.
Reproducibility of Ti values of 133 Xe clearance] 
12 Studies showing the effect on Ti values of a 
second injection of 133 Xe given about 15 mine, 
after the initial dose
Ti (minutes) after Ti (minutes) after
1st injection of 13^ Xe 2nd  ^Injection of 133
150 150
150 150
100 ' 100
63 56
55 51
. • .
55 52
hi 39
32 . 27
30 27
28 27
28 25
13 16
Standard error of the difference - 0.82 minutes.
(Calculated from lower 10 figures in the table).
TABLE II
RESULTS
The results are shown in Figs, 1 and 2 and 
Tables 2-6,
The Ti values obtained from each monitoring 
period when 133 Xe alone was introduced into the 
joint cavity on two occasions consecutively are shown 
in Table 2, The standard error of the difference 
was only 0,82 minutes,
Examples of the responses of the clearance rate 
in normal subjects to each of the drugs administered 
arc shown in Figs* 1 and 2, It can be seen that
<r * ‘ f ** *
isoprenaline (2,5yg-) markedly increased the 
clearance rate whereas thie effect was not apparent 
following the prior administration of propranolol 
(40 yg.), The injection of propranolol (40 yg.) 
alone was attended by no alteration in clearance 
rate (Fig. 1), The effect of external heating alone 
is depicted in Fig, 2, where it can be seen that the 
effect is transient and that return to baseline values 
is attended by a smooth curve on the semilogarithmic 
plot of the count rate against time. On the other 
hand, when noradrenaline (2,5y g*) is injected in the 
post-heating period the clearance rate is abruptly and 
markedly reduced at that point. When phentolamine
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40 y g. was Injected the clearance rate was Increased
(Fig* 2)t subsequently, whereas the injection of 5^ g*
of noradrenaline with 40 p g. of phentolamine was
attended by a reduction in clearance, no change in
the clearance rate was noted with 2*5 f'g. of
noradrenaline plus 40 ^  g. of phentolamine*
The T£ values obtained in the studies on normal
subjects are shown in Table 3* In all of eight
normal subjects a response was obtained to isoprenaline
(2*5 ^g*) but not to propranolol (40 ^ g.) or to
propranolol (i|0 ^ g.)/isoprenaline (2*5 ^ >g#) combination.
In all studies, noradrenaline (2*5^g*) resulted in a
marked reduction in clearance either administered alone
(1 study) or following external heating (7 studies).
In all of eight studies the injection of phentolamine
(40 f g*) resulted in an Increase in clearance* In all
of five studies where the dose ratio of noradrenaline
to phentolamine was 2*5 ^  g. *40 ^ g* no response was
obtained, whereas when the dose ratio was 5^g*i 40^ g.
all of three studies showed a reduction in clearance*
The results obtained in the studies on patients
with osteoarthritis are shown in Table 4* In 22 of 25
studies response to isoprenaline (2*5 ug*) was obtained
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LS3-
and no response to propranolol (4*0 yg.) was obtained 
in any of 17 studies* In 4* of 15 studies response to 
isoprenaline (2*5^6*) was obtained when administered 
with propranolol (4*0 ^ g.)* In all studies in
was obtained, in six studies directly and in four 
studies following heating* However, only 10 of 20 
patients demonstrated an increase in clearance rate 
following phentolamine (4*0 ^ g.) and in all of these
the remainder (7 studies) the clearance rate was 
reduced*
In the studies on patients with rheumatoid 
arthritis (Table 5), 16 of 24* responded to isoprenaline 
(2*5 f g*)i there was one equivocal response, and the 
remainder showed no increase in clearance rate* No 
response to propranolol (4*0^  g*) was obtained in any 
of 21 studies* In five studies the clearance rate 
was increased following the injection of propranolol 
(4*0 ^ g.) and isoprenaline (2*5 together, but in
another 15 studies there was no such change. Reduction
osteoarthritis response to noradrenaline (2*5y g*)
the baseline TJ value was over 50 mlnutee. In 13 of 
20 studies no response to noradrenaline (2*5^g*)
given with phentolamine obtained but in
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in clearance rate was obtained in all of 13 studies 
following the injection of noradrenaline (2*5 » in
9 studies administered alone and in if administered 
following heating. In 9 of 21 studies no Increase in 
clearance rate was observed following the injection of 
phentolamine (ifO^g.), these studies being character­
ised by baseline Ti values of less than 60 minutes.
When phentolamine (bOy £•) and noradrenaline (2.5 ^ g.) 
were administered together no response was obtained in 
1/f studies. However, reduction in clearance rate was 
observed in the other seven studies.
Repeat Studies
Certain studies in osteoarthritic and rheumatoid 
knee joints were repeated and the results are shown in 
Table 6.
Repeat studies were carried out on two patients 
with osteoarthritis in whom no response to isoprenaline 
(2,5 had been obtained on the first occasion. In
one patient the Ti value before injection was 50 
minutes and was unchanged after the injection. On the 
second occasion, using the same dose of isoprenaline, 
the values before and after injection were 30 and 29 • 
minutes respectively. 10|jg, of isoprenaline were 
then injected and the Ti value was reduced from 29
minutes to 12 minutes. In the second patient the 
respective Ti values before and after injecting 2.5 
fg. of Isoprenaline were 26 and 31 minutes and 39 and 
39 minutes, and with 10 ^ g. of isoprenaline, 39 and 
18 minutes.
In one osteoarthritic patient response to 
isoprenaline (2*5^ g«) was obtained when the drug was 
administered with propranolol (40^g.). The Ti 
values were 35 and 8 minutes respectively. On the 
second occasion, employing the same dose ratio, the 
respective values were 42 and 14 minutes, but when the 
dose of isoprenaline was reduced to 1 ^ g. and that of 
propranolol increased to 80 ^ >g. the respective values 
were 39 and 39 minutes, denoting the blocking action 
of propranolol.
In three patients, whose initial study had shown 
lack of response to phentolamine (40 ^ g.) (Ti values 
41 and 38, 24 and 24i 17 and 17 minutes respectively), 
the study was repeated with the same dose of phentolamine. 
Again no response was obtained (Ti values 36 and 36,
38 and 38, 26 and 26 minutes respectively) and when 
the study was repeated employing 200 ^ g. of phentolamine 
still no response was obtained (Ti values 36 and 35,
38 and 38, 26 and 26 minutes respectively).
i l k
In one study where noradrenaline (2.5 f'g*) effect 
had been apparent despite the coincidental admlnlstratloi 
of phentolamine (ifO^g.), the Ti values were 38 and 
90 minutes respectively. When this study was 
repeated employing the same doses the T$ values were 
30 and 72 minutes, but when the study was repeated on 
a third occasion with only 1 ^ g. of noradrenaline to 
80 ^g. of phentolamine the Ti values were 34 and 31f 
minutes denoting the oL blocking action of phentolamine.
Similarly the T-J values obtained in repeat studies 
in rheumatoid arthritis are shown in Table 6. When 
isoprenaline 2.5 ^ g* wae administered, on the first 
occasion the Ti values were 38 minutes before and 38 
minutes after injection in one patient and 26 minutes 
before and 26 minutes after in another. On the 
second occasion the results were 29 and 29 minutes, and 
20 and 21 minutes respectively. In both patients, 
however, when the dose of isoprenaline was Increased 
to 10 j'g., change in Ti values were observed, in the 
first patient from 29 to 12 minutes and in the second 
patient from 21 to 11 minutes.
In another study the isoprenaline effect was noted 
when 2.5f g* were administered in conjunction with IfO^  g.
of propranolol. The T£ valuee were 30 and 17 
minutes* The eame reeult was obtained when the 
study was repeated employing the eame dose ratio, the 
T-J- values being 36 and 20 minutes* When the study
was repeated in the same patient employing only 1 pg. 
of isoprenaline to 80 ^  g* of propranolol, the T-J- value 
before injection (38 minutes) was identical to that 
obtained after the injection*
When phentolamine (40 ^ g*) was injected intra- 
artlcularly in three studies, on the first occasion 
the basal T£ values (23» 42 and 14 minutes) were 
similar to the values obtained after injection (23*
42 and 12 minutes respectively). These studies were 
repeated and again the T£ values prior to injection 
(20, 48 and 24 minutes) were close to the post­
injection values (20, 46 and 24 minutes respectively). 
On a third occasion, the dose of phentolamine employed 
was 200 ^  g* and again there was no difference between 
the values before (20, 46 and 24 minutes) and after 
(21, 47 and 23 minutes) respectively, the injection.
In two studies, noradrenaline (2*3^g.) and
cases a response to noradrenaline had been obtained,
phentolamine administered and in both
the changes in Ti values before and after injection 
being 42 to 86 minutes and 12 to 65 minutes 
respectively. This response was confirmed when the 
studies were repeated; the corresponding changes in 
Tj values were 31 to 70 minutes and 24 to 53 minutes 
respectively. On a third occasion, noradrenaline 
(If g*) and phentolamine (80yg.) were administered 
together and in both studies the T-J values prior to 
injection (34 and 20 minutes) were identical to those 
obtained after injection, denoting the <K receptor 
blocking action of phentolamine.
The 133 Xe clearance technique offers certain 
advantages which permit measurements otherwise 
impossible in vivo. The technique is simple, requiring 
only accurate placement of the isotope and careful 
injection technique. The clearance rate is 
reproducible, the standard error of the difference of 
repeated observations being only 0.8Z minutes and the 
Tj value provides an indirect measure of nutritive or 
capillary perfusion (Friedman, 1968 t Chapter 2). This 
may be more relevant to cellular mechanisms than the 
determination of total flow to or from a tissue. 
Finally, the low energy of gamma emission (80 KeV) 
and the high airtblood partition coefficient renders 
the radiation exposure very much less than that 
incurred by standard radiographic techniques 
(Bentivoglio et al., 1963 s Harper et al., 1964), 
particularly at the dose levels employed in this study. 
One advantage which is peculiarly relevant to the 
joint is that the isotope is introduced into a 
cavity and local pressure differences (Qosselin, 1966) 
are not, therefore, likely to present a major problem. 
The validity of the clearance model in the present 
context has been discussed (Chapter 2).
DISCUSSION
iiio
The results of the present etudy indicate that 
both CX and f adrenergic receptors are functionally 
active in the control of synovial perfusion in normal 
subjects* Thus the increase in perfusion mediated by 
isoprenaline is prevented by the prior administration 
of propranolol, a blocking agent. Similarly, the 
reduction in perfusion which attends the administration 
of noradrenaline is not apparent following the prior 
administration of the selective °< blocking agent 
phentolamine. That the mechanism of this effect is 
related to the respective doses employed is demonstrated 
by the response of the normal subjects to noradrenaline 
and phentolamine. When the dose ratio was 2.5^ £• to 
hO j'g. respectively, then the effect of noradrenaline 
was not apparent. However, when the dose of nora­
drenaline was doubled to achieve the ratio 5 y g* to 
itO then the noradrenaline effect was obtained in
every case.
The response of normal subjects to phentolamine 
alone was of particular interest; in all of them, 
synovial perfusion was markedly Increased by the 
administration of this blocking agent. Phentolamine 
has been shown to possess a direct effect on blood
vessels at low concentration and a specific 
blocking effect at high doses. The molar 
concentrations of phentolamine in the synovium were 
not determined in this study and accordingly it is 
impossible to be certain whether this was "high" or 
"low". However, from the fact that the <>< blocking 
action was apparent at the dose employed, it seems 
reasonable to suggest that the increase in perfusion 
was consequent upon the c< blocking action. If this 
is so, then the fact that an increase in perfusion was 
obtained suggests that the normal synovial perfusion 
rate is under ^-adrenergic control. This has been 
shown to obtain in isolated animal preparations 
(Cobbold and Lewis, 1956&. and c: Chap. k) •
The results obtained in both patient groups were 
less homogeneous. Thus, whereas in normal subjects 
all patients responded to the intra-articular injection 
of 2.5^ g* of isoprenaline, no response was obtained 
in three patients with osteoarthritis and in seven 
patients with rheumatoid arthritis. Similarly, in 
four patients with osteoarthritis and in five with 
rheumatoid arthritis, propranolol failed to block the 
isoprenaline response, and in seven patients with
1 HD.
osteoarthritis and in seven with rheumatoid arthritis 
phentolamine failed to block the noradrenaline response. 
When repeat studies employing the same dose levels were 
performed in a selection of these patients at a later 
date, although the initial T$ values were not identical 
the same results were obtained. Subsequently, however, 
each study was repeated employing a higher dose of the 
catecholamine, or a different catecholamine to blocking 
substance dose ratio and these unusual results were 
found to be dose related. Thus in thosepatients who 
failed to respond to isoprenaline in a dose of 2.5^ g*# 
response was obtained when the dose of isoprenaline was 
10 y g. Similarly if propranolol (40^g.) failed to 
block the response to isoprenaline (2.5^g*) the 
response was prevented when the dose of propranolol was 
80 Kg. and that of isoprenaline only lj-'g.; if 
phenolamine lfO^ /g. failed to block the response to 
noradrenaline 2.5j^6«» then the blocking action was 
demonstrable when the dose of phentolamine was 80^/g. 
and that of noradrenaline only lj^  g.
The precise mechanism of this dose-related difference 
between normal and diseased subjects is not immediately 
apparent. Since the abnormalities were present in both
L£l3
groups of patients, the mechanism cannot be specific 
to either disease entity. It is noticeable, 
however, that these abnormalities tended to occur in 
patients whose initial perfusion rates were high 
(Tables 4 and 5). It is possible, therefore, that 
the local concentration of these drugs is quickly 
reduced by an elevated perfusion rate. However, 
the relationship is not absolute and there were 
several studies where high baseline perfusion rates 
were associated with normal responses. On the other 
hand, particularly in the rheumatoid subjects, it is 
possible that elevated synovial fluid protein levels 
result in a degree of protein binding and 
inactivation of the catecholamines. This explanation 
seems less satisfactory in the osteoarthritis group 
since here synovial fluid protein levels are less 
likely to be abnormal. In both osteoarthritis and 
rheumatoid arthritis, clearance rates will be shown to 
be related to a clinical index of the degree of 
inflammatory involvement of the Joint at the time of 
study (Chapter b )• It is possible that the 
differences between normal and abnormal responses are 
related to the perfusion rate only indirectly, 
through the degree of inflammatory involvement of 
the Joint; in this case, tissue volume and
lSlL
vascularity, synovial fluid protein content and 
the diffusion rates of the respective drugs, may all 
be involved* It is interesting to compare these 
findings with those obtained previously in normal and 
inflamed canine Joints (Chapter )• The results in 
normal human subjects and in normal canine studies are 
entirely consistent throughout. Similarly the 
results in rheumatoid arthritis and in osteoarthritis 
are similar to those obtained in experimental 
synovitis in dogs. The similarities are particularly 
striking in the respective responses to phentolamine.
It would seem therefore that the unusual responses 
obtained in diseased joints are a feature of the 
inflammatory response regardless of the underlying 
pathological mechanism.
Failure of response to phentolamine in the 
diseased groups in these human studies was not related 
to the dose employed, since at repeat studies 
employing a higher dose no increase in clearance rate 
was obtained. Furthermore, in three studies in 
osteoarthritis and in two in rheumatoid arthritis, 
failure of response of clearance rate to phentolamine 
was followed by undoubted c< blocking effect on 
noradrenaline. The failure of response to phentolamine
was more closely associated with high perfusion 
rates than were the other abnormalities (Tables if 
and 5)• It would thus seem reasonable to propose 
that basal vasoconstrictor tone, which is a 
feature of normal synovium, is lost in both osteo­
arthritis and rheumatoid arthritis in those patients 
with high baseline perfusion rates.
In most tissues the o( and ^ receptor 
populations are not equally balanced. Thus in 
skin, oi receptors predominate, whereas in heart |p  
receptors are more prominent. While no final 
conclusions are Justified on the basis of the purely 
qualitative data obtained in the present study, the 
consistency and degree of the responses to 
noradrenaline and the results with phentolamine 
might be interpreted to suggest that oS receptor
influence is greater than that of the
in synovium.
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SUMMARY
1. The half-life (T£) of the disappearance curve 
of 133 Xe from the knee joint has been used as 
an indirect measure of synovial perfusion.
2. The effects of intra-articularly administered 
isoprenaline and noradrenaline and their 
respective blocking agents, propranolol and 
phentolamine, on the T} values have been 
investigated in normal subjects and in patients 
with osteoarthritis and rheumatoid arthritis.
3. In normal subjects, isoprenaline increased the 
clearance rate and this effect was blocked by 
propranolol. Noradrenaline decreased the 
clearance rate and this effect was blocked by 
an adequate dose of phentolamine.
4. The injection of phentolamine, in normal subjcctj 
caused an increase in synovial perfusion, 
suggesting the presence of a basal
-constrictor tone.
5. In the patients with osteoarthritis and rhcumato: 
arthritis quantitative differences were found in 
the responses to isoprenaline and noradrenaline 
and their respective blocking agents.
6. There appeared to be a qualitative difference in 
the case of phentolamine; vasoconstrictor tone 
may be lost in inflamed joints.
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THT. EFFECTS OF HI AT. EXI PCIgl- AND HISTAMINE ON SYNOVIAL 
PERFUSION IN NORMAL SUBJECTS AND IN PATIENTS WITH
RHEUMATOID ARTHRITIS
Introduction
Physical methodsf including the exhibition of 
heat and judicious use of exercise programmes are 
widely employed in the management of all forme of 
arthritis* The rationale underlying their use is not
> „ ‘ y* ’ ' \ . , V  J.'V 'y /  • O .  -  ■ .S  V - T  .
cleart principally because no quantitative methods of 
assessment are available* In the present study the 
effects of those physical treatments and of an 
intra-articular injection of histamine on synovial 
perfusion measured by the 133 Xe clearance rate are 
examined*
MATERIALS ANT) METHODS
Subjects Studied
Fifteen healthy male subjects volunteered to 
participate and both knee joints were studied on 
different occasions* Their ages ranged from 25 to 31 
years (mean 27*6 years). None gave a history of 
disease or trauma of the knee joints.
Twenty patients with "classical" rheumatoid 
arthritis| all of whom had active involvement of the 
knee joints, were selected for study. Their mean age
was 1*2.6 years (range 32 to 61 years). Six were male.
All patients and control subjects volunteered to 
participate in this study with full knowledge of its 
content.
Injection and Counting Technique
All injections into the knee joint were performed 
in a surgical theatre. The room temperature ranged 
from 65 to 70°C. and an extraction fan was constantly in 
operation to reduce the concentration in air of the 
radioactive gas exhaled by the subject•
The subject lay comfortably in a supine position 
and the knee was extended and carefully placed into a 
position whence it could be removed and replaced 
accurately. The knee was then prepared with full
aseptic precautions and when an effusion was present 
thi6 was aspirated prior to commencing the study.
A syringe containing an air free solution of 
approximately 50 y Ci of 133 Xe in 1 ml. of sterile 
0.9# NaCl was then prepared. A fine gauge needle 
was introduced into the joint cavity by a medial 
infrapatellar approach and five minutes later the 
Isotope solution was slowly injected.
The count rate per minute was monitored using a 
collimated detector (EKCO M.54^0 A/1) with a 
1" x liH thallium activated sodium iodide crystal.
The detector was alligned 2" from, and directly above 
the patella. Pulses were fed into an EKCO rate- 
metor (M.5180) and pulse height analyser (M.5010) and 
recorded on a KEINZLE automatic printer. At the 
completion of each study the count rate, minus the 
background, was plotted onto semilogarithmic graph 
paper as a function of time. Since each semi­
logarithmic plot was mono-exponential, biological 
half lives (Ti values) could readily be obtained from 
the graph. As the semilogarithmic plots approach th 
horizontal, the errors inherent in calculating Ti 
values become magnified. Accordingly, all slopes 
with Ti values over 150 minutes are expressed simply
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Control subjects and Patients Studied
The experimental design employed in the human 
studies is shown in Tables 7 and 8.
Thirty knee joints of 15 normal subjects were 
studied (Table 7). In the first group (six studies) 
the effect of external heat was examined and in the 
second (eight studies) the effect of exercise alone 
was studied. In the third group (four studies) the 
dose of histamine employed was ly g. whereas in the 
fourth group (12 studies) the dose was 10 g, In 
six of the last group, following the monitoring 
period of the effect of histamine, the joint was 
exercised and the alteration in clearance rate was 
monitored. The other six in the fourth group were 
continuously monitored following the injection of 
histamine, for a total period of 45 minutes and thus 
served as controls for the effect of exercise 
following histamine.
Forty knee joints of 20 rheumatoid patients were 
studied (Table 2), In 12 studies the effect of 
external heating was monitored and in 16 studies the 
effect of exercise was studied. In the remaining 12
as T-J- =^150 in this study*
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studies the effect of 10 y g .  and of 250 y>g, of 
histamine (histamine acid phosphate: Evans Medical 
Ltd.) was monitored.
Each time the drug was administered intra- 
articularly to any control subject a small (<0.25 ml.) 
amount of 133 Xe was added to the solution and injected 
with the drug.
Method of Heating the Knee Joint
The patient rose from the theatre table carefully 
to avoid altering the position of the detector. He 
was then placed in a sitting position with the knee 
Joint equidistant between the electrodes of a short 
wave diathermy machine (SIM5NS ULTRATHERM 608 GB),
The control was set to position 6 (maximum heat) for 
not less than 5 minutes. Between 5 and 10 minutes 
after heating commenced, the patient began to feel 
uncomfortably warm and at that point heating was 
discontinued and the patient returned to the theatre 
table with a minimum of delay (vide infra). The 
knee Joint was then carefully replaced in its original 
position relative to the detector. In order to 
confirm that the intra-articular tissues were being 
heated, intra-articular temperatures were taken on 
three occasions with an elektrolaboratoriet thermometer
(SIEREX TE 3)• In these cases the intra-articular 
temperature rose by 1*19 1.3 and 0*9°C respectively. 
Method of Exercising the Knee Joint
In normal subjects a standard pattern of 
exercise was followed. The subject rose from the
theatre table and stood in front of a platform 18" in
* - ■ ' ' ’ ' height. "Step ups" commenced at as fast a rate as
the subject would tolerate and continued for 5
minutes. The patient then returned to the theatre
table and the knee Joint was carefully repositioned
under the detector (vide infra).
In the patients with rheumatoid arthritis it was 
not possible to adhere to a standard exercise regimen 
since the severity of knee joint involvement varied 
and since the patient was frequently limited by 
dysfunction of other joints. Accordingly each 
patient was subjected to knee Joint exercise to 
tolerance. In the most severely affected patients 
active exercise of the knee Joint against a system of 
dead weights (-J to 5 lbs.) was conducted. In the 
least affected patients "step ups” were performed in 
a similar manner to that described above. In all 
cases the exercise involved moving the knee joint 
through as wide a range as the disease would permit.
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SUMMARY . ;
This thesis describes clinical and laboratory 
investigations into the physiology and pathology of 
the diarthrodial joint employing both Xenon (133 Xe) 
and Technetium (99 mTc) as radioactive tracer 
substances.
In Chapter 1 a short historical outline of the 
appropriate topics is presented. The subjects 
covered in this chapter are the anatomy of the blood 
supply to the synovium, the methods of study 
previously employed to investigate the pathophysiology 
of the joint and the development of blood flow 
measurement with the aid of radioisotopes.
The physical and biological attributes of 133 Xef 
the basic technique of intra-articular injection of 
the isotope and the external monitoring system 
employed are described in Chapter 2. The radioactive 
xenon which is cleared from the joint may be accounted 
for in the femoral venous blood and the animal 
experiments designed to provide evidence of this 
are reported. Further direct evidence in animals 
and indirect evidence in man, to show that the 
principle route of clearance of lntra-articularly
injected 133 Xe is by the synovial venous blood, is 
also presented in Chapter 2. The diffusion and 
partition coefficients of 133 Xe for canine and 
human synovium with respect to blood were determined 
in vitro and the validity of the derivation of 
synovial perfusion from the clearance rate of.133 Xe 
and the partition coefficient is discussed critically. 
Synovial perfusion rates in normal canine and human 
joints and in joints of patients suffering from 
rheumatoid arthritis are documented.
Chapter 3 is devoted to the reproducibility and 
inherent biological variation associated with the 
measurement of the Tj- value of intra-articularly 
injected 133 Xe. The influence of the method and 
the site of injection and the effect of Increasing 
Injection volumes and of the presence of a joint 
effusion are described. The errors involved in line 
fitting to determine the T} value are quantitated.
The day to day variation in the clearance rate and 
the effect of the age and of the sex of the subject 
are reported.
In Chapter I* the effect of physical and 
pharmacological agents upon the clearance rate of
133 Xe from the canine joint are described. The 
response of the clearance rate to the local admini­
stration of exogenous catecholamines was studied and 
by employing suitably selected and adrenergic 
receptor stimulating and inhibiting compounds it 
was possible to demonstrate functionally the presence 
of both and receptors in synovium. The 
results of these studies and of studies with a new 
adrenergic blocking agent, thymoxaralne, are 
reported In Chapter 4* The presence of muscarinic 
receptors was likewise inferred from the response of 
the clearance rate to local administration of 
methachollne and atropine and the results of these 
experiments and of experiments upon the effect of 
serotonin are presented. The results of studies 
conducted with histamine, mepyramlne malleate and 
atropine which suggest that histamine acts in the 
joint to some extent through cholinergic receptors 
are presented and discussed in Chapter 4*
A limited study was conducted in diseased 
canine joints to study the effect of exogenous 
catecholamines administered locally upon the 
clearance rate. The results of these studies
suggest that both qualitative and quantitative 
differences exist between normal and inflamed joints. 
These studies are also described in Chapter 4.
In Chapter 5 the results of similar studies 
conducted in normal human subjects, in patients with 
osteoarthritis and in patients with rheumatoid 
arthritis are presented. The responses obtained to 
local administration of stimulating and inhibitory 
adrenergic compounds in normal subjects are similar to 
those obtained in the normal canine joint. The 
presence of both and receptors could be deduced 
from these results. The responses in diseased joints, 
whether afflicted with osteoarthritis or with rheumatoid 
arthritis were both qualitatively and quantitatively 
different from normal joints and were similar to the 
results obtained in the inflamed canine joint. Ths 
response of the clearance rate to the exhibition of 
external heating, to exercise and to local injection 
of histamine is documented. Again differences between 
normal and inflamed joints were apparent in the response 
to beating and to histamine injection. Exercise, 
however, caused a reduction in clearance rate in both 
normal and diseased subjects.
In Chapter 6 certain clinical applications of the 
determination of the clearance rate of intra-articularly 
injected 133 Xe are explored. Synovial perfusion 
rates in rheumatoid arthritis, osteoarthritis,
Reiter*e syndrome, psoriatic arthritis, gout and 
infectious arthritis are recorded and the relationship 
to a clinical index of local disease severity is 
examined. It is demonstrated that a joint judged 
clinically to be uninvolved may yet display evidenoe 
of involvement expressed by an abnormally fast 
clearance rate. Although change in disease activity 
during therapy with corticosteroids and with lndomethacln 
was reflected in a reduction in clearance rate the 
same did not apply to salicylate therapy and the 
results of a crossover drug trial demonstrating this 
are reported in Chapter 6 in addition to the results 
of studies on the effect of synovectomy on the clearance 
rate. The clinical implications of these findings 
are discussed.
In an attempt to devise a more sensitive index of 
change in disease activity than was afforded by the 
133 Xe clearance technique, studies were conducted 
employing intravenously administered radioactive
A
technetium (99 aTc) and the results of these studies 
are reported in Chapter 7* Preliminary studies 
conducted with joint scans demonstrated the possibility 
of quantitating these scans by reference to a joint 
"phantom" and the results of these are reported in 
terms of % of 100% uptake. Although the degree 
of uptake was related to the severity of involvement 
of the joint, the error of the method proved to be 
unacceptably high. A simpler method of quantitation 
employing lower tracer doses is described in Chapter 7* 
This method proved to possess a more acceptable degree 
of reproducibility and proved to be capable of 
reflecting change in disease activity with both 
•tejro±<2al and non-steroidal compounds In both large 
and small joints although the advantage of localisation 
of activity within the joint was lost. Pilot studies 
with this method are reported in Chapter 7 and two 
controlled clinical trials with widely employed anti­
inflammatory agents and with a newly introduced 
compound, Tbuprofen, are also reported in which the 
isotope studies were performed in conjunction with 
standard methods of clinical assessment. The results
of 99 nTc studies In normal subjects^ in patients 
with osteoarthritlB and in patients with rheumatoid 
arthritis of whom a group had previously been 
subjected to the operation of synovectomy are 
reported in terms of "% uptake" in Chapter 7*
The thesis concludes with a small study upon 
the rates of clearance of different anions compared 
with the rate of clearance of simultaneously 
administered 133 X® both in the presence of, and in 
the absence of systemic administration of potassium 
perchlorate. The results suggest the presence of a 
transport mechanism for anions from the joint cavity 
across the synovial membrane to the synovial veins.
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On all occasions the tine between the various 
manoeuvres was reduced to a minimum by practice and 
on each occasion the time taken to change positions 
was noted. In the case of the normal subjects the 
mean time to change position was 31 seconds (range 
20 to 53 seconds). In the case of the rheumatoid 
subjects the time to change positions was much longer 
(mean 96 seconds range 28 to*l80 seconds).
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Legendt Examples of the responses of the clearance 
rate to heating, exercise and the Intra-articular 
administration of histamine*
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RESULTS
HUMAN STUDIES 
The effect of Heat
The Tj values prior to heating the knee Joint in 
normal subjects (range 110 to} 150 minutes) were 
markedly higher than were the corresponding values 
following the exhibition of external heating (range 38 
to 90 minutes) (Table 9). A change in the clearance 
rate was noted in all studies (Fig* 3)• These results 
are in accord with those obtained previously in the 
normal canine Joint (Chap. ).
In the patients with rheumatoid arthritis, however, 
the response to heating was not uniform. Thus a 
marked change in clearance rate was observed in seven 
studies whereas no change whatsoever occurred in a 
further five. It is noteworthy (Table 9) that of the 
studies in which the initial T-J- value exceeded 60 
minutes change was noted on each occasion whereas when 
the initial T£ value was less than 60 minutes change 
was noted in only one of six studies. In that study 
the clearance rate following heating (T£ 18 mine.) was 
faster than the pre-heating value (T-J 30 mins.). 
Intra-articular temperatures were determined in two of 
the studies in which no change in clearance rate
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following heating was observed* and the rises in 
temperature following heating were 0*9 and 1*1°C* 
respectively.
Effect of Exercise
The Ti values in normal sribjects prior to and;
following exercise (range 140 t o )  150 and 1^5 to 
)  150 minutes respectively) were similar and no 
obvious change was noted in the clearance rate on any 
occasion.
In six normal subjects histamine was administered 
intrn-articularly prior to exercise. The T£ values 
following the injection of histamine (range 20 to 79 
minutes) were markedly lower than the corresponding 
values obtained following exercise (range 91 to 145 
minutes). The mean percentage increment was 300%.
In a further six normal subjects* who also received 
histamine intra-articularly* monitoring was continued 
for the same time period but these subjects were not 
exercised. The T£ values immediately following 
histamine injection (range 28 to 80, mean 52.5 
minutes) were lower than the T£ values recorded from 
15 to 45 minutes after injection (range 48 to 93t 
mean 66.5 minutes). The mean percentage increment 
was 1185? (Table 10).
^05
?'S
V V ^ M v / M ^ Vm ro\^^'^v*v£Vj»vjiyjivjnvji O V J l O O O O O O O O O O
vji
■s
o
fO ■*- 
0 0  On
w  m  \ j i  fo ut u< vn
<fco
Fv* v* M  V !  Vji ^  O n On —I - J  C O . 0 0 .On O  ro —1
K
£
£G
B
ro vnV^4 « ro vm v< f -  oo v*  to  ro vji on * -  - j  - j  oo Oph* -P* io w w O
t
*»
VO
VJI M  ro  V *  v_rf •£“  v j i  O n —J  —J  CO 0 3  0 00 3  VO  V>4 OO ■£- M  •£ " V j4 •£“  O  rO  VO
ro
ro
<p m  rov<v>«^-ViVji-r” V ^ s ^ r o * “I • NOvo-F-ONON&rooNVOOoroM
VJI VJI
ro
5
*
s'
£ rovn
In patients with rheumatoid arthritis, the Ti 
values before exercise (range 18 to 86 minutes) were 
lower than were the corresponding values following 
exercise (range 48 to 128 minutes)(Table 9)* Change 
in clearance rate was noted in 14 of the 16 studies 
(Fig. 3).
Effect of Histamine
In four normal subjects who received 1 ^  g. of 
histamine intra-articularly no change in clearance 
rate was observed. The Tj values beforehand were 
951 135» 150 and>150 minutes and the corresponding
values following injection were 95t 135t 150 and 
y  150 minutes respectively. When the dose of 
histamine was raised to 10 ^ /g. the T£ values following 
injection (range 20 to 83 minutes) were lower than 
the pre-injection values (range 110 to ^  150 minutes). 
Change in clearance rate was observed in all studies 
(Fig. 3) (Table 11).
In patients with rheumatoid arthritis who 
received 10^ g. of histamine intra-articularly 
values before injection (range 26 to 83 minutes) were 
similar to those obtained after injection (range 28 to 
83 minutes). In only one of these studies was there 
a change in clearance rate. In that study the T£
value obtained following Injection was l \2  which was 
Increased when compared with the pre-injection 
value (66 minutes). When the dose of histamine 
was increased to 250 \  g* change in clearance rate 
was noted in seven of 12 studies. In all of these 
studies the baseline T£ value exceeded 50 minutes.
In the remaining five studies no change in clearance 
rate attended the administration of 250 g, of 
histamine and in all of these studies the baseline 
T*J values were less than if5 minutes (Table 11),
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In the present study the effect of external
- ■ . ■' ' . .. heating in normal subjects and in several rheumatoid
patients was to reduce the T-J- value, denoting an
increase in synovial perfusion. However, in those
rheumatoid subjects whose control Tj values were leas
than 60 minutes, implying a fast resting synovial
perfusion rate, no change was noted with external
heat. That the method of heating did in fact result• >. ' ‘  ^ . , > ■ ■ ' • . * .
in an increased intra-articular temperature was 
confirmed by direct measurement in two of these
subjects. Several workers (Hollander and Horvath,‘ ' '' -v * • . ; ; ‘ \ •
1949b s Horvath and Hollander, 1949 : Hollander et al,
1951 5 Branemark et al,, 1963 and 1966 ; Ring and Coel
1 9 6 8 ) have studied the response of normal and
rheumatoid joints to external heating. Branemark et
al. (1 9 6 3 i 1 9 6 6 ) describe a pattern of response to
heating which differs in normal and in rheumatoid
subjects. Unfortunately, however, continuous
monitoring of intra-articular temperature was not
V* ' ’ V'v*'•• *
feasible in the present study and consequently no 
conclusions can be drawn on this point.
In all but two rheumatoid subjects who were
2.S.S.
subjected to exercise in this study, the T i values 
obtained following exercise were higher than those 
obtained beforehand. Thus, exercise has the effect 
of reducing synovial perfusion in most patients with 
rheumatoid arthritis. It is unfortunate that the 
design of the present study permitted only the 
measurement of a complicated response system. Thus 
either the exercise per se, or the unavoidable 
positional changes involved could have accounted for 
this effect. Intra-articular pressure changes are 
complex (Palmer and Myers, 1968) and it is possible 
that the reduction in perfusion is related to a rise 
In intra-articular pressure. In several subjects no 
change in T£ value was noted following exercise. 
However, the method of calculation of T} values of 
almost horizontal semilogarithmic plots imposes 
severe restrictions on the interpretation of these 
results. Indeed it is not possible to demonstrate 
directly a further reduction in slow perfusion rates 
by this method. Therefore, to investigate further the 
effect of exercise on normal subjects, the perfusion 
rate was first increased by the prior administration of 
histamine (10 ^ g.). When the subject was exercised 
thereafter a marked increase in ? i value was noted
JL  >0.
implying a reduction in synovial perfusion. The 
increaee in T£ values with exercise greatly exceeded 
increase attributable to the waning of the effect of 
histamine. It is probably therefore that exercise 
has the same effect in normal subjects as in rheumatoid 
patients, namely to reduce synovial perfusion,
A dose related response to histamine was noted in 
both normal subjects and in patients with rheumatoid 
arthritis in this study. However the dose levels 
required to elicit a response differed in the two 
groups. Thus in normal subjects, although no 
response was obtained with a dose of 1 yg., all of 
12 subjects responded to 10^ g, with a reduction in 
T-J value and therefore an increase in perfusion, 
However, change in clearance rate in response to 
10 y g. of histamine was obtained in only one patient 
with rheumatoid arthritis and it is noteworthy that 
the baseline T£ value of this patient was 66 minutes 
suggesting low resting eynovial perfusion. When, 
however, 250^6# of histamine were administered 
change in clearance rate was noted in seven of 12 
studies. All of the studies in which the clearance 
rate was increased by histamine were characterised by
baseline Ti values in excess of 50 minutes 
implying low resting synovial perfusion. Further­
more in each of the other five studies which 
exhibited a response to 250 ^  g. of histamine, the 
baseline Tj value was below 50 minutes implying 
fast resting perfusion. The explanation of these 
findings is not clear, but it is interesting that 
rheumatoid subjects whose control T-J* value was less 
than 50 to 60 minutes, indicating high resting 
synovial perfusion failed to respond to both 
external heating (in all but one study) and to 
intra-articular histamine. That the 133 Xe 
clearance rate does not impose a methodological 
limitation is demonstrated by the fact that Ti 
values of less than 25 are recorded in normal 
subjects and in initially slowly perfused rheumatoid 
subjects. Furthermore, one rheumatoid patient with 
a high resting perfusion rate did respond to external 
heating.
A clue to the explanation of the findings with 
histamine may be afforded by consideration of the 
differences in the drug responses between normal and 
inflamed joint© noted previously both in animals 
(Chap. £4- ) and in man (Chap. iT * page 1“13). Thus
^ I ^
the dose of o f  and f> adrenergic compounds required 
to elicit a similar response in inflamed joints was 
consistently higher as is the case with histamine in 
the present study. The ratio of tissue volume and 
vascularity to receptor concentration and drug 
diffusion rates and local binding effects may all 
contribute.
These factors however cannot be invoked to 
explain the lack of response to external heating.
It is possible that when the disease is associated 
with a high resting synovial perfusion rate, the 
peripheral vasculature undergoes changes which render 
it to some degree autonomous. However, since the 
numbers involved in the present study are small 
final conclusions are not justifiable. No rationale 
either for or against the exhibition of heat in 
rheumatoid arthritis is afforded by the results of 
this study. Conceivably, however, the reduction in 
pathologically elevated perfusion rates occasioned by 
exercise may exert a beneficial effect.
2 1 3
CONCLUSIONS
1. Both and f t adrenergic receptors are 
functionally active in the control of synovial 
perfusion in normal subjects and in rheumatoid 
and osteoarthritis. o< receptor control 
probably predominates.
2. The evidence suggests the presence of basal oL 
adrenergic vasoconstrictor tone.
3. A quantitative difference in the response to 
adrenergic agents exist in inflamed synovium. 
Higher doses are required to elicit the response,
if« Normal basal adrenergic vasoconstrictor 
tone may be lost in inflamed joints.
Exercise reduces synovial perfusion in 
rheumatoid arthritis and probably also does so 
in normal subjects.
6. Both intra-articular histamine and the exhibitioi 
of external heat increase synovial perfusion in 
normal subjects.
7. Initially slowly perfused rheumatoid patients 
respond to heating and to higher doses of 
histamine in the same way, that is by an increase 
in synovial perfusion.
8. When the resting perfusion rate is markedly 
elevated in rheumatoid arthritis, no response 
to heat or to histamine is obtained.
A!4
CHAPTER 6 r;
In this chapter I have explored some clinical 
applications of the 133 Xe clearance technique.
Synovial perfusion rates in various inflammatory 
arthritides such as rheumatoid arthritis, Reiter1s 
syndrome, psoriatic arthritis, gouty arthritis and 
Behcet’s syndrome and in "degenerative" arthritis 
are compared to the values obtained in normal subjects. 
The relationship between the T-J- value of the 133 Xe 
clearance rate and a clinical index of the severity 
of Joint involvement is explored and the application 
of the method to the early diagnosis of arthritis is 
evaluated.
The results of studies with steroidal and non­
steroidal anti-inflammatory agents are reported and 
the sensitivity of the 133 Xe clearance method is 
compared with that of better established clinical 
methods of assessment.
Finally the effect of the operation of anterior 
synovectomy of the knee upon synovial perfusion was 
studied in an attempt to devise a satisfactory method 
of assessment of that operation and the results are 
discussed.
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SYNOVIAL PERFUSION MEASURED BY THE 133 XENON CLEARANCE 
TECHNIQUE IE VARIOUS ARTHRITIDES
Introduction
In Chapter 2 it was noted that synovial 
perfusion rates are elevated in patients with 
rheumatoid arthritis* In this section the results 
obtained in larger numbers of patients with rheumatoid 
arthritis are reported and observations were 
extended to include patients suffering from various 
other arthritidee.
SYNOVIAL PERFPEIOW RATES IN VARIOUS DISEASE STATES
Patients Stwdiae
133 Xe studies were performed on 130 knee 
joints of patients with "classical" or "definite" 
rheumatoid arthritis* The mean age of these patients 
was 48*2 years (range 35 to 71 years) and 34 were 
male* In all cases the relevant knee joint was 
involved clinically or showed radiological evidence 
of previous involvement in the form of articular 
erosions*
Forty-four knee joints of 30 patients with 
osteoarthritis were studied* all of whom had 
clinical or radiological evidence of involvement of 
the knee joint* In none were tests for rheumatoid 
factor positive and in all the erythrocyte 
sedimentation rate was normal* Their mean age was 
62*4 years (range 40 to 78 years) and four were male* 
None of these patients was suffering from any other 
disease and in particular diabetes mellltus and 
hypertension were excluded*
Twenty-nine studies were performed on the knee 
joints of 16 patients with Reiterfs disease in all of 
whom the knee joint was clinically involved. All
3-1 b
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had urethritis conjunctivitis and a sero-negative 
polyarthritis and four had keratodermia blenorrhagica. 
Their mean age was 30*1 years (range 18 to 47 years)* 
Fifteen studies were conducted in fourteen 
patients with psoriatic arthritis* In all cases 
there was prominent involvement of the distal inter- 
phalangeal Joints and in eleven patients there was 
either clinical or radiological evidence of 
sacrolliltls* Both skin and nail changes were 
present in all of these subjects and the treatment 
of the dennatological manifestations was being 
supervised by the Dermatology Departments of the 
Royal Infirmary, the Western Infirmary or the 
Victoria Infirmary in Glasgow. In nine* the knee 
joint studied was involved clinically but in the 
remaining six the knee Joint was neither involved 
clinically at the time of study nor was there either 
clinical or radiological evidence of past involvement* 
Four studies were performed in two male patients 
aged 43 and 33 years who had clinical and radiological 
evidence of gouty arthritis of the relevant knee 
joint* One of these studies was performed during an 
acute episode of gout in the joint*
RESULTS
The results are shown In Table 1. The mean •
2 S.Ds. of the entire normal groups was 0.38 i 0.1*4 
m l/100 m l/m ln 4 The values (mlAOO ml/min.) obtained 
for patients with rheumatoid arthritis (mean 2#57 • 
S.E.M. 0,13), psoriatic arthritis (mean 1*86 £ S.E.M. 
0*37) and with Reiter’s disease (mean 1*98 ~ S,E.M,
0*27) were significantly higher than the values obtained 
in normal subjects (mean 0*38 - S.E.M. 0*03)* There 
were however no significant differences between the 
values obtained in psoriatic arthritis, in Reiter1s 
disease and in the rheumatoid arthritis patients.
The mean value for the osteoarthritlc knees (1*01 - 
S.E.M. 0.1 ml/100 ml/min.) was significantly higher 
(p <0,001) than the values obtained in the normal 
group but was significantly lower than the values 
obtained in either rheumatoid arthritis or Reiter’s 
disease.
The values obtained in the patients with psoriatic 
arthritis (mean 1.86 -  S.E.M. 0.38 mlAOO ml/min.) are 
individually recorded (Table 2 ). It can be seen 
that in two of the six patients whose knee joints were 
termed "not clinically involved" based on the absence of 
pain, stiffness, heat, swelling or tenderness both at
the time of study and in the past history, the 
perfusion rates were elevated over the normal mean ♦
2 S.Ds. whereas in the other four studies in that 
group normal values were obtained*
The perfusion values obtained in patients with 
chronic gouty arthritis (0*44, 0*4 and 0*13 ml/100 ml/ 
mln*) were low but the value obtained in the patient 
whose knee joint was the seat of acute gouty arthritis 
at the time of study was 1*34 mlAOO ml/min*
The values obtained in patients with septic 
arthritis (1*92 and 2*26 mlAOO ml./mln.) in 
tuberculous arthritis (1*65 and 2*04 mlAOO m l / m l n . )  
and in Behcetfs syndrome (2*9 mlAOO ml/bin*) were 
outwith two standard deviations from the mean of the 
normal group. ,
'^2J
2  A l l
PJS S S S S m
Thus it can be seen that high perfusion values 
were by no means confined to patients suffering from 
rheumatoid arthritis#
The values obtained in Reiter1s syndrome, 
Infectious arthritis and Behcet1s syndrome were of ths
same order of magnitude as the values obtained in
/
rheumatoid arthritis# Since all of these diseases 
are characterised by chronic inflammation, of which 
vascular changes are an Integral part, these findings 
are in accord with current pathological concepts.
The marked differences between the results 
obtained in quiescent and acute gouty arthritis are 
of interest but the numbers studied are insufficient to 
support specific conclusions.
Whereas in psoriatic arthritis all of the values 
obtained in symptomatic knees were elevated, the 
results in the clinically uninvolved joints were not 
concordant. In two of six studies the perfusion 
rates obtained were outwith the normal range (mean ♦
2 S.Ds. of the normal group). It is Interesting in 
this context that capillary abnormalities in uninvolved
skin of psoriatic patients have been reported
(Davis et al., 1968).
It ie possible that a similar mechanism obtains in 
the synovium.
The results obtained in osteoarthritis are also 
interesting. Osteoarthritis is considered by many 
non-rheumatologists to be a hypertrophic degenerative 
pathological process. The results of this study are 
at variance with this concept. Thus, the mean value 
obtained in osteoarthritis (mean 1.01 ~ S.E.M. 0.1 
minutes) was significantly higher (p<0.001) than the 
mean value of the normal group. Inspection of the 
individual results revealed blood flow values of 
2.0, 2.0, 2.2,2.J and 2.8 ral./lOO ml./minutes in 
Individual oeteoarthrltlc knees. This would seem to 
Indicate that, in some situations in osteoarthritis, 
the synovial perfusion rate may be as high as those 
recorded in the inflammatory arthritides. This
finding is in accord with those of Davison and Wisham 
(1958) who showed high clearance rates of radioactive 
sodium from oeteoarthrltlc knees and with the finding 
of elevated intra-articular temperatures in this 
disease (Hollander et al., 1956)• All of these
observations tend to suggest the presence of an 
vascular lesion of the synovium in osteoarthritis
in addition to the well established cartilage 
disorder.
The results of this study show that elevated 
synovial perfusion rates are a non-specific finding 
and occur regardless of the underlying pathological 
process. These results support the concept that a 
vascular derangement is a feature of the inflammatory
. . ■ V « • • ■' •
response in the synovium.
THE RELATIONSHIP BETWEBH THE Tj VALUE AND CLINICAL 
ASSESSMENT OY THE JOINT AT THE TIKI, OF STUDY.
Method
The diagnostic categories of the patients studied 
in the previous section were reviewed and more 
stringent standards were imposed for the purposes of 
the present study* Thus only patients with 
"classical" as opposed to "classical or "definite" 
rheumatoid arthritis were retained and only the 
results obtained in those patients who demonstrated 
both clinical and radiological evidence of osteo­
arthritis of the knee were analysed. All four 
patients with Reiter1s syndrome who had keratodermla 
blenorrhagica were selected and four further patients 
who had a seronegative polyarthritis, involving the 
knees, ankles and sacroiliac joints, conjunctivitis, 
urethritis or balanitis and evidence of tendinous 
calcification were accepted as unequivocally 
satisfying the diagnostic category of Reiter1s 
syndrome. .
Patients Studied
Forty-three studies performed on the knee joints 
of thirty-nine patients with "classical" rheumatoid
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figure. .1
The relationship between the T$ value and the clinical 
knee score in the individual disease groups studied.
arthritis were suitable for further analysis* The 
moan age of those patients, of whon twelve were Bale, 
was 55*7 years (range 40 to 69 years)* Similarly, 
the results from eighteen studies performed on nine 
patients with osteoarthritis were analysed further.
Four of these patients wore male and the age range 
was 45 to 73 years (moan 60.9 years). Twelve studies 
performed in eight male patients with Reiter*s 
syndrome were analysed* The mean age of these 
patients was 18 to 43 years (mean 33»4 years).
The injection technique (page ) and counting 
technique (page \ly ) have been described and the method 
of clinical assessment of the joint has been detailed 
(page UZ.).
Results and Interpretation
Figure 1 illustrates the relationship between the 
clinical index of inflammation and the T-J value obtained 
in these studies. When the clinical index is high, 
the T-J- value is low and conversely when the index is 
low the T£ value is high. The correlation coefficient 
when all diseases were considered together was 0.76.
The relationship was
a.a-3
individually analysed in each of the disease groups*
The correlation coefficients obtained 
were 0.82 for Reiter*s syndrome, 0.75 f o r  rheumatoid 
arthritis and 0.21 for osteoarthritis.
A correlation coefficient of 0.82 does not of 
course imply a causal relationship between the 
variables and Indeed Indicates that only approximately 
65$ of the correlation is accounted for by the variables 
studied. Thus 35$ remains to be accounted for by 
other factors. However, these results do support 
the previous observations of high clearance rates (low 
Ti values) in inflamed joints (page ~J I). It would 
seem reasonable to suggest that the rate of clearance 
does reflect to some extent the degree of inflammatory 
involvement at the time of study. Indeed, considering 
that the clinical index involves the estimation of 
four parameters, all of which have to be assessed 
qualitatively by patient and/or clinician, it would be 
surprising if this index correlated more closely with 
a single quantitative measurement.
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SYNOVIAL PERFUSION OF CLINICALLY NORMAL KNEE 
JOINTS IN PATIENTS WITH RHEUMATOID ARTHRITIS
In recent studies on the pathogenesis of 
rheumatoid joint inflammation, Hollander and his co­
workers have injected immune gamma globulin molecules 
or lgG fragments isolated from serum into clinically 
uninvolved joints of patients with rheumatoid 
arthritis (Restifio et al., 1965 : Hollander et al., 
1966 : Quismorio et al., 1968 : Hollander and 
Rawson, 1968). Inflammatory reactions were induced 
by these injections and the suggestion was made that 
fragments related to the lgG molecule might be the 
antigen which induces the production of rheumatoid 
factor.
The question may be posed as to whether a 
"clinically uninvolved joint" is also a joint 
unaffected by rheumatoid pathology. Sokoloff and 
Gleason (1954) demonstrated in a small series of 
necropsy examinations of rheumatoid patients that 
the sternoclavicular joints showed histological 
changes characteristic of rheumatoid arthritis 
although in none of the cases was there a record of
the joint having been involved clinically. However, 
it was not indicated that evidence of involvement had 
been sought in the sternoclavicular joint specifically 
during life and, as suggested by the authors 
themselves, routine clinical examination is unlikely 
to elicit involvement of these joints when arthritis 
of other larger joints is attracting attention.
In this study patients with "classical" rheumatoid 
arthritis (Ropes et al., 1959 ) were selected who did 
not have evidence of clinical Involvement of the knee 
joint in the disease process. These patients were 
subjected to 133 Xe studies to determine whether the 
rate of synovial perfusion in these "clinically 
uninvolved" joints was normal.
Patients studied
Twenty-two patients were studied. Each had 
"classical" rheumatoid arthritis, all having articular 
erosions, a peripheral 8ymmetrical polyarthritis of 
more than six months1 duration and positive serological 
tests for rheumatoid factor. Sixteen were female and 
their ages ranged from 35 to 66 years.
Ho patient gave a history of pain, swelling,
a  3 0
stiffness or dysfunction of the relevant knee joint.
On careful clinical examination by several clinicians 
independently there was no evidence of swelling either 
due to effusion or to synovial hypertrophy or abnormal 
warmth of the overlying skin and there was no joint 
tenderness or restriction of movement. All the 
patients had normal radiographs of that knee joint.
The method of injection (page L), counting 
techniques (page and derivation of synovial
perfusion (page have been described.
All patients volunteered to participate in the 
study with full knowledge of its content.
TABLE I I I
The T£ values and synovial perfusion rates recorded ucinf 
133 Xe clearance technique in 22 clinically uninvolved ki 
in patients with rheumatoid arthritis. Also shov/n are t \  
mean values and ranges obtained in 40 knee Joints of norm 
subjects and in 82 clinically involved knee joints of
patients with rheumatoid arthritis
Patient T-J value (mins.) Synovial Peri
ml/100 ml/mir
2
3
4
5 - 6
7
8
■ 9
10 
11 
12
13
14
15
16
17
18
19
20 
21 
22
Mean
S . E . M .
40 normal subjects Mean
Range
82 rheumatoid knee 
joints (knees 
clinically involved
35 1.98
38 1.82
b e 1.51
50 1.39
52 1.3356 I.2/1
68 1.02
82 0.85
92 0.75
95 0.73
105 0.66
106 0.65150 0.46
160 0.43180 0.39
190 0.36
BbO 0.29
260 0.27320 0.22
325 0.21360 0.19
<*65 0.15
138 Mean 0.77
25.9 :S.E.M . 0.12
252 Mean 0.28
95-630 Ran^e 0.11-0.7,
b 3 1.61
10-13*i 0.52-6.93
*^LL
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The results are shown in Table 3* In seven 
studies the synovial perfusion exceeded 1 ml.AOO ml./ 
minute (Ti value < 70 mins.). In a further five 
patients the values obtained were between 0.5 and 
1*0 ral.AOO ml*/minute (T£ values between 82 and 
106 minutes)*
Figure 3 shows the distribution of the T$ values 
obtained in the clinically uninvolved joints and 
also the Tf values for two other groups, namely, 
unselected patients with "classical" or "definite" 
rheumatoid arthritis attending the Centre for 
Rheumatic Diseases and a series of 40 normal 
volunteers who had no evidence of joint disease*
The range of T} values in the rheumatoid patients 
was 10 to 134 minutes (synovial perfusion 0*52 to 
6*93 ml•/100 ml./nlnute)• The range in the normal 
joints was 95 to 630 minutes (synovial perfusion 0*11■ ' i ■
to 0*73 ml.AOO ml ./minute). In the rheumatoid 
group only two patients out of 82 had a Ti value in
excess of 100 sins, and in the normal group only one
knee of 40 had a T i value of less than 100 minutes.
Rheumatoid arthritis 1© a polyarthritis and the 
distribution of clinically involved joints in any 
particular patient appears to be quite random 
although certain joints are affected more frequently 
than others. Joints which do not appear to be 
involved on one examination may be inflamed at a 
later date and, though perhaps less commonly, joints 
obviously inflamed on one occasion may be quiescent 
at a subsequent examination. The question therefore 
arises as to whether any diarthrodial joint may be 
considered to be uninvolved in rheumatoid arthritis.
No histological information is presently available on 
this point.
Several workers (Sokoloff and Bunlm, 1957 * 
Branemark et al,, 1963bt Kulka, 1964) have presented 
evidence which suggests that an early feature of the 
pathology in rheumatoid arthritis is an abnormality 
of small blood vessels. It seemed appropriate there­
fore to employ a method of measuring synovial perfusion 
in this study.
The results obtained in the clinically normal
DISCUSSION
knee joints of patients with "classical” rheumatoid 
arthritis show that in seven of the twenty-two knees 
examined the synovial perfusion rate was markedly 
abnormal the levels being of the same order of 
magnitude as those found in a series of clinically 
affected joints in rheumatoid patients. In a 
further five knees the synovial perfusion rate was 
greater than the values commonly encountered in 
normal subjects.
All patients with rheumatoid arthritis attending 
the Centre for Rheumatic Diseases with clinically 
uninvolved knee joints were not studiedt the 22 
who were examined were not chosen for any reason 
other than convenience, freely given consent and 
availability. The study therefore is "highly 
selected”. In selecting only patients with "classical 
rheumatoid arthritis, however, there is likely to have
4been a bias in favour of more advanced and generalised 
joint involvement.
The results of the previous study (page ^ 2-9 
showing that there was a relationship between clinical 
Involvement and synovial perfusion are not at variance
with these results. Since the correlation was not 
linear (r * 0.75) then approximately only 50# of the 
relationship was accounted for by the variables 
studied. The results of the present study represent 
a proportion of the remaining 50#* results of
the* study clearly demonstrate that a joint which ia 
normal clinically may yet show evidence of involvement 
in the disease process expressed as an abnormally 
high synovial perfusion rate.
THE EFFECT OF XWTRH-ARTXCULAR ADMINISTRATION OF 
HYDROCORTISONE ON THE 133 XENON CLEARANCE RATE,
Either systemic or local corticosteroid therapy exerti 
a powerful non-specific suppressive effect on the 
inflammatory process. Since the clearance rate of 
133 Xe from the Joint cavity bears a relationship to 
the degree of Joint inflammation at the time of study 
it could be expected that changes in the state of the 
Joint induced by corticosteroid therapy would be 
paralleled by changes in clearance rate, A preliminary 
study was therefore conducted to determine whether local 
treatment with high doses of hydrocortisone would Induce 
a change in the rate of clearance of intra-articularly 
injected 133 Xe.
Patients studied
Twenty-five patients suffering from "classical" or 
"definite" rheumatoid arthritis were selected for study. 
Their ages ranged from 42 years to 61 years (mean 49*6 
years) and all had clinical and radiological involvement 
of the relevant knee Joint. Nine were male.
Methods
133 Xe studies were performed in the usual manner 
and the T£ value was calculated as has been previously
described (page [ f \ ) • At the conclusion of the 133 Xe 
studies 100 mg. of hydrocortisone hemisuccinate were 
injected into the Joint cavity and the 133 Xe studies 
were repeated, firstly at 24 hours after injection and 
then again at one week. One patient failed to attend 
for the third 133 Xe study one week after injection.
Prior to each 133 Xe study clinical knee assessments 
were performed in the manner previously described 
(pagel\"0 by the same observer. This study was not 
"double blind", both assessor and patient being aware 
of the treatment administered.
The T i values and the results of the clinical knee 
assessments, obtained prior to the injection were 
compared with those obtained at 24 hours and the 24 hour 
values were compared with the results of the same studies 
repeated one week later. Statistical analysis was 
performed using the paired Student t-test.
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Legend: The relationship between tho change in T-J value
and the change in clinical knee score before and after 
intra-articular corticosteroid therapy#
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The mean and standard error of the T£ values 
24 hours following the administration of hydrocortisone 
(mean 62 . 4  -  S . E . M .  1 0 . 2 7  minutes) were significantly 
higher (0.013 0.001) than the corresponding values
prior to the injection (mean 3 4 *5 6  - S . E . M .  3 . 8 9  
minutes). The values obtained for clinical knee 
assessment 24 hours after the injection (mean 5.7 - 
S . E . M .  0.72) were significantly lower (p =<10.001) 
than the pre-injection values (moan 9 . 4  i  S . E . M .  0.57 
minutes). In 1 9  patients the T£ values fell, in two 
cases they were the same and in four cases higher 
values were obtained 24 hours after the treatment.
The correlation coefficient between the alteration in 
T-J value and the change in the clinical index was 
0.52 (Fig. 3).
There was no significant difference between the 
T£ values (mean 62.44 - S.E.M. 10.27 minutes) or the 
values obtained for the clinical score (mean 5*7 - 
S.E.M. 0.72 minutes) at 24 hours and the corresponding 
values/obtained one week after the injection (mean 52.42 
- S.E.M. 4*79 minutes and mean 5*8 - S.E.M. 0.75 minutes 
respectively) in the 24 patients who completed the trial 
(0.3^ p^ 0.7 and 0.95^ P > 0.9 respectively).
A M
Although this preliminary study was not double 
blind and did not incorporate a placebo, the numbers 
of patients studied, the level of significance 
achieved and the high degree of objectivity in the 
method of measurement all support the conclusion 
that intra-articularly administered hydrocortisone 
in high doses reduces the rate of clearance of 133 Xe 
from the knee joint implying a reduction in synovial 
perfusion. It is particularly interesting that 
those patients whose H i value failed to be reduced 
were those who did not obtain clinical benefit from 
the injection. Failure of response to local 
installation of corticosteroid has been noted by 
others ( McCarty ,8, Hogan, 1964)
and it has been established that locally administered 
corticosteroid may induce a "crystal synovitis"
This may explain the results recorded here.
The alteration in H i value is related to the 
change in clinical knee assessment. The correlation 
coefficient between these parameters was 0*52.
DISCUSSION
It is impossible to determine from the foregoing 
results which of these indices is the more sensitive 
and it is likely that they are complementary 
parameters each reflecting, primarily, different 
aspects of the same process. This relationship 
between improvement as judged by clinical index and 
by T£ value suggested that the 133 Xe clearance 
rate might be of value in the objective assessment 
of anti-inflammatory drug effect, thus prompting 
the succeeding study.
THE EFFECT OF HOW-STEROI DAE ASTI-INFLAMMATORY DRUQ 
THERAPY ON THETl VATJIE
Introduction
The exhibition of large doses of an anti­
inflammatory agent results in a reduction in the rate 
of 133 Xe clearance.
The "test” of any new method of assessment is to
/
evaluate it in a relevant clinical situation. Thus 
in the context of an index of anti-inflammatory effect 
it is essential to show that meaningful results can be 
obtained under the conditions of a clinical trial. 
Accordingly, 133 Xe clearance rates were measured in 
conjunction with several established indices of 
anti-inflammatory effect, in such a situation, employing 
widely used anti-inflammatory agents.
TABLE: IV
Patient No, Week 1 Week 2 Week 3
1 Indomethacin Placebo Salicylate
2 Placebo Indomethacin Salicylate
3 Salicylate Indomethacin Placebo
k Placebo Indomethacin Salicylate
5 Indomethacin Salicylate Placebo
6 Placebo Salicylate Indoraethaci
7 Salicylate Placebo -
8 Indomethacin Salicylate Placebo
9 Indomethacin Salicylate Placebo
10 Indomethacin Salicylate Placebo
11 Salicylate Placebo Indomethaci
12 Placebo Indomethacin -
13 Salicylate Placebo . Indoraethaci
Sequence of administration of salicylate indomethacin 
and placebo in the thirteen patients studied.
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MATERIALS AND METHODS
Thirteen patients with classical rheumatoid 
arthritis (Ropes et al., 1959; entered a three week 
double blind trial during which they received three 
course of treatment each lasting for one week: 
Enteric-coated sodium salicylate ("Entrosalyl", 
Cox-Continental Ltd.) 1.2 g. four times per day, 
Indomethacin ("Indocid", Merck, Sharp and Dohme Ltd.) 
25 mg. four times per day and lactose as placebo.
The order of treatment was allocated randomly and 
the sequence is illustrated in Table k where it can be 
seen that if patients commenced on placebo, 5 patients 
commenced on indomethacin and if patients commenced on 
aspirin.
Two patients (7 and 12) failed to complete the 
trial. One patient (case 7) completed one week's 
salicylate therapy and one week on placebo but on the 
third day of the period on indomethacin therapy she 
developed severe headaches and took no further 
medication. The second patient (case 12) completed 
the first two weeks of the trial successfully, during 
which he received indomethacin and placebo but failed
to attend for assessment at the conclusion of the 
third week.
This study was performed in a double blind 
fashion, the physician assessing the patient’s 
response being unaware of which treatment was being 
given. The patients were assessed at the end of 
each week’s treatment. All female patients were 
post-raenopausal and all the patients volunteered to 
participate in this study with full knowledge of 
its content.
133 Xe studies (page ^ I) were performed at 
each attendance on one knee joint, selected for 
study at the beginning of the trial on the basis of 
severity of clinical involvement.
Prior to each 133 Xe study, clinical knee 
assessments were performed by the same observer on 
each occasion. At the same time the patients were 
questioned regarding side effects and the articular 
index (Ritchie et al., 1968) was performed as a 
measure of total articular status. This index is 
based on the response of the patient to firm pressure 
over the joint margin, the response being graded as 
follows!
0 *= no pain; ♦! » patient complains of pain;
♦2 = patient complains of pain and winces;
+3 = patient complains of pain, winces and withdraws. 
Certain joints are examined by passive movement, e.g, 
cervical spine, hips and mid-tarsal joints, and some 
joints are considered as single units, e,g, temporo­
mandibular joints, cervical spine, the sterno- and 
acromio-clavicular joints, the metacarpo- phalangeal 
and proximal interphalangeal joints in each hand and 
the mid-tarsal and metatarso phalangeal joints in 
each foot. The maximum possible score for an 
individual patient is +78, This articular index has 
been shown to have an acceptable degree of intra­
observer reproducibility; the mean intra-observer 
error difference in 18 patients examined by the same 
observer within 30 minutes is of the order of 1*2 
score units and the standard error of this difference 
is 1.1 score unite (Ritchie et al,, 1968), This 
articular index has also been shown to compare 
favourably with the articular score employed by the 
Co-operating Clinics Committee of the American 
Rheumatism Association (1963)> the correlation 
co-efficient being 0.89*
TA3L* V
Moan and ?• ! ,M# of the values obtained on 
placebo, salicylate and indomethacin therapy 
of the articular Index, total knee score and 
Ti of the 133 clearance from the knee.
■v - ■_ <v (niautcs)
2/*.7- *1
(n c 13)
Salicylates 25.3^1.3(n = 12)
Indoacthacln 32.3-3*9
(n « 12)
Total Articular 
Knee Score jndex
7 .6^0 . 8  1 2 .(-2 . 0
3.8^0.9 10.3^2 .9
TABLE VI
The individual T-J values (in minutes) recorded 
while the patients received placebof salicylate 
and indomethacin therapy
* *• * 3
• ' .
Placebo Salicylate Indomethacin
1 . 18 ., . • 19
. 7 • - . *j> t»  ^# A.;* V -
19
2. . 20 • 26 , 24
* 16 31 50
4. >8 22 55
5. 23 24 32
6. 20 27
7. 43 ; 27 -
8* 14 28 52
9. 30 ‘ 17 20
10. 16 . 33 • 22
1 1. 13 21 23
12. 35 mm *.*A- ^ . VjS* • 42
13. 23 23 25'
Mean 24.7 25.3 32.3
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RESULTS
The results are shown in Tables 5> 6 and 7.
Table 5 shows the mean and S .E .M.  of the values for 
the half-life (T-J minutes) of the 133 Xe clearance, 
the knee score and the articular index while the 
patients received placebo, salicylate and indomethacin 
respectively. It can be seen that the Tf values 
while the patients received indomethacin (mean 32.3 
i S.E.M. 3*9) were significantly higher by a paired 
student*s t-test (p<'0.05) than the values obtained 
while the patients received placebo (mean 24.7 - 
S .E . M.  3*1)* The T£ values while the patients 
received salicylates (mean 23*3 - 1.3 SE.M.)  were 
slightly, but not significantly, higher than the 
placebo values (p>0.8). There was no significant 
difference between the T-Jr values on salicylate or 
indomethacin (p>0.2) therapy. The T-J values are 
individually recorded in Table 6.
The values obtained for total knee score while 
the patients received placebo (mean 7.6 - S .E .M.  0.8) 
were significantly higher as tested by a paired 
student*s t-test than the values obtained while the 
patients received either salicylates (p <0.001) or
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indomethacin (p< 0*001) but there was no difference 
(p> 0.8) when the values obtained on salicylates 
and on indomcthacin were compared. Table 7 shows 
the results obtained for each component of the knee 
score. Both salicylate and indomethacin signifi­
cantly reduced pain, tenderness and stiffness. 
However, whereas indomethacin significantly reduced 
the degree of swelling as compared with placebo 
(p<0.01), salicylate therapy did not (p>0.1).
There was, however, no significant difference 
between the degree of reduction of swelling achieved 
by salicylate compared with indomethacin therapy 
(p>0./»). No significant correlation was found 
between the total knee score, or any of its 
individual components, and the T-J- value.
The values for the articular index (Table 5 )
▲
while the patients received placebo (mean 18.6 - 
S.E.M. 2.0) were significantly higher by a paired 
student’s t-test than the corresponding values when 
they were treated with either salicylates (mean 8.6 
£ S.E.M. 2.1)(p <0.001) or indomethacin therapy 
(mean 10.3 - S.E.M. 2.9)(P <0.02). There was no 
significant difference between the values obtained
3 M L
while on salicylate or on indomethacin therapy 
(p >0.h).
Only one patient failed to complete this trial 
on account of side effects (case 7)• She developed 
severe headaches while receiving indomethacin. Five 
of the eleven patients on sodium salicylate complained 
of mild dyspepsia which required no therapy and two 
patients developed tinnitus and diminution in hearing 
during the last two days of salicylate therapy.
Whilst on indomethacin therapy four petients complained 
of headache, two of those patients also experiencing 
mild dyspepsia.
"The properly controlled quantitative approach 
holds the only real hope for dealing with the oncoming 
flood of new drugs" (Beecher, 1959)* This statement 
made 10 years ago remains true today. In rheumatoid 
arthritis difficulties lie in the inherent variability 
of the disease process and in the lack of availability 
of methods for measuring the response to drug therapy. 
These difficulties are more fully discussed elsewhere 
in this thesis (page^u^).
In the present study the relevance of 133 Xe 
studies to assessment of the anti-inflammatory effect 
of drug therapy was investigated under the conditions 
of a clinical trial. Sodium salicylate, indomethacin 
and placebo were each given for one week in a double 
blind trial. Although the T£ values showed a 
significant change with indomethacin, there was no 
significant change with sodium salicylate. The dose 
of sodium salicylate was adequate (5 g* per day) and 
indeed two patients developed salicylism. Furthermore, 
both local (knee score) and general (articular index) 
clinical indices demonstrated that sodium salicylate 
exerted significant clinical benefit. Since the
DISCUSSION
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133 Xe clearance did not show changes with the "sheet 
anchor" of drug treatment, this technique will not be 
of value on its own in the clinical assessment of the 
short term response of rheumatoid arthritis to anti­
inflammatory therapy when salicylates are employed as 
"standard treatment". Further evidence to support 
this assertion is presented in Chapter 7.
The results are of some interest however since 
indomethacin significantly altered the Tj values 
whereas sodium salicylate did not. There are 
several possible explanations of this phenomenon.
Sodium salicylate may exert a weaker anti-inflammatory 
effect than dose indomethacin in these doses. In 
experimental animals Winter (196/*) showed that 
indomethacin exerted a more powerful inhibitory effect 
on carrageenin oedema than sodium salicylate. However, 
clinical experience (Sunshine, 196*f 5 Pinals and 
Frank, 196?) suggests that these drugs in adequate 
anti-inflammatory doses are approximately equipotent, 
although Pitkeathly et al.,(1966) demonstrated a 
greater improvement in grip strength with indomethacin 
than with sodium salicylate. It is interesting to 
note that, in this study, indomethacin but not 
sodium salicylate reduced swelling significantly.
3 . ^
However, all other clinical indices showed significant 
change with both drugs.
A further possibility is that indomethacin exerts 
a more selective effect on the vascular component of 
inflammation than does sodium salicylate. This would 
explain the alteration in a parameter which measures 
blood flow. There is evidence that indomethacin 
exerts an effect on cerebral blood vessels (Vecchio 
and Fontana, 1965)* Sicuteri et al. (1965) noted that 
indomethacin decreased cerebro-spinal fluid pressure 
and elevated the retinal artery pressure and concluded 
that indomethacin has a vaso-reactive effect on 
cerebral blood vessels. It may be that the 135 Xe 
technique is recording similar changes on the peripheral 
vascular system in the knee.
These results demonstrate that the rate of 
clearance of 133 Xe from the knee joint and the clinical 
indices of inflammation may be altered by Indomethacin 
therapy. However, the beneficial effect of salicylates 
as measured by the clinical indices, is not attended by 
an alteration in the 133 Xe clearance rate. .
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EFFECT OF SYNOVECTOMY ON THE SYNOVIAL PERFUSION 
3A:Vl IT ASUP " BY THE 153 Xe CLEARANCE RATE
The operation of synovectomy, introduced into the 
therapeutic armamentarium early this century, is 
employed as empirically today as it was then. "As 
long as this proof is lacking we shall, in my opinion, 
have to regard this treatment (Synovectomy) like all 
the others in rheumatoid arthritis, as an empirical one 
and we shall have to discuss the best way to obtain 
evidence of the influence of this procedure on the 
natural history of the disease” (Qosling 1 9 6 9 )*
One major obstacle to the investigation of this 
problem has been the lack of suitable quantitative 
methods which are biologically meaningful. Since the 
1 3 3  Xe clearance rate provides a measure of synovial 
perfusion, it seemed reasonable to study the effect of 
synovectomy on this parameter, in an attempt to 
provide such a method.
The present study was designed to investigate the 
effect of synovectomy on synovial perfusion measured 
by the 133 Xe clearance technique in patients v/ith 
rheumatoid arthritis.
PATIENTS AND METHODS
Two groups of patients were studied. The first 
group, comprising eight patients with "classical" 
rheumatoid arthritis (Ropes et al., 1959) had 133 Xe 
studies performed before synovectomy at one to three 
months afterwards and at one year following operation.
The mean age of these patients was 52«4 years (range 
35 to 61)and five were male. The second group, 
comprising 21 patients with "definite" or "classical" 
rheumatoid arthritis had 133 Xe studies performed 
between two and three years (mean 2.9 years) following 
the operation of anterior synovectomy of the knee.
In all of these patients the sheep*s cell agglutination 
test was positive and X-rays of the knee joints showed 
articular erosions. Sixteen were female and the mean 
age was 54*6 years (range 26 to 71 years). Clinical 
assessment of the joint was performed by the same 
observer prior to each study and the patient was asked 
whether the result of the operation was "excellent", 
"satisfactory", "poor" or "bad". 133 Xe studies were 
performed in the usual manner and the synovial perfusion 
rate v/as calculated from the T-J- value (Equ.*7 s page S'S") 
Tcchnioue of Operation
The operation of synovectomy of the knee was
I
performed by the same surgeon under pneumatic 
tourniquet control through an elongated medical para­
patellar incision. The synovium and menisci were 
removed and the cruciate and collateral ligaments and 
popliteus tendon were cleared of granulation tissue. 
Synovium from the posterior aspect of the joint was 
removed with the knee in full flexion using small bone 
nibblers. The patella was left intact in all cases.
The joint was closed in two layers with a suction drain. 
Guarding plaster was applied and the knee was 
manipulated at two weeks under general anaesthesia.
SYNOVIAL BLOOD FLOW VALUES
S. B. F. 
ml./lOOml.^nin.
before & after synovectomy 
(8 patients)
4 r
PRE-OP. ^ 2  POST-OP. 1 YR. POST-OP.
Mean 1 S.E.M. 1*41 ±0*25 0 -8 7 1 0  09 1 -2 71 0 -3 4
Legend* Synovial blood flow values in 8 rheumatoid 
patients before, 3 months following and one year 
following the operation of synovectomy*
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Group I
Figure shows the synovial perfusion values 
obtained before one to three months after and one year't ’ ■* ' \v;i£9* i — *’ •*'>•'* . * ’.<» • <->' S ■.* l* ‘ * ’ . * ’*• 1 A.;*■ . * "V - . T-J/ ’ y • V^y ■ . # '*% A* t>.-. •*! ;/*• *after operation. The values one to three months 
following operation (mean 0.87 - S.E.M. 0.09 ralAoo ml/ 
nin.) are significantly lower (p< C.05) than the values
. . . .  • 4.obtained before operation (mean 1.A1 - S.E.M. 0.25 
ml/100 ml./min.). However, the values obtained one 
year after operation (mean 1.27 - S.E.M. 0.3i* mlAOO ml/ 
nin.) did not differ significantly from the pre-operative
• ' ; ’ A ’■- ■ r. + - ' '/ jtry-. r\ * ' *•'*■. • * - • ■ ’ ' . . \ "V*  ^>. , ’ v * •
values (p> O.A) nor from the one to thre e months 
post-operative values (p>0.2) by a paired student 
t-test. All eight patients recorded the results of 
their operation as "satisfactory". The values for 
knee score both one to three months (mean 3.2 - S.E.M#
0.2 units) and one year post-op<.rativcly (mean 3*6 - 
S.E.M. 0.3 units) were significantly lower (0.05>P>0.01 
and (0.05> P 7 0.01) respectively, than the pre­
operative values (mean 6.7 - S.E.M. 0.6 units).
Group II
Figure 5 shows the synovial perfusion values obtaine 
two to three years post-operatlvely. Included for
MEASUREMENT OF SYNOVIAL BLOOD FLOW
S.B.F. NORMAL (12)
m I./100 ml.^nin.
4 r
s » -
RHEUMATOID (43) POST-SYNOVECTOMY (21)
4
•4
>
Mean ± S.E.M. 0 -4 6 ± 0 - 0 8 1-56+ 0 1 2 1-97+0-23
5 ,
Legend: Synovial blood flow values 2 to 3 yoars followin
synovectomy compared with those obtained in normal subjec 
and in unoperated patients with rheumatoid arthritis.
comparison are synovial perfusion values, derivedi ■ ' ,
from normal subjects and £*3 patients with rheumatoid 
arthritis who were not subjected to operation, 
reported previously (page 2.^5). The p< rfusion 
values obtained post-opcratively (mean 1.97 - 
S.E.M. 0.23 ml/100 ml/min.) are of the same order 
of magnitude as the values in non-operated rheumatoi< 
arthritis. More refined statistical analysis is 
not justified since the groups of patients are not 
matched for clinical involvement.
The relationship between the clinical indox of 
inflammatory involvement and the relevant T£ values 
were analyeod, The #r1 value obtained was 0.32 
which is not significant.
Four of these patients considered that the 
result of their operation was "bad", the remaining 
17 recording the result as "satisfactory".
The clinical results of synovectomy of the knee 
are well documented (Speed, 1925 J Wolcott, 1927 5
V
Heyman, 1928 : Inge, 1938 : Ohormley et al.!9/fl: London, 
1955 $ Carruthers, I960 I Aidem and Baker, 196^ J 
Qariepy et al., 1966 : Marmor, 1966 : Stevens and 
Whitefield, 1966 s Vainio, 1966 : Barnes and Mason,
f » •
1967 s Branemark et al., 1967 5 Lembo, 1967 : Mikkleeen, 
1967 2 Ramadier et al., 1967 and Paradies, 1969) and 
have boen recently reviewed by Paradies, 1969. Most 
series record a "satisfactory" figure of over 80% in 
terms of pain relief, although a variable degree of 
reduction in range of motion is recorded in a 
significant percentage of cases. ParadLes (1969) 
records a progressive diminution in the percentage of 
"satisfactory" results as the length of follow-up 
increases. Thus, at 2 years, 65% in his series were 
"satisfactory" however at 3 years, only ^0% remained 
"satisfactory". The results of a series which included 
long-term follow-ups (London, 1955) also seems to 
demonstrate a similar tendency to recurrence of 
disease activity with increasing time after operation. 
Thus, at the clinical level, there is some evidence to 
suggest recurrence of disease activity following
DISCUSSION
synovectomy of the knee*
Experimental synovectomy (Key, 1925) has been 
less intensively studied* Suleimam<196lf) demonstrated 
that granulation tissue, with disturbed vascularity, 
grows in following experimental animal synovectomy 
and Lindstrora (1966) showed that, following "atraumatic" 
synovectomy in rabbits complete regeneration of normal 
tissue could occur but in "traumatic" cases granulation 
tissue, with wide tortuous blood vessels, grew in*
The caloric response in traumatic cases was abnormal* 
Branemark et al* (1967) demonstrated abnormal tissue 
following synovectomy and Mitchell and Cruess (1967), 
employing tritiated thymidine, showed that metaplasia 
of existing mesenchyme, rather than hyperplasia of 
remaining synovial tissue, contributed to the re-growth 
of villi, in the space of 30 days following 
synovectomy in rabbits.
However, some workers (e.g. Marmor, 1966) have 
presented evidence that regenerated synovium and its 
vasculature may be normal in human subjects. Thus it 
seemed reasonable to study the effect of synovectomy 
on the clearance of 133 Xe which provides a measure of 
blood flow.
The results of this study are of some interest.
The values obtained one to three months following
• y y f* %r * . * 1 \ *■ ■, * - <*• v . ■ '.v v- ’ > ■* v  * - ■«
operation were significantly lower than were the pre­
operative values presumably reflecting reduction in 
vascularity of the regenerating tissue. At first 
eight it may seem surprising that the values were not 
lower post-operatively considering that the great mass 
of synovium is removed at operation. However, this 
method does not measure total volume of vascular 
tissue. It is an index of the degree of vascularity 
of the tissue close to the site of deposition of the 
isotope. Furthermore, there is evidence that tissue 
re-growth following synovectomy occurs within a few 
weeks (Mitchell and Crucsc, 1967)» and it seems 
probable that these results include some degree of 
regeneration. The results one year following operation 
however were similar to those obtained pre-operatively. 
This suggests that the tissue through which the isotope 
is clearing is vascularly abnormal. Experiments 
previously reported (page~75~) suggest that the route 
of clearance of 133 Xe from the synovectomised joint is 
similar to that which obtains in unoperated rheumatoid 
arthritis. Thus it would appear that the re-growfc
’•synovial tissue” is vascularly abnormal* It is 
interesting to note that all patients considered tl 
results of their operation to be ♦*satisfactory” an<
r
this impression is borne out by the results of the 
clinical knee scores. It is possible therefore tl 
the results of the 133 Xe studies are anticipating 
clinical change* The number studied is small, 
however, and firm conclusions are not yet justifies 
The values obtained in the second group of 
patients are clearly different from those obtained 
normal joints. It is interesting to note how wel! 
they accord with values obtained for patients with 
rheumatoid arthritis who had not been subjected to 
synovectomy. The 43 values for rheumatoid patien* 
were obtained simply by studying every patient 
suffering from ’’classical” or ’’definite” rheumatoid 
arthritis with clinical involvement of the knee jo:
who presented as an outpatient at this hospital be* ' 0
September, 1967 and February, 1968. The clinical 
score was performed in all these cases in the same 
manner and by the same physician who examined clin: 
the knee joints of the 21 patients who had a knee 
synovectomy. In the case of the 43 patients the
correlation coefficient between the clinical knee 
scoro and the relevant T*J value was 0,76 (Chapter 6, 
page However, in the case of tho 21
synovectoraieed knees reported in this study (Fig. 5) 
the correlation coefficient was 0.32. Although once 
again refined statistical analysis of these two figures 
is not valid for the reasons mentioned above, the 
difference between a good correlation in the one case 
and none at all in the other is sufficient to suggest 
that a meaningful difference does exist. However, 
the reason for this discrepancy is obscure. It may 
be that abnormalities or delay in the re-growth of the 
nerve supply following synovectomy (Goldie et al., 1969! 
may have an effect on the post-operative clinical score, 
However, there is insufficient evidence on this point 
at present.
These isotope studies suggest that the operation 
of synovectomy has a limited "life span” and this is in 
accord with clinical findings in long term follow up 
studies (London, 1955 s Paradies, 1969). It would 
seem reasonable to suggest that the re-growth of 
vascularly abnormal, synovium occurs in the early months 
poet-operatlvely. This vascular abnormality may be 
the precursor of florid inflammatory change to follow
-2^3
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or alternatively it may well have no clinical 
relevance in terms of patient disability and relapse. 
It will be interesting to see on long terra follow up 
studies whether the 133 clearance technique will 
prove to possess predictive power.
SUMMARY
1. Synovial perfusion is elevated in the inflammatory 
arthritides and in some patients with osteo­
arthritis. The elevation is therefore non-specific
2. The increase in 133 Xe clearance rate from the 
joint is related to the severity of involvement 
at the time of study in the inflammatory 
arthritides.
3. The synovial perfusion rate may be elevated in 
joints of patients with rheumatoid arthritis 
despite absence of clinical signs of involvement 
in the disease process. The method may therefore 
prove to be of value in the early diagnosis of 
arthritis.
4. The clearance rate may be reduced by hydrocortisone 
administered intra-articularly and by oral 
indomethacin but not by oral malicylate therapy.
■ . i - wThe sensitivity of the 133 Xe clearance method is 
probably less than that of the standard clinical 
methods of assessment.
5* Synovial perfusion, although reduced in the early 
months following synovectomy, returns to its 
pre-operatively elevated level within one year. ’ 
Synovial perfusion rates are elevated between 2 and 
3 years following operation. It is possible that 
the 133 Xe clearance method may be of value in 
the assessment of the results of this operation.
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CHAPTER 7
In an attempt to discover a more sensitive 
objective method of assessment of change in the 
severity of the inflammatory process than was 
afforded by the 133 Xe clearance method, I studied 
the localisation of radioactive technetium (99 mTc) 
in the joint following intravenous injection.
A method of quantitation of articular scans 
is described which discriminated between severely 
involved, moderately involved and normal joints.
The method, however, was time consuming, required 
high tracer doses and did not possess an entirely 
satisfactory degree of reproducibility.
A second simpler method for quantitating *
isotope uptake was studied, which required lower 
tracer doses and possessed a higher degree of 
reproducibility. Studies are reported which 
demonstrate that differences between normal and 
inflamed, large and small joints may be detected 
by this method. Change in disease activity 
consequent upon the exhibition of corticosteroid 
therapy could also be detected.
Thereafter two studies designed to assess 
the sensitivity of 99 mTc uptake when compared 
with clinical methods of assessment are reported, 
the results of which suggest that this radio­
isotopic method compares favourably with the 
better established techniques*
9 9 mTc uptakes in synovectomised and 
unoperated patients with rheumatoid arthritis and 
in patients with osteoarthritis are compared with 
those obtained in normal subjects and the 
relationship between 99 mTc uptake, 133 Xe 
clearance rate and clinical evaluation is 
examined. .
Finally, the fortuitous observation that the 
rate of clearance of ionised radioisotopes 
differed from the rate of clearance of 133 Xe 
prompted the final study reported in this thesis. 
Currently synovial fluid is considered to be 
composed of an ultrafiltrate of plasma to which 
is added hyaluronic acid and protein by the 
synoviocytes. The results of this study suggest 
that the position may be more complex and that 
active transport mechanisms exist across the 
synovial membrane.
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THE ARTICULAR SCAN Iff PATISNTS WITH RHEUMATOID
' . " . ARTHRITIS ' " ■
Introduction
"Measure what is measurable and what is not measurable 
make measureable". Oalileo*
This adage is particularly relevant to the 
study of the connective tissue diseases* Lack of 
reliable quantitative indices finds expression in 
conflicting results of drug trials (O'Brien, 1967) 
and in ignorance of the effect of widely applied 
surgical procedures (page W°).
Rheumatoid arthritis remains an incurable 
disease and its management must include the use of 
non-specific suppressive agents* The great majority 
of pharmacological agents in this class are drugs of 
relatively small effect* The difficulty of assessing 
any such drug is compounded by the spontaneous 
alterations in activity which are a feature of this 
disease and whereas there is no difficulty in detecting 
major changes in disease activity clinically, the small 
changes produced by these drugs present a major problem 
to the assessor* a
Anti-inflammatory effect or spontaneous change 
in disease activity may be detected either in terms 
of subjective or objective methods of assessment*
In an exhaustive series of meticulously controlled 
studies Beecher (1959) has validated the use of 
subjective methods of assessment provided only that
*' *  ^ \ i : , 1 vjpj ■' .• ■ ’ ■ : i - ft
they be susceptible of quantitation* Indeed, it is
clearly better to employ a relevant subjective than 
an irrelevant objective method. The methods which 
are currently employed in this field include clinical 
indices based on pain and tenderness (Co-operating 
Clinics of the American Rheumatism Association, 1965 
McCarty et al*, 1965 t Lansbury, 1966 : Mainland,
1967 1 Ritchie et al*, 1968), alteration in grip 
strength (Wright, 1959 * Ingpen, 1968) or in joint 
circumference (Boardman and Hart, 1967), duration of 
morning stiffness and aspirin count, articular and 
skin temperature changes (Hollander et al., 1951 1 
Hollander and Moore, 1956 I Branemark et al., 1966 t 
Haberman et al., 1968 t Goldie, 1969)# synovial fluid 
white cell count and enzyme levels, rate of absorptioz 
of phenylsulphonylphthalein from the joint cavity 
(Nakamura et al., 1967) and alteration in haemoglobin, 
erythrocyte sedimentation rate and other blood
constituents* No single method has proved to be 
entirely satisfactory and it is still common practice 
to employ several methods concurrently (Steinbrocker 
et al*9 1949).
The availability of radioisotopes has widened the 
scope of applicable techniques* The various 
radioisotopes which have been injected intra-articularly 
and the clearance rates of which have been related to 
the severity of local disease are reviewed in Chapter 1* 
Apart from the disadvantage of local injection and the 
restricted applicability to only the particular joint 
injected, the clearance rate of 133 Xe dLd not change 
following the exhibition of large doses of oral 
salicylates for one week, suggesting that the 133 Xe 
clearance rate would be of only limited value in the 
assessment of non-steroidal anti-inflammatory agents* 
Radioisotopes, however, may be utilised in a different 
manner* The local accumulation of radioactivity 
following Intravenous injection of the Isotope may be 
monitored* The Isotope which has been employed most 
frequently in this way is radioactive technetium (99 nTc
The value of radioactive technetium (99 mTc) as a 
scanning agent has been studied in many situations
(McCready, 1967 i Anon., 1968). Amongst the many 
organs qualitatively displayed by the isotope are the 
stomach and salivary glands (Harden et al., 1967a and 
the heart cavity (Witcofski and Bolllger, 1965)» the 
brain (Pavia et al., 1966), extra~cranial tumours 
(Whitley et al., 1966), the placenta (Larson and Help, 
1965) the Inflamed joint (Weiss et al., 1966 t 
Alarco«-Segovia et al., 196/b,b:^crarty et al., 1970a 
and b , Sholkoff and Glickman, 1969*)•
Clearly purely qualitative display will present 
difficulties in the detection of small changes and 
accordingly in the present study an attempt was mads 
to derive a means of quantitating radioactive 
technetium articular scans.
2J
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Radioactive Technetium
99 fflTc was obtained as the pertechnetate by 
elution with 10 al* of sterile physiological saline 
solution from a column generator loaded with 
molybdenum-99* The eluate was sterilised by auto- 
claving and delivered to the Centre for Rheumatic 
Diseases at noon* All studies were performed between 
the hours of noon and 4 p*m* owing to the short 
physical half life (6 hours) of the isotope* This 
short half life, in addition to the lack of beta 
emission (99 mTc decays by emitting a gamma ray of 
emission energy lhO keV) renders this an ideal scannlnj 
agent with a wide margin of safety (Smithf 1965)* A 
1 millicurle dose administered Intravenously results 
in a total body exposure of 17 rallllrads*
Patients Studied
Twenty-four patients with "classical" or "definite 
rheumatoid arthritis were studied, all of whom had 
marked involvement of the joint studied* Four of 
these patients were submitted to repeat examination 
one week after the initial scan was performed to
determine the variability of the method. All 
female patients were post-menopausal. The mean age 
of these patients was 50.1 years (range 39 to 66 
years) and eight were male.
Two members of the medical staff served as 
controls and scanning studies were performed on 
their elbows, writs, hands and knees. Four hours 
before scanning, each subject received 600 mg. of 
potassium perchlorate, orally, to block the uptake 
of 99 mTc by the stomach and thyroid gland.
A dose of approximately 1 mCi of 99 mTc- 
pertechnetate was given to each patient and control
subject and the relevant joint was scanned 25 minutes
' • ■ ' • • -
after the administration of the dose. In the first 
six patients serial scans ware conducted over a 
period of 3 hours to determine the optimum scanning 
time and counting conditions.
Visualisation
The pattern of radioactivity in the joint was 
visualised with a Picker-Magnascanner V, scanning In 
the antero-posterior position. The line spacing and 
scan speed varied with each joint; in the knee* a 
line spacing of 1 cm. and scan speed of 100 cm./mln.
were found convenient, whereas for the wrist joint
a line spacing of 0.5 cm. was required. The time
taken for each scan was approximately 10 to 15 minute*
depending upon the joint being scanned.
Quantitation
Quantitation of the uptake of the isotope, as
opposed to photographic display of the distribution ol
radioactivity, was achieved in the following way
(Hlldltch et al., 1967)* the area corresponding to
the joint being scanned was drawn on the scanning
paper. The uptake by the joint, together with
background radioactivity in the tissues and in the
atmosphere, was calculated by counting the number of
dots enclosed in the scanning area. An estimate of
the background count, obtained by counting an area
adjacent to the joint area was subtracted from the
original count. The final count was then corrected
for decay U6lng the midpoint of the scanning time as
the theoretical time of scanning. A phantom of the
joint, which contained a known percentage of the dose
given to the patient, was scanned under conditions
Identical to those employed when scanning the joint
except that the dot factor, which varies the number of
dots recorded in proportion to the intensity of 
radiation received, was increased.
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Legendt The display of 99 mTc in the wrist joint and 
netacarpophalangeal joints in a patient with rheumato! 
arthritis.
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Legend* The display of 99 mTc over a knee joint 
a patient with rheunatoid arthritis.
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PERCENTAGE UPTAKE OF 99Tc IN MODERATELY AND SEVERELY
INFLAMED KNEE JO INTS
moderately inflamed ........  severely inflamed
T IM E  IN M IN U T E S
Legend: Serial scans of knee joints affected by
rhouaatoid arthritic: ......... , moderately infl
, severely inflamed. Percentage uptake o 
99 mTe is plotted against time.
RESULTS
The results are shown in Figs, I-V and in Table 
1, In normal subjects there was virtually no uptake 
of Isotope by any of the joints examined and it was 
impossible to visualise the joint by scanning.
In contrast to these results, patients with 
rheumatoid arthritis exhibited a satisfactory uptake 
of the Isotope in all the joints# allowing the joint 
to be visualised by the scanner, Representative 
examples of the pattern of display of the Isotope in 
the wrist and hand and in the knee joint are shown in 
Figs, 1 and 2,
Figure 3 shows the results obtained when serial 
scans were performed in six patients. Broadly 
speakingf two patterns emerge. In some patientsf an 
initially rapid uptake is followed by decay of 99 »TC| 
while in others the uptake appears to be initially lei 
rapid and to Increase more slowly. Because of this 
temporal variation it was necessary to scan all 
subjects at a standard time and it was decided to scar 
all Joints 25 minutes following injection.
The results of repeated estimations of Isotope
TABLE I
Reproducibility of uptake of 99 mTc in 
wrist Jointst at an interval of 1 week
m.:Patient Scan 1 Scan 2
1 0.12% 0.13%
2 0.087% 0.11%
3 0.089% 0.095%
t♦ 0.078% 0.06%
5 0.085% 0.11%
6 0.12% 0.18%
7 0.081% 0.11%
■ . * -• “ v -
8 0.10% 0.10%
Coefficient of variation ■ 25%
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Legends Uptake of 99 »Tc at 25 fflin. in wrist joints 
correlated with degree of inflammations mild, moderate and severe*
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Fig. 5
Legend? Uptake of 99 nTc at 23 nin. in knee joint 
correlated with degree of inflammation: mild,
moderate and severe.
uptake by an individual joint in four patients 
(each wrist joint being scanned on both occasions) 
are shown in Table 1.. The coefficient of variation 
was 25%.
The percentage of the initial dose taken up by 
the wrists (Fig. 4) and by the knees (Fig* 5)
correlated with the degree of inflammatory involvement
of the joint as judged by tenderness of the joint to 
direct pressure. Clinically three degrees of 
tenderness were recognised: "mild", "moderate" and
"severe". In the wrists tho uptake varied from
0.06% when mildly inflamed to 0.18% when the joint was 
very tender. The knee however showed much higher 
uptake of 99 mTc and the separation between the three 
degrees of tenderness was even more marked. The range 
of uptake for a mildly Involved knee was 0.1% to 0.45% 
of the dose of 99 mTc, for moderately Inflamed knees 
from 0.45% to 0.75% and for severely Inflamed knees
from 0.85% to 1.45%. The pattern of uptakes shown in
Fig. 3 also corresponded to the degree of Inflammatory 
Involvement, rapid uptakes being observed in the 
presence of "severe" inflammation and slow uptakes in 
the case of the "moderately" Inflamed joints.
' « - ' * ^  ■. -V ' M :• / . ■ v - • S >
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In order to Investigate if the 99 mTc uptake 
by the joint was purely a reflection of the increases
- r »V ■ . *3 v s ^ v r,\*' v ‘ *•' > H.v - X *•«
blood flov; through the inflamed joint, or whether 
99 raTc is actively taken up by the synovial membrane, 
the following experiment was performed. A patient
• : , k'Av_ p >. :v^ - # * *
going for synovectomy of the knee was given 1 mCi of 
99 mTc intravenously 25 min. before the tourniquet
** * f  ** ** ' •" -V ■ ■■ * ’ ' ' ' V- '• • ‘ ** ,, • ,
was put over the patient’s leg. At the time when
the tourniquet was put on, 20 ml. of heparinized
blood were collected from the opposite arm to that
in which the 99 mTc had been Injected. All the
* • ■ . ♦ • . / ‘ ' synovium was collected after removal, and the
radioactivity of equal quantities of blood and
* P - * • * • - ** • i t kEynovial membrane was counted. The ratio of the 
radioactivity of blood to that of synovial 
membrane was 1.68. This indicates that 99 mTc is 
probably not actively trapped by the synovial
membrane and that rather, the 99 mTc circulates in
the blood through the joint tissues.
2 ^ 3
The present study has shown that radioactivity 
may be displayed in joints Involved In rheumatoid 
arthritis, after the administration of 99 mTc# The 
results of the studies designed to compare the 
activities of the Isotope in blood and in synovial 
membrane suggest that the presence of the Isotope 
in the joint is accounted for not by active synovial 
concentration of 99 «Tcf but rather by the passage 
of the isotope through the vascular channels in the 
synovium# If active concentration of Isotope by the 
synovial cells were taking place one would expect 
. that the ratio of isotope activities in equal 
volumes of synovial membrane and blood at a given 
time would be greater than unity. That this is not 
the case favours the alternative explanation of 
passage of isotope through the vascular channels in 
the joint. If one accepts this explanation, it is 
not surprising to find increased values for Isotope 
concentration over joints which are involved in the 
rheumatoid inflammatory process, for in this disease 
an enormous increase in the vascular supply of the 
inflamed synovium occurs.
DISCUSSION
2 2 2
Tentative support for this hypothesis comes 
from the observation that the concentration of 
isotope in the joint at any one time shows a 
correlation with a rough clinical assessment of the 
degree of inflammation which is present. It may be 
that the isotope readings give a truer Indication of 
the extent and the amount of inflammation in the 
synovium than does the clinical assessment for it is 
notoriously difficult to make an accurate clinical 
assessment of the degree of Inflammation. This 
speculation must be tempered with the knowledge that 
with present techniques the coefficient of variation 
of the Isotope methods is high.
The procedure which this study describes may 
have value in the assessment of the anti-inflammatory 
activity of drugs in rheumatoid arthritis for if 
diminution in inflammation is usually accompanied by 
diminution in the blood flow to the synovium, then a 
reduction in the display of 99 ®Tc in the joint, 
proportionate to the diminution in inflammation, 
might be expected. u
The technique may also be of value to assess 
the completeness, or otherwise, of synovectomy,
v  _ -r (# ‘ ■ -\ ’ . * * *
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for presumably if it proved possible to remove 
entirely the vascular synovium, a dramatic 
reduction of the concentration of isotope in the 
joint should be achieved*
2 J U 3
SUMMARY
1. In an effort to obtain an objective index of 
articular inflammation, radioscans have been 
performed on a variety of joints in twenty-four 
patients with rheumatoid arthritis of varying 
severity, 25 minutes after the intravenous . 
administration of 1 raCi of radio-technetium (99 mTc). 
Localisation of the isotope in the joint was easily 
demonstrated using a Picker-Magnascanner V.
2. It has proved possible to quantitate the display 
cf the isotope in a joint. The method is 
sufficiently reproducible for clinical use and the 
uptake has been found to be a function of the 
clinical severity of joint inflammation.
3 . Further studies have shown that the isotope is 
not actively concentrated by the diseased synovial 
membrane and this finding suggests that the display 
of isotope in an inflamed joint may reflect enhanced 
vascularity of the synovial membrane and other 
joint tissues.
QUANTITATION OF RADIOACTIVE TECHNETIUM LOCALISATION 
IN THE KNEE AND PROXIMAi, INTERFHALANGEAL JOINTS BY 
‘ EXTERNAL DIRECTIONAL COUNTING
In the succeeding two sections of this 
chapter a simpler method of quantitating 99 mTc 
uptake by the joints requiring a lower tracer dose 
is proposed and the reproducibility of this method 
is quantitated.
QUAKTITATION OF RADIOACTIVE TECHNKTIUM LOCALISATIOH 
IN THE K?r JOIT’T FT' UTTER?'At DIRECTIOHAL COUWTIWa
Introduction
The photoecan display system, employed in the 
previous study, yielded a picture of the isotope 
content of the area over a relatively short period of 
time and the method of quantitation was tedious. 
Furthermore, a dose of the order of one millicurie of 
the isotope was required to achieve optimum scans.
This dose precluded frequent repitition of the studies 
which would be necessary in a clinical trial of a
therapeutic agent.
‘ . - • ' - ..., ' .
It seemed possible that continuous external 
directional counting over the knee joint following 
the intravenous administration of the isotope might 
overcome these problems. Thus, more information 
might be derived from the pattern of uptake than was 
afforded by a single photoscan and with a more sensitiv 
detecting system a much lower dose of the isotope 
would be required. Finally, this might be expected 
to provide a method which would be simpler to 
quantitate.
3-*2%
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Patients Studied
Studies were performed on 20 clinically active 
knee joints of patients with classical rheumatoid 
arthritis (Hopes et al., 1959)* Their mean age was 
52.8 years (range Jf2 to 65 years)* Five were male. 
In five patients repeat studies were performed at 
2lf hours to determine the day to day variability of 
the method and a further si* patients received hydro­
cortisone (Ultracortenol 10 mg.) intra-articularly, 
the studies being repeated one week later.
Isotope studies were performed on eight healthy 
male volunteers aged between 20 and 28 years (mean 
24*5 years). Hone gave a history of disease or 
trauma to the knee joint. The isotope studies were 
repeated at Zk hours in two of these subjects to 
determine the day to day variation in the method.
Clinical knee assessments (page \*7-) were 
performed by the same observer prior to each isotope 
study.
Isotope Studies
The patient reclined comfortably in bed and the
knee was Immobilised during the study.
One millicurie in 5 al. sterile NaCl of 9 9 mTc 
obtained daily at noon and studies were performed 
between then and 4 p.m. because of the short half 
life of the isotope (6 hours).
Approximately 200 ^ Ci of 99 mTc in 1 ml. of 
KaCl were administered intravenously into a vein in 
the antecubltal fossa. In early feasabllity studies 
it had been noted that excess counts were frequently 
present over the injection site when compared with 
the identical area on the opposite arm at the 
conclusion of the study. Accordingly, great care 
was taken to ensure that the injection was truly 
intravenous.
A collimated 1" x 1.5” thallium activated sodlun 
iodide crystal connected through an Ecko ratemeter 
(M.5180) and pulse height analyser (M.5010) to a 
Kienale automatic print-out was positioned directly 
over the patella touching the skin*
Counts per 40 seconds were taken with the 
counting conditions adjusted for 99 mTc and counting 
commenced 120 seconds prior to the injection and
continued until the count rate was declining. The 
results obtained were plotted onto graph paper and 
the peak count rate and time to reach tho peak were 
read from the graph.
At the conclusion of the study the count rate
- ■ ■ ' * i . ■
over the injection site and over the corresponding 
area on the opposite arm was measured. If the 
injection site displayed excess counts the etudy was 
disregarded.
TABLE II
NORMAL
Peak Counts
8,900
13#100
5,700
11,800
7,500
9,300
6,100
12,000
Mean
S.E.M.
9,300
987
Time to 
peak (mine.)
18
16
23
47
22
30
18
12
23.3
3.89
RHEUMATOID ARTHRITIS
Time toPeak Counts
28,000 
23,000 
18,000 
16,800 
10,100 
6,400 
14,000 
13,400
19.900 
7,900 
9,300
10,300
3,000
26,400
30.000
12.000
34.900 
19,500 
24,000 
14,000
17,145
1,882
Time to peak rheumatoid v. normal subjects 
Peak counts rheumatoid v. normal subjects
peak (mi 
16
13
5 
20 
10 
33 
18 
22
9
9
31
15
23
6
13
15
18
20
13
8
15.!
1.6!
0.1> p ^ 0.05 
0.05 > P7 0.01
Legend: Time to peak and peak count rates over the knee 
in normal subjects and in rheumatoid arthritis.
TABLE III
The results obtained when the peak counts were 
measured in 7 subjects on two occasions with a 
time interval of 24 hours.
Subjects 1st Occasion 2nd Occasic
• ■ • ■ ' ' . . •• . ' i : ■ ’ ,Normal 6,300 6,400
Normal 6,400 5,800
Rheumatoid arthritis 13,000 12,700
Rheumatoid arthritis 12,700 13,100
Rheumatoid arthritis 25,000 23,900
Rheumatoid arthritis . 18,000 17,700
Rheumatoid arthritis 32,000 , 32,600
• ■ ” zi,y'i-f . • 'v-v,
Standard Error of the difference 222 minutes,
Legend* 
The 
values 
obtained 
for 
knee 
soore, 
peak 
oomits 
and 
time 
to 
reach 
peak 
oounts 
in 
the 
six 
patients 
prior 
to 
seek 
following 
intra-artioular 
injection 
of 
hydrocortisone.
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The results are shown in Tables 2, 3 and 4.
The peak values obtained in the normal subjects* * ' * , - * . r , • xi t* v - ‘ .*>0' 4 ' *•* ' * * j  % -
(mean 9,300 i S.E.M, 987 counts per min.) were
* ' 5 \  e ' * ' * - * J *significantly lower (0.05 > P 7 0.01) th^n the peak 
values obtained in the rheumatoid patients (mean 
17,145 - S.E.M. 1,882 counts per min.). The time 
to reach the peak in the normal subjects (mean 23^3 -
S.E.M. 3.89 mins.) did not differ significantly 
(0.1 > p> 0.05) than the time to reach a peak in the 
rheumatoid subjects (15*9 - S.E.M. 1.69 mins.)
(Table 2).
Table 3 shows the results obtained in the two 
normal subjects and the five rheumatoid subjects in 
whom isotope studies were repeated 24 hours later.
The standard error of the difference was 222 counts 
per minute for the peak count rate.
' The results of the isotope studies and clinical 
knee assessments befbre and after the intra-articular 
injection of hydrocortisone are shown in Table 4*
The means of the peak values and clinical assessments 
prior to the injection (mean 18,466 - S.E.M. 3»014 
counts per min. and mean 7 - S.E.M. 1.13 respectively)
RESULTS
differ significantly (0*05 > p >  0.01 and 0*05 0*01
respectively) from the means of the same parameters 
one week after the injection (mean 9|283 - S.E.M. 
lf^99 counts per min- and mean 3^3 - S.E.M* 2.07* - ' I
reelectively).
The mean values of the time to reach the 
peak prior to the injection of hydrocortisone 
(16 - S.E.M. 3**fl mine*) did not differ 
significantly (0.8>P“>0.7) from the values obtained
ir '■ - •  ^ k' , . • '
one week after the injection (l/f.6 ^ S.E.M. 1.09).
' Discussion
5 - r** ' ■*s **’" '>-»k*i.-*'. * - \' • ^rm •*j .tL: ;%‘ 'if **1* H 9« , — W— _ .In this study a simpler method of measuring
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the same phenomenon as is reflected by the photo­
scan display system is introduced. A major 
advantage of the revised technique is the reduction 
in the dose of isotope required.
In early feasibility studies it was noted that
r * t  *1* ^  \ • .%„/ ' i ,  • '»  *kM " | v  , it X- ■in many cases, despite no obvious fault in the 
injection technique, a significant proportion of
• 1 1 vr—• " ' • ■ ’ *
the administered dose remained at the injection
.* ,-Y-. \sx t ^ > r Ct- *‘"\r. .*V5^  ^^  T*4^site. In the most obvious cases this was manifest
in the results by a very slow rise to peak count 
rate. To obviate this problem great care is
required when administering the isotope and the
injection site should be monitored following each
* v* '• f‘ '■*' r*- ?;.> *■/* *, Jv • 'f«,V ,^  v ^ r * * V  :*i* **■’
study. - '• . •
Provided care is taken these isotope studies 
would seem to possess an acceptable degree of 
reproducibility. The standard error of the differ©] 
in the repeat isotope studies was 222 counts per 
minute for peak uptake of the isotope.
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Legend to Fig.6*
Linear plots of 99«nTc.count rate over the knee 
Joint in the same patient on three occassions at weekly 
intervals.The top graph was recorded while the patient 
was receiving placebo9the middle one during aspirin 
therapy and the lower one during corticosteroid therapy*
i  t  ’ •. .* *  ■ # <, -v ' f*  * * * ; < ♦ ’’ -r *■ ’ . - f ‘ * • '  '*•,
These results also suggest the possibility 
that 99 mTc uptake might be a useful adjunct 
to the objective assessment of the effect of 
anti-inflammatory drugs* Thus, in this study,
99 mTc peak uptake parallelled the clinical knee 
assessment when the knee joint was treated with 
local anti-inflammatory therapy* The dose of 
the Isotope employed in this study (200 ^ Ci) was 
sufficiently low to allow repeat studies and,
. • • ■ * v- ~w;- •• % v .  -• v ’ v ’-t ’
indeed, considering the magnitude of the count 
rate obtained with this dose, it appeared feasible
to reduce the doee even further in future studies.
In Fig. 6 arc shown results obtained in a
single patient who received placebo, aspirin 
(4 g* P<?r day) and pro'nicolone (10 mg. per day) 
orally for one week each. iiereas the graph is 
lowered only a little by aspirin a mar’ ed change 
is seen after prednisolone. This result supports
? ip’, <« <*„ i rJ  -s , . ' j i *v‘t ~ i ■ ..v v  * . '* C 't* A-”*'.
the validity of studying 99 eTc uptake as a 
measure of change in joint inflammation.
A method for the quantitation of Joint 
inflammation based upon the rate of uptake of 
99 mTc by the Joint is described. The method is 
reproducible and shows differences between normal 
and diseased joints. It has been shown to be 
capable of reflecting the effect of anti­
inflammatory therapy.
SUMMARY
QUANTITATION OF 1ADIOACTIVF TECHNETIUM 
IN THE PROXIMAL INTERPHALANQEAL JOINTS 
■ : -...■ -v pfMirawiAL
Introduction
Following intravenous injection elevated count 
rates of radioactive technetium are recorded over 
inflamed when compared with normal joints. The 
time selected for determination of count rate was 
15 minutes after injection. Elegant studies on 
the distribution of intravenously administered 
radioactive technetium within the joint by McCarty 
•t al.t (1970b) have demonstrated that at this time 
the radioisotope is located intravascularly. At 
a later time following injection leakage of the 
tracer occurs into tissue and synovial fluid and 
count rates at one hour following injection will 
include the binding of 99 mTc by inflamed tissue 
protein. Since this introduces a further variable 
factor which cannot be adequately quantitated it is 
reasonable to employ early count rates in comparative 
studies of inflamed and normal joints.
In the present study the count rate at 15 mins. 
after injection over the proximal interphalangeal 
joints of the hand was determined in normal subjects
LOCALISATION 
BY KiTERWAL
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and in patients with rheumatoid arthritis. The 
effect of oral low dose corticosteroid therapy. • i * r “ * it .
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upon the count rate was also determined in 
conjunction with more established Indices of 
joint inflammation.
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MATERIALS AND METHODS
Patients
Twenty-eight patients with "definite” or 
"classical" rheumatoid arthritis as defined by the 
diagnostic criteria of the American Rheumatism 
Association (Ropes et al*, 1959) too* part in the 
study* There were 27 females and one male. The 
mean age was 56*7 years with a range of 22 to 76 
years.
Thirteen healthy volunteers (8 female, 5 male) 
with a mean age of 23*1 years (range,22 to 35 years) 
served as controls.
All patients and control subjects volunteered 
to participate in this study with full knowledge of
its content*
• 1 - ■ ■ • ’ ' ■ 
Isotope Studies
Approximately 200 ^ Ci (standardised by count 
rate) of 99 »Tc in 1 ml*.of sterile NaCl was 
administered intravenously into a vein in the 
antecubltal fossa of the left arm. The count rate 
was monitored continuously for 15 minutes over the 
proximal interphalangeal joint of the index finger
2-9XL
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of the right hand. Peak values were then obtained 
for the other proximal interphalangeal joint®, 
counting for one minute over each joint. The 
sequence of counting was consistent being from the 
first to fourth proximal interphalangeal Joints, the 
right hand being counted first.
In previous feasibility studies it had been 
noted that excess 99 mTc counts were occasionally 
present over the site of the intravenous injection 
when compared with the identical area on the 
opposite arm at the conclusion of the study. Because 
of thia great care was exercised to ensure that the 
Injection was truly intravenous and verification 
that the total dose of 99 mTc had been administered 
intravenously was carried out by washing the syringe 
through with intravenous blood and by comparing 
counts at the Injection site with the corresponding 
site on the right arm at the end of the study. In 
no Instance were excess counts recorded at the site 
of injection.
During the Isotopic studies the patient's hand 
was positioned on blocks of adjustable height below 
a lead shield 0.5 cm. thick with an aperture Z cm.
3lQ$l
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In diameter. The joint to be counted was placed 
directly below the aperture, the counter resting on 
the shield which was supported by two lead supports 
6 cm. high and 12 cm. apart. The counting equipaenl 
consisted of a collimated 1 x 1.5 inch thallium 
activated sodium iodide crystal connected through 
an Ekco rateraeter (M.5180) and pulse height
analyser (M.5010) to a Kienzle automatic print-out.
. + The initial count rate per 10 seconds was 15,000 -
3% at 16 inches and the background of the order of
50 to 100 counts per 10 seconds. The results were
related to the dose administered and expressed as a
percentage of the administered dose corrected for
counting geometry.
Repeat uptakes of 99 mTc in the proximal
Interphalangeal joints were measured in 9 patients
at 24 hours to determine the reproducibility of
the measurement.
The effects of oral prednisolone therapy 5 mg.
twice daily on the proximal Interphalangeal Joint
uptakes of 99 mTc were studied in seven patients.
The effects of 99 mTc uptakes were compared with
the joint circumference as measured ty a plastic 
spring gauge (del gy; Ltd.) described by Boardman and 
Hart (1967) and with the grip strength as measured 
by the mean of three readings over a baseline of 30 
mraHg. for each hand* Prior to each isotope study 
each joint was assessed by the same observer* A 
history of pain and of stiffness was elicited and 
graded* Firm pressure was exerted over the joint 
margin and the response graded* An assessment of 
the degree of joint warmth and swelling was graded* 
Grading was on a 0 to 3 basis where 0 = absent;
1 as slight; 2 « moderate and 3 e severe* The 
maximum score for an individual joint was +15*
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The results are summarised in Tables 3# 6 
and ?•
* Table 5 summarises the results of repeat 
99 mTc uptakes in the eight proximal interphalangea 
joints in 9 patients at Zk hours. It can be seen 
from the table that in all eight joints the mean of 
the differences and the standard errors of the 
difference are acceptably small. The mean 
difference for eight studies was 0.66 with a 
standard error of the difference of 0.36.
Table 6 summarises the results of the mean 
and S.E.M, of the 99 mTc uptakes in the proximal 
interphalangeal Joints of each hand in 13 non- 
arthritic healthy controls and in ZZ patients with 
rheumatoid arthritis. From the table it can be 
seen that the uptake in all the joints was 
significantly higher (p^O.OOl) in the rheumatoid 
patients. No significant difference was noted 
in any of the mean uptakes in the proximal 
interphalangeal Joints in the normal patients. 
However, in the patients with rheumatoid arthritis 
the mean uptakes in the first three right proximal
RESULTS
om
H
• VO VO
f  i -  m
y *? v 
(-*  *-•
•  •
vn On 
On O
CD 0 4  O n
o  •  •  •
ro8
p- o  ov
•  o  ro
f  ;£
£♦
$
•  •
ro  S£
& $
W  U 1
•  -~i vo
0 0  *  *
I Kjl -cd vnft 7+
t->  M  
•  •
£  >3
KJ\
o  •
b 8
51 <8 2
•  •
O  <7\ 
ro  03
ro
f r &
• f  VJ1 VJ1O  •  CT\ —I
b Y *
f c &
-p -  p - ov 
o  •  •  •
• 00 V * Q
o  r  \ ZM b+b*
l-> V* v/t •  CD VO
I v o
- J  tv
f t  T+ 
* -• »-■
Y is
8 n
>3 M
H  i j l  ®
•  VO O
0 \  •  •
p *
?♦?*
CT\ -P- 
—J V^ J
M  U> Ov • •  •
3  9 Yb+ b+
y  k
ro v» o i
•  O n - 4
h * •  •
p - Ov
Cn p- 
$ 6  
k  is
t-» P " VJ1 
• VO O
CD •
Ol VJI
o  •  •  •
8
ro  o i  o i
O  • o i  -4  • vji •  •
O  M  VO ^VJ1
r * t *  •  •
t_> vp 
V *  O
ON P“ VJ1
o  • • •• vn -a oo§ * g*&
04 VJ1
O  • VJ1 —4
Y  08
•  •
so On 
sO \J\
VJ1 OlO • • •• no v-n vo° ^  v,*• •
S
I
I *• <'\i * y . * Y - .
• . ‘ ' § ^
interphalangeal joints were significantly higher 
than the mean uptake in the fourth right proximal 
interphalangeal Joint (p <0.025) and in the left 
hand the mean uptake in the fourth left proximal 
Interphalangeal joint was significantly lower 
(p<0.05) than the mean uptakes in the first three 
proximal interphalangeal joints.
The effects of prednisolone 10 mg. per day for 
one week on the 99 ®Tc uptakes and joint circumfer­
ences of the proximal Interphalangeal joints are 
summarised in Table 7. With the exception of the 
fourth right and second left proximal inter­
phalangeal joints, the 99 mTc uptakes were 
significantly reduced with prednisolone therapy, 
as tested by a student’s t-test for paired values*
In each proximal interphalangeal Joint the 
mean of the differences before and after prednisolone 
therapy exceeds the mean of the differences observed 
in the reproducibility study, with the exception of 
the left fourth proximal interphalangeal joint where
the mean of the differences in the prednisolone trial
i no ♦ tr 0.36, whereas in the reproducibilityWas JL.JLo — o , Tj * . • .
study it was 1.66 - S.E.M. 0.56. This casts doubt
on the validity of the significance value for the
. . . r  *
fourth left proximal interphalangeal joint.
When each Joint was considered Individually
significant reduction in joint circumference was - . * • • ‘ ■ • \ . ’■ ' - 
observed in only the second right proximal inter­
phalangeal Joint. However, when means of the 
four joints in each hand and the mean of all eight 
joints were considered the differences were 
statistically significant (Table 7)*
The mean and S.E.M. of three readings for 
grip strength in the right and left hands was 
76.29 - 10.l»2 minHg. and 88.71 - 11.96 mraHg. 
respectively and after prednisolone therapy the 
respective values were 94*14 - 9*77 ramHg. and 
107.7 i 13.08 mraHg. Although increased In both 
hands the differences were not statistically 
significant in either hand as tested by the
. " •• . v-5 . J . >V, ■ • ■ 4 '
student’s t-test for paired values.
There was no significant correlation between 
any of the clinical features studied, Joint 
circumference or grip strength and 99 »Tc uptake 
in any of the fingers or individually in the means 
of these parameters in either hand.
Rheumatoid arthritis is an inflammatory 
polyarthritis affecting both large and email joints. 
Radioactive isotopes have mostly been employed to 
assess inflammation in large joints. McCarty and 
his colleagues (1970a and b) have sclntlphotographs 
of small joints in the hands demonstrating 
Increased localisation of radioactive technetium 
in Inflamed tissue. If, as seems likely, the 
major application of radioactive technetium in 
arthritis is to provide a method of assessment of 
anti-inflammatory drug effect, then it is clearly 
essential that it be susceptible of quantitation, 
that it be reproducible, that clinically acceptable 
doses of the tracer be used and that it shows 
changes with conventional doses of anti-inflammatory 
compounds.
In the present study an extremely low tracer 
dose of radioactive technetium (less than 200 fCi) 
was employed and clear differences in uptakes 
between normal and Inflamed proximal Interphalangeal 
joints, when considered individually or as a mean
for each or both hands, were detected. In order 
to obtain adequate definition in technetium scinti- 
photography, large doses of radioactive technetium 
of the order of mllllcuries are necessary (McCarty 
et al., 1970a and b). This method affords the 
opportunity of defining localisation of 
radioactive technetium within the joint, but 
the high doses required severely limit the number 
of repeat observations possible. Although the 
advantage of definition within the Joint is 
sacrificed with the present technique, nevertheless 
the very small doses of the isotope employed allow 
frequent repeat observations such as are required 
to follow anti-inflammatory drug effect without 
exposing either patient or physician to undue 
radiation hazard.
Repeat observations within twenty-four hours 
were associated with an acceptably high degree 
of reproducibility. Changes following one weekfs 
oral treatment with low dose corticosteroid 
therapy were clearly demonstrated when the means 
of the four proximal Interphalangeal joints of 
each hand and the means of all eight proximal
' . * .. ‘ •' ' . *• >
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interphalangeal joints were considered. That 
it is probably preferable to consider the mean 
values for either or both hands rather than for 
individual joints is suggested by the fact that 
changes were not demonstrable in two of the 
joints studied.
Changes were observed in joint circumference 
before and after corticosteroid therapy. These
* /  ‘t- • fc.. v  ■ . ♦ V  • * * . , 't •
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changes were significant when the means of the 
values for either hand or for the mean of both 
hands were considered. In only one individual 
Joint, however, was the change significant.
This finding accord© with the suggestion that it 
is preferable to consider the mean values rather 
than the values for individual joints. Although 
no significant correlation was found between any 
of the clinical parameters of inflammation, joint 
circumference, or grip strength in individual 
Joints or in mean value© for either or both hands 
and the technetium uptake, there was a relation­
ship (r » 0.69 P <0.0$) between the degree of 
change of both technetium uptake and joint 
circumference before and after corticosteroid
therapy. McCarty et al. (1970b) have shown a 
high correlation between scintiphotography and 
clinical assessment. The reason for the 
discrepancy between their results and those in 
the present study is not immediately apparent.
These workers have also shown that isotope studies 
may be positive prior to clinical expression of 
disease. It is possible that the Isotope studies 
are therefore more sensitive than is clinical 
assessment.
The difference in grip strength before and 
after corticosteroid therapy was not statistically 
significant. In this study, therefore, the 
changes exerted by corticosteroid therapy were 
most apparent in the Isotope studies and less obvlou 
either Joint circumference or grip strength. It is 
possible that the technetium count rate provides a 
more sensitive index of change with anti-inflamaator 
drug therapy than is afforded by Joint circumference 
or grip strength.
SUMMARY
A simple radioisotopic method for the 
study of inflammation in the proximal inter­
phalangeal Joints in patients with rheumatoid 
arthritis is described. The tracer dose of 
radioactive technetium is extremely small 
permitting frequent repeat observations. The 
method is reproducible and shows differences 
between normal and inflamed joints. Elevated 
uptakes can be reduced by low dose corticosteroid 
therapy. The method may prove to be more 
sensitive than joint circumference and grip 
stnei^ th.
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STUDIES ON THE RELATIONSHIP BETWEEN RADIOACTIVE 
TECHNETIUM COUNT RATE AND CLINICAL METHODS AS 
INDICES OF INFLAMMATORY ACTIVITY
Although the 99 mTc count rate is elevated in 
inflamed joints and may be reduced by anti­
inflammatory therapy, the sensitivity of the 
method in relationship to currently employed 
methods of assessment remained to be established. 
Two studies were conducted to this purpose. The 
basic protocols were similar, each study comprisin 
a crossover clinical trial in which selected 
patients each received sequential courses of 
anti-inflammatory therapy of one week’s duration. 
At the conclusion of each course of therapy a 
standard set of assessment methods were completed 
and the results by each method were compared. In 
the first pilot study the numbers studied were 
small and the assessor and patient were aware of 
the identity of the treatments. Well establishei 
drugs were employed. In the second study the 
number of patients studied was larger and the trL 
was double-blind. This study incorporated a 
newly introduced anti-inflammatory compound 
ibuprofen (Brufen i Boots Pure Drug Co. Ltd.).
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Legend: The number of patients receiving each treatner
in each of the three periods.
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Ten patients with "classical" rheumatoid 
arthritis (Ropes, Bennett, Cobb, Jacox and Jeesar, 
1959) took part in a triple crossover clinical tri 
over a period of 3 weeks. Four patients were mal 
and the six female patients were poet-menopausal. 
The age range was 39 to 58 years. ch patient 
volunteered to participate in the trial after 
explanation of its content and implications.
-All patients received three successive
- • , ■ ’ ■ . Y
treatments of a wee1* each on sodium salicylate 
(Entrosalyl) 5 g. per day, indomethacin (Indocid) 
100 mg. per day and lactose as placebo, all given 
as Zt divided doses in non-idcntical capsules. The 
order of treatments administered is summarised in 
Table 8. At the conclusion of each week’s 
treatment the patients were all assessed by the 
same observer. Each patient was asked general 
and then specific questions designed to elicit 
both the efficacy and side effects of the previoui 
week’s treatment. An articular index (Ritchie 
et al., 1968) was performed, and measurements v/er< 
made of grip strength (Wright, 1959) of 
circumference of the finger joints using a 
millimetre gauge (Roardman and Hart* 1967).
M ATERIAL AflD METHODS
One knee joint, selected for a study at the 
first assessment on the basis of severity of 
involvement, was then examined. A history of pain 
and of stiffness was elicited. The degree of 
tenderness, measured ae the response to firm pressure 
over the joint margin was tested and the degree of
1 - > ► r f . . ' ':>* . v . -->4'■* * A  > .  'V  -" ' . •*>  Jl. v* S  V  - .joint swelling was also subjectively assessed.
Grading for each of these  ^criteria was on a four 
point scale where 0 = absent, 1 * mild, 2 * moderate 
and 3 « severe.
A narrow bore needle was inserted into the 
Joint cavity and as much’ synovial fluid as possible 
was withdrawn. Approximately 30^ Cl of 133 Xe in 
0.3 ml. of sterile sodium chloride were Injected 
into the joint cavity and the needle withdrawn.
The wound was sealed with adhesive. A detector 
incorporating a lrf x 1.1/21' thallium activated 
sodium iodide scintillation crystal and photo­
multiplier (Ekco M5*f00A/l) was positioned over the 
joint. Immediately afterwards approximately 200 y Ci 
of radioactive technetium as per-teohnctate in
solution were injected into a vein in the antecubital
.
fossa. The dose was standardised by the count rate 
per minute. A double channel counting oyetem
allowed the separate monitoring of 133 Xe and 
99 mTc through the same detector. Pulses from 
the detector v/ere fed through 2 pulse height 
analysers (Ekco 5010), the settings of one being 
adjusted to the 99 mTc peak and the other to the 
133 Xe peak. Counting was achieved through two 
ratemeters (Ekco M5183A) and, in the case of 99 mTc, 
a Kienzle printer. The 133 Xe counts were 
displayed linearly on graph paper by a direct 
writing pen recorder (Potentiometcrschreiber,
RE 511).
Counting commenced three minutes before the 
intravenous injection of 99 mTc and approximately 
two minutes after the intra-articular injection of 
133 Xe and was continued for 30 to l\5 minutes.
The 133 Xe graph was sampled at one minute intervals 
and plotted on semllogarithmic graph paper as a 
function of time. A straight line was obtained 
in each case from which the half-time (Ti) in 
minutes for the clearance of 133 Xe from the knee 
Joint could be obtained following corrections for 
background and for overlap of the higher energy 
99 mTc activity onto the 133 Xe channel. The 
99 mTc print-out was also sampled at one minute
' ^  'r' ' ■ '  * • * . »y.... ■ ,/y y  . **■ * - * ■ « * ,*• • „ -*• - > .•> ./ ■''
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intervale and plotted linearly ae a function of
>■'* •* *T jcfy y * '* * ^  . j, '  . _ "* • *■*'• • *»* r‘ ■ ,'v * *’ * /i ^ ^  ^
time. Monitoring was continued until a peak 
count rate for 99 niTc had been obtained. At the 
ond of each study the count rate over the site of 
injection of 99 niTc was compared with that obtained 
over the equivalent area on the opposite arm* In 
any study in which a marked discrepancy wae found, 
indicating faulty injection technique, the results 
from that patient were rejected. Four studies 
were unsuitable for analysis for this reason.
>v ?*• r  ‘ ■ -w‘. .V S  *:£?''■ v j  • A  ■ •• .. /  ' *  **■*'£- ■ ♦ v * Jfc* " 'j-Patients were asked at the end of the three 
weeks of the trial to give a single preference for 
one of the three treatments.
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The individual values obtained on each 
treatment are shown in Table 9. This trial was 
in part an attempt to compare different methods of 
assessing the effect of treatment and Table 10 
shows how consistent wore the 6 techniques 
employed in each patient. In one patient (No.3) 
all 6 methods indicated that the same treatment was 
best. In two patients 3 of the 6 methods gave the 
same result, whilst the results of K of the 6
T \ .  ‘ •. *’  >  ***' ‘ <  % * * V .  V j '  * '  . *  -  .  '  , , - v .  - * •"* v  * * •
methods coincided in 3 patients. Thus in 8 out of 
10 patients at least Z* of the 6 assessment techniqu 
g#ve the same answer. Of the individual methods, 
articular index and the radlotechnetium tect 
corresponded to this answor in all 8 patients, 
whilst the xenon clearance test differed from this 
in 2 and* joint sizes only corresponded in 3 of the 
8 patients.
Also shown in Table 10 are the decisions which 
each patient made as to the single most effective 
treatment. In 8 of the 10 patients this decision 
reflected the majority preference indicated by the 
assessment methods. On© patient (No.7) selected 
placebo as the single most effective treatment and 
in that patient the. assessment methods were totally
* * ' ■ O  *! ■ '-*• .«•* . V  ,• " r ^  v- V w  a V  * *  \ *  ■ , •"'!’ '
' ■ . . ' * • * -
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TAHLE XI
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VALUES ASSIGNED WITH EACH DRUG GIVEN
Dummy
Variable Salicylate Indomethacin Placebo Comparison t€
d. ♦ 1 - 1 0 Salicylate
indomethacj
d2 - 1 - 1 + 2
* w * '* ■
Lcncnd: Values assigned to the Dummy Variables used in th<
analysis of covariance.
discordant. In the final patient (No.5) who was 
unable to select a single most effective treatment,
3 out of the 6 methods of assessment suggested that 
salicylate was best. These were the articular index, 
knee score and peak 99 nTc count rate.
The results were further analysed statistically. 
Each of the 6 methods of assessment was considered 
separately, using analysis of variance techniques to 
decide whether there were significant differences in 
value of any of the methods when patients were given 
the 3 treatments. As shown in Table 8f the triple 
crossover design in 10 patients did not produce a 
balanced design due in part to rejection of results 
of 99 mTc studies and 2 patients started on 
indomethacin whilst 4 each started on salicylate and 
placebo. The statistical method used took account 
of this imbalance in the design. Dummy variables 
(Quenouille, 1953) were used to test the treatment 
effects of salicylate against indomethacin (d^) and 
placebo against active drugs (d^)* These two 
comparisons were chosen to be orthogonal and form 
together the total variance between treatments.
Table 11 describes the values assigned to and d^.
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Analysis of covariance were performed separately 
for each of the 6 assessment criteria using the
’V ? W»;v. * I i * - ' y - >•"‘ *‘5  •/ * . jr... , ,1 ■' * V' A  . i ’dummy variables and separating out the effects due 
to patient variation and to period effect leaving 
a residual variation measuring treatment effect 
• lone. Regression coefficients measuring d^ and 
were determined and their significance tested . 
in the analysis of variance# A two-tailed 
significance level was assigned to each drug 
comparison by using the square root of the F-ratios 
obtained in the regression analysis and entering
* ' " j  * -  - , 4 *v,. S . . ’
tables of Student’s t-test with 16 degrees of 
freedom. Table 12 shows an example of one analysis 
using the figures for articular index.
Table 13 shows the significance levels obtained 
by these analysis. Also shown in Table 13 are the 
overall mean values for each assessment methodf 
corrected for period effect by the use of the 
relevant regression coefficients. It can be seen 
that for the comparison of placebo versus active 
drugs, all the parameters except joint size showed 
a significant improvement in favour of the active 
drugs# This was more marked for the measures?chts 
of articular index (p^O.OOl), knee score and
MEAN 
DIFFERENCES 
S 
SIGNIFICANCE 
OF 
THE 
DIFFERENCE 
BETWEEN 
THE 
VALUES 
OBTAINED 
FOR 
EACH 
ASSESSMENT 
METHOD 
WHEN 
EACH 
ACTIVE 
DRUG 
WAS 
COMPARED 
INDIVIDUALLY 
WITH 
PLACEBO.
technetium peak count (p *<0.005), whilst grip 
strength reached a significance of p <0.01 and 
non clearance times reached p<0.05* The tests 
of indomethacin versus salicylate did not reach 
conventional statistical significance for any of
v -*■ ■•■••.'■‘I  £ -i. “ * '*V -*.«-• • ' r ' «> • «r* . <  / .  " . :’«encr . r .I-* •. ; u. - .* f<i ^ ( j  * . - t
the parameters, although the technetium peak count 
came near to this at p- 0.1. With the exception 
of joint size, however, the mean scores for all
Ti ,r ‘ -*? r*&!;% . * • / - v^'V* * S' . * ‘ ‘
the methods on indomethacin treatment were better 
than those on salicylate.
Further analysis were made to compare placebo 
against each of the two active drugs Individually. 
This was done by forming a ©et of t-tests derived
pfrom the residual squares (s ) in each analysie of 
covariance, using the value as the standard
error of the difference between the means, where
■ ' ■ * ,<f . ' . • ‘v . \ ■ ; ‘
n * the number of patients on which each mean score
was based. Table 1U shows these results. 
Indomethacin was shown to be significantly better 
than placebo by all the methods except joint size 
with xenon clearance times the least significant of 
the five. Salicylate was better than placebo 
according to articular index, knee score and tech­
netium peak count, but no significant difference was
shown using Joint size, grip strength or xenon 
clearance times.
y  ' • U  ■' \  . . y  * \  iv * ' * *  ’ • - i ■ .-r " ^ i  m - . * i ' »«iL ry  i-* .v  T % -V  y  '  • ’ •*• ► \  , ' ‘V'Y T 5^?
In the present clinical trial the results 
obtained by two new methode of assessment were 
studied in conjunctioh with previously established
DISCUSSION
methods* The results clearly show that the 133 Xe 
clearance method offers at beet only poor dis­
crimination when compared with standard clinical 
methods, as has been noted previously (Chapter 6). 
Thus, although a difference at the 5% level of 
significance was demonstrable between placebo and 
active drug therapy by this technique, the standard 
methods articular index, knee score and grip 
strength distinguished the effects of treatment at , 
the 1 level or better. Since the Xenon clearance 
time reflects synovial tissue perfusion alone 
(Chapter P)which is only one feature of the total 
inflammatory response, this result is not altogether 
surprising.
The change in joint circumference provided even 
poorer discrimination than did the results of the 
xenon studies. Although joint siz»s has been shown
I • . ’ - y  i /  yjr
to change with adequate anti-inflamAatory therapy by
. - * ' ' r * y .*some workers (Boardaan and Hart, 1967) • alteration 
attributable to drug effect has been less obvious in
other clinical triale (Pitkeathley, Baiierjee, Harris 
and Sharp, 1966)» There are many possible
explanations for this discrepancy. Mor:t of the 
Joint swelling In the patients in this study 
represented irreversible change and probably could 
not be modified by short term anti-inflammatory 
therapy.
On the other hand, the simple determination of 
peak count rate following an intravenous injection of 
a measured dose of radioactive technetium seems to 
offer an index which more closely mirrors clinicali • i ' . ' - ‘
change. Thus, the same order of levels of, 
significance achieved when active therapy was 
compared with placebo by means of the articular index 
(p <0.001), knee score (p <0.005) and grip strength 
(p <0.01) was also seen with the technetium peak 
count rate (p <0.005). Furthermore, the technetium 
peak count rate gave the same treatment preference as 
did the articular index for all 10 patients and both 
these measures corresponded to the majority trend in 
the 8 patients showing consistent results (Table \o), 
whilst the xenon clearance test fell short of this.
In 8 of the 10 patients the result by the radio­
technetium peak count rate agreed v/ith the patients*
own treatment preference. Criticism may be 
levelled at the use of patient preference in a trial 
which is not blind, but the high level of agreement 
of the patients* choice with both subjective and 
objective measurements in this study provides sorao 
support for its inclusion.
The mean scores for technetium peak count, 
articular index, knee score and grip strength all 
showed better values on indomethacin than on 
salicylate, and although none of the parameters 
showed a statistically significant difference the 
nearest approach to this was the technetium peak 
count (p ^0.1). Although most authorities consider 
indomethacin and aspirin in these doses to be 
roughly equipotent (Sunshine, Laska, Meisner and 
Morgan, 1964 : Pitkeathly and others, 1966 : Pinals 
and Frank, 1967) there is some evidence to suggest 
that indomethacin exerts a more powerful anti­
inflammatory effect than aspirin (Gaspardy, Gaspardy 
Balint and Kemeny, 1966). The trend of the 
findings in the present study agree with this.
The results of this small but objective study 
therefore sTiow that the measurement of peak count
•ii£
rate of radioactive technetium in capable of 
demonstrating anti-inflammatory effect in a short 
term clinical trial of non-steroidal anti­
inflammatory drugs. The direction and the degree 
of change of this measurement compare favourably 
with results obtained by other clinical methods.
Ten patients with "classical" rheumatoid 
arthritis entered a triple crossover clinical trial 
of anti-inflammatory treatment using sodium 
salicylate 5 g. per day, indomethacin 100 mg. 
per day and placebo, each treatment being 
administered for one week. Six methods of 
assessment were employed including an articular 
index, joint size, grip strength, a knee score and 
two new methods of assessment derived from isotope 
studies. Peak uptake by the knee following 
intravehous administration of radioactive technetium 
and the half life of intra-articularly injected 
xenon were determined each week. The articular 
index, grip strength, knee score and radiotechnetium 
peak count rate discriminated change in the 
inflammatory process as a result of treatment 
better than did joint size or xenon clearance 
measurements.
SUMMARY
A STUDY ON THE EFFECTS OF ANTI-INFLAMMATORY DRUG 
THERAPY W RHEUMATOID ARTHRITIS: THE RELATIVE
EFFICACY OF SEVEN METHODS OF ASSESSMENT
Introduction .
In thie study both subjective and objective 
methods of assessment were employed in a double­
blind four week crossover trial of placebo, 
aspirin, prednisolone and a newly introduced 
anti-inflamraatory compound, Ibuprofen (Brufen, 
Boots Pure Drug Co. Ltd.) in order to derive 
information on both the clinical efficacy of the 
drugs and the relative efficiency of the methods 
of assessment.
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MATERIALS AND MFTHQDS
Patients Studied
Twenty-four patients with "classical" or 
"definite" rheumatoid arthritis (Popes et al.t 
1959) entered the trial* The mean age was 47.7 
years (range 18 to 67 years) and eleven were female. 
Each patient received aspirin ("Entrosalyl", 
Cox-Continental Ltd., 4 g. per day), ibuprofen 
("Brufen", Boots Pure Drug Co. Ltd., 1.2 g. per day) 
prednisolone (10 mg* per day) and lactose as placebo 
The order of treatment was randomised and the 
compounds were administered, orally, in identical 
capsules, for one week each.
At the conclusion of each week's treatment the 
patients were reviewed. An articular index 
(Ritchie et al., 1968) which provides a measure of 
joint tenderness and which correlates with the 
articular index of the Co-operating Clinics of the 
American Rheumatism Association was performed*
This index takes only two to three minutes to 
perform and both the inter- and the intra-observer 
errors have been determined. Although the inter­
observer error is large, precluding the comparison
of results obtained by different observers, the 
Intra-observer error is only 1.2 score units.
One knee Joint, selected for study at the first 
assessment on the basis of severity of involvement, 
was then examined. The Joint margin was subjected 
to firm pressure and the response graded on a 0 to 3 
basis where 0 e absent, 1 e slight, 2 * moderate and 
3 e severe.
The circumference of the proximal inter- 
phalangcal Joints and the inter-phalangeal joint of 
the thumb in the right hand were measured using the 
Qeigy apparatus, the totals for all five Joints being 
recorded. Grip strength (sura of three readings) in 
the right hand was determined using a modified 
sphygmomanometer cuff and baseline level of *30 mmHg.
The patient then lay comfortably and the knee 
joint which had previously been examined was exposed. 
Employing full aseptic precautions 0.5 ml* of a 
solution of radioactive xenon (133 Xe) in sterile 
0.9% NaCl (Amersham, England) was carefully Injected 
into the Joint cavity. Immediately thereafter 
approximately 200 y Ci (standardised by count rate) of 
radioactive technetium (99 mTc) were injected
intravenously. A lightly collimated thallium 
activated sodium iodide crystal and photomultiplier 
(Ecko M5hOOA/l) positioned vertically above and 2M 
from the patella conducted the pulses through two 
pulse height analysers (Ecko M5010) which were set 
at the counting conditions for 133 Xe and 99 ale 
respectively. Recording was accomplished through 
two ratemeters (Ecko M5183A) and the 133 Xe counts 
were displayed upon a Servoscriber KE511 chart 
recorder, the 99 nTc counts being displayed on a 
Kunzle digital print-out. The counts were 
corrected for background (of the order of 1# of 
count rate) and overlap (of the order of 18%) and 
the 15 minute count rate for 99 mTc, and the half­
life (Ti value, minutes) of the semllogarlthmlc 
plot of the 133 Xe were determined.
At the conclusion of theso studies the patients 
were asked to assess numerically their clinical 
status the previous week. The grades allowed 
were 0, 1, 2, 3 and U ranging from 0 « excellent 
to k * very bad.
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RESULTS J"L "r"'' ''
The results are shown In Tables 15 and 16.
The mean value of the patients1 score for 
general assessment while on placebo (3*79 - 0,09) 
was significantly higher (p<0*001) than while on 
ibuprofen (1*96 - 0.25)» aspirin (1*75 - 0.12) and 
prednisolone (0.79 - 0.23)* There was no 
significant difference in the mean scores while on 
ibuprofen and aspirin» but the mean score while on 
prednisolone was significantly lower (p<0.001) 
than the mean scores while on Ibuprofen and aspirin.
The mean value obtained for the articular index 
while the patients received placebo (/*0.7 - 2.65) 
was significantly higher (p<0.05) than the mean 
values obtained with ibuprofen (30.7 - 2.66) and 
also (p <0.001) with aspirin (26.6 - 1.95) and 
prednisolone (17*6 - 1.6b)* The values obtained on
prednisolone differed significantly from the values 
obtained on aspirin (p<0.01) and on ibuprofen 
(p <0.001) but there was no significant difference 
between the values obtained on Ibuprofen and on 
aspirin.
. ^  I*   ^ 1 .• A*r ' ; ,  ' ' '. * ' - < v ^  l': - ' • '
Similar results were obtained with the knee 
tenderness score. The mean value on placebo (2.8 
- 0.08) was significantly higher (p <0.001) than th 
values obtained on ibuprofen (1.9 - 0.14)» aspirin 
(1./; m 0.12) and prednisolone (0.46 i 0.12). The 
values obtained on prednisolone were significantly 
lower than those obtained on aspirin (p<0.01) or 
ibuprofen (p <0.05) and the values obtained on 
aspirin were significantly lower (p<0.05) than on 
ibuprofen.
The values for grip strength on prednisolone 
differed significantly (p<0.001) from the values 
obtained on aspirin, ibuprofen and placebo. Howeve: 
there was no significant difference between the 
values on aspirin and on ibuprofen, or between the 
values on either drug and on placebo.
The values obtained for Joint circumference 
while the patients received placebo were slgnlflcan 
higher (p <0.001) than the corresponding values 
obtained during the period of prednisolone treatment 
However, there were no significant differences 
between the values obtained while the patients
3^3
received either aspirin or ibuprofen and either 
the placebo values or the prednisolone values.
There was a significant difference (p<0.05) 
between the Ti values of the 133 Xe clearance 
rates obtained during placebo treatment and during 
prednisolone treatment. However, there were no 
significant differences between the Ti values on 
either aspirin or ibuprofen and the placebo values
The mean value for 99 «Tc count rate obtained 
on placebo therapy was significantly higher than 
the mean value obtained on prednisolone (p <0.001) 
and aspirin (p <0.05) but was not significantly 
different from the value obtained on ibuprofen.
The difference between the ibuprofen and aspirin 
values was not significant.
* This study was designed to provide comparative 
information on two inter-related topics, namely, 
the efficacy of the drugs administered and the 
reliability of the methods of assessment employed* 
The form of the study was a double-blind crossover 
short term clinical trial* The incorporation of a 
period of placebo administration has been criticised 
on ethical grounds. The minimal requirement in 
this situation is freely given consent by the inform* 
patient* It is then the responsibility of the 
trialist to provide adequate and reliable informatloi 
upon which the clinician can base a valid conclusion 
on the efficacy of the compounds studied* The 
inclusion of a period of placebo administration 
permits some degree of standardisation and in 
addition safeguards against the results 
drug x » drug y * nothing. A great deal of 
knowledge is now available on the placebo reaction 
as a consequence of the meticulously controlled 
work of such workers as Beecher (1959)» Lasagne 
(1955)i Joyce (1961) and others. The placebo 
reaction is an unwelcome but inevitable feature of
DISCUSSION
drug trials and, in my opinion, renders the 
incorporation of a period of placebo administration 
mandatory. A farther problem encountered in short j 
term clinical trials ie that of "carry over" effect 
of one compound into the succeeding assessment period 
Assessment at the conclusion of a full seven days9 
therapy affords some protection against this effect 
which is further reduced by random allocation to 
treatments. This problem however is only minimised 
in this way and can neither be eliminated nor eveh 
quantitated without the aid of mathematical methods 
requiring the assistance of computer analysis.
The results of this study clearly show the effee 
of low dose corticosteroid therapy in rheumatoid 
arthritis. The difference between the placebo and 
the prednisolone values is significant by any of the 
methods of assessment, thus underlining the relative 
unimportance of the method of assessment employed in 
the evaluation of a drug of major effact. The
* . ’ jgjgr • ' • ’ ■ . . . *
biological difference obtained is large enough to 
counteract a large degree of insensitivity or lash ol 
specificity In the monitoring system employed.
The situation, however, Is rather different 
when the results obtained with placebo, salicylate 
and ibuprofen are* considered. The difference 
between placebo and the two active compounds is 
indicated by the significantly lower values 
obtained for general assessment, articular index . 
and knee tenderness. Tt is noteworthy that the 
values obtained by all three methods while the 
patients were receiving salicylate were lower than 
were the corresponding values obtained for ibuprofen 
With only knee tenderness however wore the.* > * . 'j* -*< & , >’•. * V ; V v  v '> \ ,\ * ' ■ . * • *r‘, V !differences significant# The count rate of
99 mTc is significantly higher on both ibuprofen
■ _ . . ' ■ ■ . . ■ _
and placebo, than on salicylate therapy* However,
. 1 ' • ‘ • . . ‘ - * ’ * ■ ■ ’• * • -v , * ; /  v  . ,
l^V 1 - ‘ , • , ' * w* ‘ «*> • .* ‘
three factors may have contributed to this result;
W“ - * . » '• . , . * V# i. v* *'AC '  ^ i  /; . -f . ■ ■ .  ^ t
the method may not be sensitive enough to detect .
’’ : • ..'V'V {'r'- -r ^  ' ’ \ ' •. *. • v- 'i? ■ *#' • . •.
small changes; the number studied may have been
too small; or the compound may indeed be less• • • y ' - . :■ '• ' _
effective than aspirin as has been suggested
; • v ’ ’ ■v; . *r?v \ . •
previously (Boardman et al., 1967)*
. •* . • * 
The measurement of joint circumference, grip . .
■ . ’ * ’ ’ . - • * ,• . ' • *’ 
strength or 133 Xe clearance rate wore not \
significantly different while the patients were
receiving placebo, salicylate or ibuprofen*
r . • Y#7* ' . • *>■ y' - . . • i rf*-' X *“ . . «** vJr . 4 , '■ •*. A —■ * • ** . t ■ ^  % *■
’ * . "  ' • ‘ ~ ’
- . ‘ . '
■V •*,; * * / ' * 4 ^ -i:3 *'although In all cases the results showed a
tendency to improvement with the active drugs.
That the 133 Xe clearance rate, changes less with 
salicylate than with either indomethacin or cortico­
steroid therapy has already been noted (Chapter 6). 
Failure of Joint circumference and grip strength
to change significantly during adequate anti­
inflammatory therapy may be related to the presence 
of irreversible changes in the rheumatoid hand. 
However, since these methods cannot be relied
* >y - ***
upon to show changes with standard treatments in 
rheumatoid arthritis, it is difficult to justify 
their retention in the assessment armamentarium 
in short term studies of non-steroidal 
anti-inflammatory compounds.
Certain conclusions are suggested by the 
results of this study. Prednisolone therapy can 
be shown to be effective in the treatment of 
rheumatoid arthritis by any method of assessment. 
Objective, semi-objective and subjective 
assessment methods are available to demonstrate 
the efficacy of salicylate therapy. That 
ibuprofen is effective in the treatment of
' ’ - „ ' '
• . - ■ ’ ' ' ' “*• l ‘ ”>' ; ■ '
’ . •*' .  • " . ' - ■ "  •• • ' -^ v -' £<~ ■£' v «■/ ■ £ •• • ’
rheumatoid arthritic ir suggested by subjective
. -Jfc. . •'v - *« • V - ' • 'U ‘‘ J‘ . 4 ,
and semi-objective method® of assessment.
Howeverf consideration of the biological 
significance of all of the results suggests 
that it is lece effective than high doee 
salicylate therapy. It is possible that the 
determination of 99 mTc count rate and of joint 
tenderness best demonstrate this point. The 
methods of assessment, joint circumference, grip 
strength and 133 Xe clearance rate cannot be 
relied upon to demonstrate anti-inflammatory 
effect on non-steroidal compounds and ar© less 
sensitive than the 99 mTc count rate, articular 
index and joint tenderness and the patient*c
S ’ Cl *’&/ A  /r  '■ " -i V iV  * . ■ • wies; ^ m I '  \  ■ '" >' x>' .■ ’ «*** *&&*" -  ' 7own general assessment of joint pain. These 
conclusions are in accord with those obtained in 
the smaller pilot study previously reporter. 
Clearly, the precise value of 99 mTc studies as 
routinely employed Indices of anti-inflamcntory 
effect must await confirmation of these results , 
by other laboratories. However, the oonclueion© 
suggested by the studies reported in this thesis 
are promising.
In a quadruple crossover double-blind 
clinical trial of prednisolone, salicylate, 
ibuprofen arad placebo involving twenty-four 
patients, six methods of assessment in addition 
to patient preference were employed concurrently.
The results suggest that the order of anti­
inflammatory potency of these treatment periods 
was prednisolone aspirin ibuprofen placebo 
and further suggest that the discriminatory 
power of the methods articular index, knee 
tenderness and 99 mTc count rate exceeded that 
of grip strength, joint circumference or 133 Xe 
clearance rate.
SUMMARY
3 3 J -
RADIOACTIVE TECHNETIUM COUNT RATE IN ARTHRITIS 
RELATED TO THE CLINICAL DEGREE OF INVOLVEMENT AT 
THE TIME OF STUDY AND TO THE 133 Xe CLEARANCE RATE
Introduction
In this chapter studies have previously b een
reported on the relationship between clinical
findings and the 133 Xe clearance rate and between
clinical findings and the 99 mTc count rate over the
joint at 13 minutes following intravenous injection
of technetium. -
In the present study the relationship between
the 99 mTc count rate and clinical assessment of the
joint at the time of study v/as investigated in larger
numbers of patients (group 1) with osteoarthritis and
with rheumatoid arthritis, some of whom had been
subjected to the operation of anterior knee
synovectomy. The 99 mTc count rate at 15 minutes
in a large number of normal subjects was determined
for comparison with the disease groups.
In a further group of patients (group 2) with
rheumatoid arthritis the relationships between
clinical assessment of the joint and concurrent
estimations of 99 mTc count rate and 133 Xe c l e a r a n c e
rate were also investigated.
MATERIALS ATTD METHODS
qROU? 1
P a t i e n t s  S t u d ie d
131 knee joints of 66 patients with "classical" 
or "definite" rheumatoid arthritis (Ropes et al.f 
1959) were studied, 54 were female and the mean 
age of these patients was 51*4 years (range 17 to 
71 years), 26 of these patients had previously been 
subjected to the operation of anterior knee 
synovectomy at varying time interval© (mean 32-8 
months - range 8 to 61 months) prior to these studies 
38 studies were conducted on the knee joints of 
19 patients with osteoarthritis. All exhibited 
both clinical and radiological evidence of involve­
ment of the relevant joint and serological tests for 
rheumatoid factor were negative, 16 of these 
patients were female and their mean age was 65*8 
years (range 54 to 92 years).
A l l  o f  t h e s e  p a t i e n t s  w ere  s e l e c t e d  from t h e  
O u t p a t i e n t  C l i n i c  a t  th e  C e n tr e  f o r  R heum atic  
D i s e a s e s ,  G laeg ow , on th e  b a s i s  o f  c e r t a i n t y  o f  
d i a g n o s t i c  c a t e g o r y ,  a v a i l a b i l i t y  f o r  s t u d y  and  
f r e e l y  g i v e n  c o n s e n t  by t h e  p a t i e n t .  No s e l e c t i o n
on the basis of severity of involvement was 
imposed and these studies were conducted between 
December, 1969 and April, 1970,
The results of these studies were compared 
with the results of 20 identical studies performed 
in volunteer hospital personnel and in medical 
student®. None of these subjects had either past 
or present clinical evidence of involvement of the 
joint in any traumatic or inflammatory disease 
process. Fourteen of these subjects were female am 
their mean age was 29 years (range 18 to 48 years). 
Both knee joints of each subject were studied.
Repeat studies were conducted at 2I4 hours in 
9 normal subjects and 11 patients with rheumatoid 
arthritis and within 30 minutes in 3 normal subjects 
and 5 patients with rheumatoid arthritis to 
determine the reproducibility of the method.
Clinical score
Clinical knee assessments ("clinical score") 
v/ere conducted by the same physician prior to each 
isotope study. A history of pain and of stiffness 
was elicited and graded. The knee joint margin 
was subjected to firm pressure and the response
.533.
graded. An assessment of soft tissue swelling. . j * •
(w h e th e r  due t o  f l u i d  o r  t o  s y n o v i a l  h y p e r tr o p h y )  
w as g r a d e d .  G rad in g  was on a 0 t o  3 b a s i s  where 
0 * a b s e n t ,  1 e  B l i g h t ,  2 » m o d e r a te  and 3 s  
s e v e r e .  The maximum t o t a l  s c o r e  f o r  an  
i n d i v i d u a l  J o i n t  was t h e r e f o r e  +12.
T ech n etiu m  S t u d i e s
The isotope was administered intravenously, 
the dose being standardised by count rate 
(10,000 counts per minute ^ 2% at 16 inches from 
the detector -f50yCi) and the count rate over the 
joint was monitored by a thallium activated 
sodium iodide scintillation crystal and photo­
multiplier (Ekco M.5400A/1) placed vertically 
above and 1/4" from the skin over the patella. 
Pulses were fed through a pulse height analyser 
and ratemeter (Ekco M.5183A) and displayed on a 
Kunzle digital print-out. . Monitoring commenced 
two minutes after injection and was continued for 
15 minutes. The count rate was recorded at that 
time in all studies and expressed as a percentage 
of the administered dose following comctions for 
counting geometry and background ( 2% count rate). 
At the conclusion of each study the count rate over
the site of injection of 99 mTc was monitored and 
compared with the count rate on the same area of 
the opposite arm to exclude extravascular 
deposition of some of the dose (page 2.$! ).
R e p e a t  S t u d i e s  .
In 9 normal subjects and in 11 patients with 
rheumatoid arthritis identical studies were 
performed on a second occasion 2k hours later. In 
a further three normal subjects and five patients 
with rheumatoid arthritis, immediately following 
the first isotope study a further dose of 
approximately 250 yCl was injected intravenously 
and the count rate again monitored for 15 minutes. 
The second dose was also standardised by count 
rate (50,000 counts per minute - 2% at 16 incheB 
from the detector) and therefore both the first and 
the second 15 minute count rates over the joint 
could be related to the count rate administered.
For comparison, the second readings were converted
to an equivalent of 10,000 counts per minute at 
16 inches.
Patients Studied .
A further group of 16 females and 6 male 
patients with "classical" rheumatoid arthritis 
(Ropes et al., 1959) were studied. Their ages 
ranged from 36 to 62 years with a mean of k5*7 
years. Each wae carefully selected for study
, • \  V  ->Y' * C: ■ J ' •. ' • '-r' . , » ' /." 1on the basis of severity of involvement in 
addition to the criteria applied in selecting the 
first group and consequently the period of time 
required for their collection was longer (January, 
1969 to August, 1969)* Clinical assessment wae 
performed by the same physician prior to each
study in the manner previously described.• - * • . ■ •
V- • ’ • •; * ,J ~Ji\, r * /•, . r - \ * *'
Concurrent 133 Xe and 99 mTc Studies
Immediately following the performance of the_V '-i y ■ -■* i • -kf"' - ■ \ . • ' . •
clinical knee score the patient was positioned 
lying supine with the knee joint exposed and 
extended. Employing full aseptic precautions 
a narrow gauge needle wae inserted into the joint 
cavity by a medial infra-patellar approach and 
any free fluid present was aspirated. A sterile 
airfree solution of 133 Xe in 0.5 nil. of sterile
GROUP 2 .
3 37
0.9% NaCl wae slowly Injected into the joint cavity. 
The needle wae withdrawn and the wound sealed with 
adhesive tape.
The detector was positioned vertically above 
and 3 inches from the skin over the patella. The 
99 mTc solution ( 5 0 ,0 0 0  counts per minute i 1% a t  
12 inches from the detector^ I*0 0  j*Ci) was injected 
intravenously and the 99 mTc count rate was 
monitored for 15 minutes through the system 
previously described. The 133 Xe pulses were 
conducted through a  second pulse height analyser 
and ratemeter (Kkco M .5010)
suitably adjusted to the counting conditions for 
133 and were displayed on a direct writing pen
r e c o r d e r  ( S m it h f s  S e r v o s c r i b e  2 ) .
A f t e r  c o r r e c t i o n s  f o r  back grou n d  (1% c o u n t  
r a t e )  i s o t o p e  d e c a y  and o v e r l a p  o f  t h e  h ig h e r  e n e r g y  
99 mTc o n to  t h e  133 Xe c h a n n e l ,  t h e  99 mTc c o u n t s  
w ere  p l o t t e d  l i n e a r l y  a g a i n s t  t im e  and t h e  15  m in u te  
c o u n t  r a t e  was r e c o r d e d  w h i l e  t h e  133 Xe c o u n t s  w ere  
p l o t t e d  s e m i l o g a r i t h m i c a l l y  a g a i n s t  t im e  and t h e  T£ 
v a l u e s  w ere  o b t a i n e d  from t h e s e  g r a p h s .
'TIME IN MINUTES
1 &  I
■'* isS&Wii
y
Logend to Fig.7
The mean and 2 standard deviations fron the mean 
of the results obtained in all the normal subjects.
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The results are shown in Fig. 7 and Tables 17
' . * ' ' ■ . • • .* 1 
to 20.
The mean i 2 standard deviations from the mean 
99 mTc count rate at increasing times after injection 
are shown in Fig. 7* Table 17 shows the paired 
values obtained on the same and on successive days 
in normal subjects and in patients v/ith rheumatoid 
arthritis.
The mean and S.E.M. of the 99 mTc uptake in the 
different disease groups studied, together with the 
values obtained in normal subjects are shown in 
Table 18. The values in synovectomised (mean 78.0 
- S.E.M. 3*7) and in unoperated patients with 
rheumatoid arthritis (mean 90.6 - S.E.M. 3»2) were 
significantly higher than the values obtained either 
in patients with osteoarthritis (mean 63.3 - S.E.M. 
2.3) or in normal subjects (mean 57*8 i S.E.M. 1.3). 
There was no significant difference between the
values in normal subjects and in osteoarthritis, but
* ■ . • « * , •* , * •• ■ . * * .
the values obtained in synovectomised patients were 
significantly lower than were the values obtained in 
unoperated patients with rheumatoid arthritis.
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TABLE 
XIX 
- 
CORRELATION 
BETWEEN 
CLINICAL 
FINDINGS AND 
"^'Tc 
COUNT 
RATE 
(Gr6up 
1)
•3>3Q
' * ' '
* _' • ’i. \* • , * , A * .}•,«* 'V^uJ ^ ’! . . ’ * ■’ ">*•/ ? .
The values obtained for total clinical score 
in both osteoarthritis (mean 5*2 - S.E.M* 0.51)
' .« •*•' '■'* '* *• *.j? ' v*' ,A' s V ♦ ‘ ’ 4’* • • • ' • -and unoperated patients with rheumatoid arthritis 
(mean 5*17 -* S.E.M. 0.34) were significantly higher 
than the values obtained in synovectomised patients 
with rheumatoid arthritis (mean 3»9 - S.E.M. 0.42). 
There was no significant difference between the 
values obtained in osteoarthritis and in unoperated 
patients with rheumatoid arthritis. The mean and 
S.E.M. of the Individual components of the clinical 
score are also shown in the table. J
The relationship between the total clinical 
score and its individual components and the 99 mTc 
uptake at 15 minutes after injection are shown in 
Table 19. In osteoarthritis the relationships 
between pain and uptake (r * 0.43)1 swelling and 
uptake (r « 0.36) and total score and uptake 
(r s= 0.43) were significant. The relationships 
between tenderness and uptake (r *= 0.28) and 
between stiffness and uptake (r = 0.24) were not 
significant. The corresponding *r* values in 
synovectomised patients with rheumatoid arthritis 
for pain (r = 0.39)» swelling (r = 0.39) and total
T
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v 
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Count 
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0.89 
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0
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X U Q
score (r * 0*34) and uptake were also significant 
and again the relationships between tenderness 
(r *b 0,16) and stiffness (r « 0*06) and uptake were 
not significant. In unoperated patients with 
rheumatoid arthritis the relationships between pain 
(r = 0.35), tenderness (r « O.Zf8), swelling (r = 0,53) 
stiffness (r = 0,24) and total score (r = 0,52) and 
uptake were all significant. The relationship 
between the total scores in unoperated patients 
with rheumatoid arthritis which gave a total of more 
than 6 and the 99 mTc uptake was significant 
(r = 0.34)*
The results obtained in the second group of 
patients with rheumatoid arthritis are shown in Table 
20, The mean and S.E.M. of the values for pain, 
tenderness, swelling, stiffness and total knee score 
were Z.b - 0.15; 1.9 - 0.19; 1.7 - 0.23; 1.8 - 0.26 
and 7*8 i 0.63. The relationships between clinical 
knee score and 99 mTc count rate (r = 0.89), between 
clinical score and Ti value (r = 0.63) and between 
Ti value and 99 mTc count rate (r » 0.58) are 
significant.
i U -
■* ' • ' * .
Discussion .
Although other radioactive isotopee have been 
employed in articular scanning studiee (Danieleson 
et al., 1963 1 Fellander and Lindberg, 1966 : 
Rolopainen and Rekonen, 1966 t Bauer, 1968 :
Kettunen and Rekonen, 1968 : Bauer and Smith, 1969), 
radioactive technetium offers the particular 
advantage of low radiation hazard (Smith, 1965 : 
Anon., 1968 : McCarty, 1970a). This hazard may be 
even further reduced by the very low doses ( 50 Ci) 
employed in the present study which is made possible 
by the use of external directional counting as 
opposed to articular scanning. The technique 
sacrifices the advantage of localisation of uptake 
within the joint. Provided however that only 
quantitative information on the joint as a whole is 
required, for example in following anti-inflammatory 
drug effect, the advantage of repeated measurement 
may outweigh this disadvantage. The count rate 
over the joint is reproducible both from day to day 
and when repeat measurements are made on the same 
day (Table 1). At the time chosen for deteminatioi 
of count rate (15 mine.) it would appear from the 
elegant studies of McCarty et al., (1970a) that 
these isotope studies are providing a measure of
vascularity.
McCarty et al., (1970a) have studied the 
distribution and protein binding of 99 mTc and 
have attributed the basis of "early11 and "late" 
maximal visualisation (page 2-^1) to vascularity on 
the one hand and to the binding ability of inflamed 
tissue protein on the other. The term "vascularity* 
includes the vascularity of juxta-articular bone, 
peri-articular soft tissue, skin and patella in 
addition to synovium. The relative contributions 
of these various components remains to be 
determined. However, from the marked changes 
induced by anti-inflammatory therapy (page 3^ *1.), it 
would seem reasonable to propose that a large 
proportion of the total is contributed by synovium 
and peri-articular tissue.
Since counting equipment and conditions vary, 
each laboratory must establish its own normal range 
and to this purpose we have studied a large number 
of normal subjects. The mean and two standard 
deviations at increasing time intervals following 
injection are shown. In an analogous manner to that 
employed in radioisotope thyroid tests the count 
rate has been expressed as a percentage of the
3 L X
administered dose. If results are expressed as
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percentage uptake then comparable values should be 
obtained by different laboratories. This may 
prove to be an advantage of the present technique 
in routine clinical practice.
The patients studied in the first group, 
although selected in terms of attendance at a *- .•/. * ' . - • ‘ ' i i m ’ *• .' V. * v" / • . • . , >, " v \ * .'V.,. • : v ■ ' * C- '1-.»''*• ^  ' w.'Rheumatology Centre, were not thereafter further
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selected in terms of disease severity. Inclusion 
in this group was determined by freely given consent, 
availability and certainty of diagnostic category.
The values obtained for 99 mTc uptakes in both 
synovectomised and unoperated patients with 
rheumatoid arthritis were significantly higher than
• ' - ' . ' ■ . . -V ■ ' * ' ■ • ■■ •„the values obtained either in osteoarthritis or in
. . • .
' ’ . 14 '* ■ , ' ■ |normal subjects. Although the mean value obtained 
in osteoarthritis was higher than that obtained in 
normal subjects this difference was not significant.
Assuming that the 99 mTc count rate reflects
. • * ’ * • •  . * , f ’ • ' ' >
vascularity, these studies are in accord with the 
pathologies of the respective diseases. Thus it 
could be anticipated that such a parameter would be 
elevated in the disease with the most marked
- ; ' V  . - % . V "  • V  * y  - ‘  , > < 1 4 * v
inflammatory component. . .
It is interesting to compare these findings 
with the results obtained with the 133 Xe clearance 
technique (Chapter 6). In both the difference 
between normal subjects and patients with rheumatoid 
arthritis is marked# In both there is a difference 
between patients with rheumatoid and with osteo­
arthritis. However, whereas with the 133 Xe 
technique there is a significant difference between 
normal subjects and patients with osteoarthritis, 
the difference is not significant by the 99 mTc 
method. It should first be emphasised that direct 
comparison between the two studies is not possible 
since there were differences between them both in 
terns of time of study and in terms of patient 
selection. However, both studies incorporated 
large numbers of patients which would to some extent 
reduce the differences and the assessing physician 
was the same in both studies. A further difference 
between the results obtained by these different 
ieotopic techniques lies in the studies on 
synovectomised patients with rheumatoid arthritis. 
Whereas the results obtained by the 133 Xe clearance 
technique demonstrated no difference between operated 
and unoperated patients, the results obtained by 
the 99 mTc method show reduced values in operated
patients* Again, however, the studies cannot be 
directly compared for similar reasons. These 
differences however may be related to the 
differences in the two techniques* Whereas on 
the one hand the 133 Xe clearance technique provides 
a measure only of synovial tissue perfusion, the 
results obtained by the 99 mTc method provj.de an. 
index of vascularity of all tissues beneath the 
detector. It is therefore possible for example 
that in osteoarthritis, synovial perfusion may be 
elevated producing an increased 133 Xe clearance, 
rate, but the peri-articular tissue may be less
'**.•5 . ' . t 'j . .
N^l*. Vr \ - ^  . ' ' V if : * * *r’ -* * - '* ' . . ' rn * • '•* a, *'iseverely involved resulting in less elevated 99 mTc 
uptakes. Similarly, in synovectomised patients 
with rheumatoid arthritis the synovium may be 
vascularly abnormal producing an increased 133 Xe" „ . 5 •- . ■
clearance rate, but the peri-articular tissues may 
be less severely jjivolved resulting In 99 mTc
’ - • - ■ Vr . > ' • M  k *■ ''* ** ' ' V'i . V  A  T '4“ ‘ ' • * .* ■. . . -*> • * w ■' . ^  *» '. • ■ ~ • v  - . ' ■ ,'y f'~\ a  . ' %• *. ■ •«« *
uptake which is pathologically elevated but lower
~ . . * ' • ' . *. * * -, • ’ • * ' • *.;V- '* ><*
than that obtained in unoperated patients. There 
is however no means of establishing this hypothesis 
at present and although attractive, the idea must be 
regarded as conjectural.
The relationship between the individual 
components of the clinical knee score and the 
99 mTc uptake was also studied. In both osteo­
arthritis and in synovectomised patients with 
rheumatoid arthritis the relationships between paii 
and uptake, swelling and uptake and total score an< 
uptake were significant whereas the relationships 
between tenderness and uptake and between stiffness 
and uptake were not. In unoperated patients with 
rheumatoid arthritis, in which the number© studied 
were larger, all relationships were significant. 
These results suggest that both pain and swelling 
are more discriminating variables with regard to 
99 mTc uptake than are either tenderness or 
swelling. The better relationship to swelling is 
easily understood in terms of 99 mTc uptake as an 
index of vascularity. The reason for the 
relationship to pain is less obvious. It is 
possible that the same chemical mediators of 
inflammation which produce pain also produce an 
increase in vascularity, however, there is 
insufficient information on this topic at present 
to sustain valid conclusions. It should be noted, 
however, that although statistically significant 
the *rf values obtained in this group of patients 
are of the order of O.i* to 0.5* This suggests
that only approximately 16 to 25% of the relation­
ship is accounted for by the variables studied
p(r = coefficient or "index" of determination).
The biological significance of these results is 
therefore limited and other variables neither studied 
nor identified are of importance.
The second group of patients reported in this 
study were selected rather differently from the 
first. Thus in addition to the criteria previously 
applied the knee joint was obviously severely 
involved in the disease process. The difference in 
severity of disease is shown by the difference in 
their mean total scores (5.17 group 1 and 7,8 group
2), Furthermore, although the assessing physician 
was the same, the studies were not conducted 
contemporaneously. There were differences in the 
methodology due to the necessity of employing higher 
doses in the double isotope studies. However, it 
would have been possible to apply a correction factor 
for this. In balance it was felt to be unjustifiable 
to include the results obtained with the first group 
reported.
Although direct comparison is invalid, the 99 mTc
count rates obtained were of a higher order of 
magnitude than those obtained in normal subjects 
when suitably corrected for counting geometry and 
the Ti values were also less than those obtained in 
normal subjects (Chap, (o ), denoting increased
 ^ r » » .
clearance rates and synovial perfusion rates in 
thl6 group of patients. The relationship between
the T-J value and the clinical score (r » 0.63) is
• '  . . ’ • _ • . "  •
significant and accords well v/ith that obtained in 
a previous study (Chap. ^ : page 'i^ T). The 
relationship between the 99 raTc count rate and Ti 
value is also significant. Surprisingly, the *rf 
value between total clinical score and 99 raTc count 
rate (r = 0.89) ie very much higher than that 
obtained in the patients in the first group studied. 
McCarty et al., (1970b) have also noted a highly 
significant relationship between clinical assessment 
and 99 mTc "photoscans". Why then should the 
relationship between these variables be so different 
in different studies? In the present study the 
striking difference between the two groups of 
patients is the severity of local disease shown by 
the difference in mean total knee scores. However, 
when those knee scores from the first group in
excess of 6 were separately related to 99 mTc 
uptake the •r* value (0.34) was no higher than for 
the group as a whole. The difference therefore 
cannot be directly related to severity alone.
Since pain and swelling appeared to be the more 
discriminating variables in the first group studied, 
a further possibility remained that a difference 
existed in the relative contributions of the 
discriminating components of the total score in the 
two groups. However, consideration of each 
component of both groups as a percentage of the 
total score reveals that this is not the case. It 
is not possible to explain the discrepancies from 
the facts available. . It would seem however that 
the 133 Xe clearance rate, 99 mTc studies and the 
clinical score each provide information on different 
but related aspects of the inflammatory response. 
Each must be considered complementary and not to 
replace the other. The 99 niTc uptake will probably 
be of most value in assessment of disease severity 
and of response to treatment.
SUMMARY
1) 99 niTc uptakes in synovectomised and unoperated
patients with rheumatoid arthritis were higher than 
those obtained either in osteoarthritis or in 
normal subjects.
2) 99 mTc uptakes were lower in synovectomised
than in unoperated patients with rheumatoid arthritis.
3) The values for pain, swelling and total clinical 
score were more closely related to 99 mTc uptake 
than were the values for tenderness or stiffness.
4) There is a relationship between 133 Xe Ti value,
V 199 mTc uptake and clinical score. The degree of 
significance of the relationship varies with 
different groups of patients studied.
ANION TRANSPORT FROM THE SYNOVTAL CAVITY
In the concluding section of this thesis I 
have employed 133 Xe and 99 mTc together in an 
attempt to delineate the mechanism of removal of 
anions from the articular cavity. The results 
show that an anicn transport mechanism across the 
synovial membrane exists and suggest that the 
mechanism is an active one.
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Introduction
Although the clearance rates of several small
molecular weight substances from the synovial
cavity have previously been studied (Harris and
Millardt 1956 s Laing and Kimt I960 : Hernborg,
1969 and Chapter l)y the mechanisms involved have
received less attention* Whereas there Is some
evidence to support the relationship between the
133 Xenon clearance rate and local tissue perfusion
(Chapter 2)# the assumptions Involved In relating
the clearance rates of the Ionised radioisotopes
and blood flow Is less securely based* Laing and
Kim (I960) have noted that the clearance rate of 
131the anion ^ Iodine was faster than the clearance 
rates of the cations or but were unable
to explain these differences*
In the present study the clearance rates of 
Ionised radioisotopes have been compared to the 
clearance rate of simultaneously Injected inert 
133 Xe both in the presence and in the absence of 
potassium perchlorate In an attempt to define
further the mechanisms involved.
33“ 3
MATERIALS AND METHODS
Experiments were conducted on both etlfle joints 
of anaesthetised adult greyhound dogs weighing from 
20 to 36 kg. at the Wellcome Surgical Research 
Institute. Anaesthesia was Induced with sodium 
thiopentone (20 mg/kg*) and maintained through a 
Starling respiratory pump and Boylefs anaesthetic 
machine with a 5i3 mixture of nitrous oxide and 
oxygen and 1% trichloroethylene. Monitoring was
accomplished by periodic determinations of blood 
gasesf pulse rate and blood pressure. When the 
animal was anaesthetised and In position, a fine 
guage needle was introduced into the stifle Joint 
cavity and the position checked by the aspiration of 
synovial fluid. The volume of synovial fluid 
aspirated was noted and the volume of subsequent 
isotope solutions was adjusted to approximately 
equal the volume aspirated.
A detector (Bkco 5590) was positioned directly 
above and 1 cm. from the skin over the patella and 
pulses were fed into a pulse height analyser and 
ratemeter (Ekco 1750) which was suitably adjusted 
to the counting conditions for the different isotopes
studied and continuously recorded on a Rikadenki 
chart recorder (B.24)« Room background (of the 
order of 1 to 2% of the total count rate) was 
recorded at the beginning and end of each experiment 
and overlap of the higher energy radioisotopes onto 
the lower energy channel was calculated at the 
beginning of each experiment. The radioisotopes 
employed (133 Xe, 21* Na, 131 I and 99 mTc) were 
obtained from the Western Infirmary, Qlasgow.
In three preliminary experiments, 133 Xe wae
injected in the first with 24 Na, in the second with
99 mTc and in the third with 131 I and the count
rates of each isotope pair were monitored
alternately for 10 minutes each .from 0 to 60 mins.
after injectic
The design of succeeding experiments with the
Isotope pairs 133 Xei 131 I and 133 Xe* 99 mTc were 
identical. Both isotopes were injected into the 
first stifle joint studied and the count rates of 
each monitored alternately for 8-10 minutes, for 
50 to 60 minutes. Potassium perchlorate (lg. in 
50 ml.) was then injected intravenously and 30 
minutes later Identical doses of both Isotopes were 
injected into the opposite stifle joint. The
count rates of each were again monitored 
alternately for 8-10 minutes, for 50 to 60 minutes. 
Ti values were obtained from the semilogarithmic 
plots of the count rates. In four experiments 
with the isotope pair 133 Xe I 99 mTc, the animal 
died between the periods of study of each joint.
A total of 13 experiments with 133 Xe * 99 mTc 
alone, 9 experiments with 133 Ce : 99 mTc following 
perchlorate, 6 experiments with 133 Xe * 131 I 
alone and 4 experiments with 133 Xe t 131 I 
following perchlorate were conducted in this 
manner.
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RESULTS
The results are shown in Tables21 and 22.
The Ti value obtained in the three preliminary 
experiments were 57 and 81 minutes for 133 Xe and 
24 Naf 42 and 30 minutes for 133 Xe and 131 It and 
69 and 23 minutes for 133 Xe and 99 mTc respectively. 
Thus whereas the clearance rate of 24 Ra was slower 
than that of 133 Xe, the converse result wae obtained 
for both 131 I and 99 mTc, both clearance rates 
being faster than that of simultaneously administered 
133 Xe.
Tabled, shows the Ti values obtained alternately 
for 133 Xe and for 99 mTc at the time periods 0 to 
10, 10 to 20, 20 to 30, 30 to 40, 40 to 50 and 50 to 
60 minutes after injection in the 13 experiments in 
which these isotopes were injected alone and in the 
9 experiments in which the Isotopes were injected 
into the opposite stifle joint following an 
intravenous injection of perchlorate. In the 
absence of perchlorate the Ti values obtained at all 
times for 99 mTc were less than those obtained for 
133 Xe denoting faster clearance of the anion.
- . * . f ' V  . ) , ‘ ' v - , v ‘ , y .  ,, . /  - t i  ’ . ; / • ' .  » _ . Jr , , -r ‘ - • ' \f > ‘ ’  * " **
O N
l
t“ * H  
OH VC 
t-» A
cr < o 91 
*+
cr c
3."
c t  Cb
D* •  
ti
s s
Du A  Cb3- 9ct- »-■
cr ct­
o  a  
C *1 
«♦ n  SB
(B c t  
•
H­O P> 
►1 e t
D cr c-t. •
o  ®
30'St* tl
t-*■s a 
2 B
cr p
t-* •-% 
o  c t  ►1 •  P tic t
.• 5­
C l.
O
9
a.
»-*•
o
CD
c t
A
O.
OH
OH
ICl>
t-»  OH
M  >4 
A
P“ 
O n I
Os
I vn
p ­
O n I
O N  
I M
P“ 
NO I
O N
I ro
NJ1
t-» Ol
H  X  
A
. 8
\S .
- J
I - o
on 
O  I
I I
I I
t~* OH
M X  
A
O n 
I O
O n I
. P
rovo I
O n 
I O n
OH
M  I
O n  
I ro
O n 
O  I
O n  
I OH
O n  
CD 1
on
I V J\
P“ I
t-» OH
H  >4
I ro
O N  |
OO I
I I
a  1
P" 
I O N
on 
O  I
p ­
I ON
on 
on 1
ro
t-> 0*1
M  >4 
A
ro 
ro 1
OH
I o h
ro
P~ I
I  00
P­
I O N
P ­
On I
P ­
I o
on 
o  1
p­
I ro
P­
I ro
t-» OH 
M  >4
O n 
I O
h-> |
O n
I ro
P­
O  I
O n 
I t-«
on I t-*
on 
I ro
O N00 |
on I O
On00 I
P
o
p
ro
o
roP
t
P­P
on
o
on
t
?
t-*
o
p
ro
o
ro
p
s
f
p ­
p
on
O
on
I
Conversely, however, following a preliminary 
injection of perchlorate the Ti values for 155 Xe 
were less than those obtained for 99 mTc denoting 
slower clearance of the anion*
Table 22 shows the Ti values obtained alternately 
for 135 Xe and for 131 I at the same time periods 
following injection in 6 studies in which the 
isotopes were injected without and in k studies in 
which they were administered following the prior
f - »>'-«% - . ' * . . . . ’ ' ■. . » • •'
r :',-V ■' • *.**7 9 ■>' V -•* * ’• r,:,‘ . • v; ^
administration of perchlorate.
Whereas the Ti values for 131 I are all less 
than the corresponding values for 133 Xe in the 
absence of perchlorate, when perchlorate had 
previously been injected, the converse was found in 
all cases, the Ti values for 133 Xe being less than 
those obtained for 131 !• Similarly, therefore, 
the clearance rate of 131 1 exceeds that of 133 Xe 
in the absence of, and is less than that of 133 Xe 
in the presence of perchlorate.
The results of this study show that whereas 
the rate of Na clearance from the articular
.  ' ’ ‘ ' * •- -*V* -• ’ . , . » r ; t • ’
cavity is reduced when compared with simultaneously 
monitored 133 Xe, the clearance rates of both 99 mTc 
and 131 I are faster than the 133 Xe clearance rate. 
These results are in accord with those of Laing and 
Kim (i960) who demonstrated slower clearance of 
cations than anions.
However, when the clearance rates of 131 I and 
99 niTc are compared to that of simultaneously 
administered 133 Xe following perchlorate the rate 
of clearance of both anions was reduced when 
compared with that of the inert 133 Xe. These 
results suggest the presence of an anion transport 
mechanism from the articular cavity through the 
synovial membrane to the synovial blood vessels. 
Although anion movement in these studies is clearly 
taking place in the direction of a concentration 
gradient perchlorate inhibition supports the 
contention that this is an active process* It 
remains possible, however, that the anion transport
DISCUSSION : , ;
system is dependent upon active cation transport* 
This possibility remains to be studied at a more 
fundamental laboratory level*
The discovery of one transport mechanism in 
the joint may well presage the delineation of 
others and lead to a fuller understanding of ion 
fluxes across the synovial membrane.
The rate of clearance of the cation 24 Na was 
slower than the clearance rate of the inert 
reference radioisotope 133 Xe,
The clearance rates of both anions, 131 I and 
99 mTc, exceeded the 133 Xe clearance rate in the 
absence of, and were slower than the 133 Xe 
clearance rate in the presence of pre-treatment 
with potassium perchlorate,
Thesd results suggest the presence of an 
anion transport mechanism from the joint cavity.
SUMMARY
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